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I Introduction 
Plants have been used in traditional medicines for thousands of years. It is estimated that 75% of 
populations in developing nations rely on plant-based medicine as their primary health care needs 
(Maroyi, 2013). Plant-derived products and secondary metabolites represent approximately 50% 
of drugs in medicinal markets. The last few decades has brought plant’s new function to produce 
heterologous proteins with the employment of recombinant DNA and protein technologies. Plants 
are currently used as a host for the production of biopharmaceuticals (Raskin et al., 2002; 
Schillberg et al., 2013; Egelkrout et al., 2012). 
I.1 Molecular farming 
The term Molecular farming or Molecular PharmingTM is defined as large-scale production and 
purification of pharmaceutically and commercially valuable proteins in transgenic plants or plant-
based systems (Franken et al., 1997). In 1986, human growth hormone was recombinantly 
expressed in tobacco plants and sunflower calluses (Barta et al., 1986). In 1989, the first 
functional antibody was produced in tobacco plants (Hiatt et al., 1989), which indicated that 
plants are able to assemble complex glycoprotein correctly. In 1990, the first full-size native 
human protein (human serum albumin) was produced in tobacco and potato plants (Sijmons et 
al., 1990). Since then, several pharmaceutical proteins were produced in plants including 
antibodies, blood products, cytokines, growth factors, hormones, recombinant enzymes, and 
vaccines (Twyman et al., 2005; Schillberg et al., 2013; Huang and McDonald, 2009). However, 
only two plant-derived pharmaceutical proteins (PDPs) have passed through regulatory approval 
so far. In 2006, the Dow Agrosciences LLC received United States Department of Agriculture’s 
(USDA) approval for a plant cell produced animal vaccine (Concert™) against Newcastle 
disease. In 2012, Protalix obtained a licensing right from United States Food and Drug 
Administration (USFDA or FDA) to commercialize ElelysoTM (taliglucerase alfa) for the 
treatment of adults with the type I Gaucher disease. Over the past few decades, the production of 
recombinant biopharmaceuticals in plants has been achieving broad acceptance (Schillberg et al., 
2013; Fischer et al., 2000; Giddings et al., 2001). 
 
Conventional production systems that use microbial fermentation, mammalian cell cultures, 
transgenic animals and insects hold drawbacks in terms of cost, scalability, and safety issues 
(Egelkrout et al., 2012; Paul and Ma, 2011; Xu et al., 2012; Swartz et al., 2001; Chu et al., 2001; 
Houdebine et al., 2000). Those systems have either limitation in production capacities or have 
particular risks for contamination with human pathogens. Thus, the interest to use plants as a 
production system is expanding to overcome some of the major constraints related to 
conventional systems. Albeit bacterial and fungal expression systems are fairly low-cost and 
potent technologies, they are not ideal to produce many mammalian proteins due to differences in 
protein processing, codon usage, and the formation of inclusion bodies. Moreover, they are not 
able to generate the correctly processed pharmaceutical proteins when particular post-
translational modifications are required. Several recombinant biopharmaceuticals are routinely 
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produced using mammalian expression system, because they can synthesize and process 
mammalian products properly. However, this system is expensive for large-scale production of 
therapeutic proteins. Plant expression systems bear convincing advantages compared to other 
systems. Plant cells can generate complex glycoproteins and do post-translational modifications 
similar to mammalian cells with minor differences. Plants are safer production system, because 
they are not host for human pathogenic microorganisms or prions (Egelkrout et al., 2012; 
Schillberg et al., 2013; Ma et al., 2003; Goldstein et al., 2004). In addition, edible plant organs 
can be employed for production of oral vaccines (Sala et al., 2003; Egelkrout et al., 2012).  
 
Four approaches have been developed to generate biopharmaceuticals in plant-based systems; 
plant cell culture, transient expression system by using Agrobacterium tumefaciens/plant viruses, 
expression in transplastomic plants, and expression in stably transformed plants (Fischer et al., 
2004). Plant cell cultures have several advantages over intact plants. They can be used as 
bioreactor when controlled and sterile conditions are desirable. Furthermore, the purification of 
secreted recombinant proteins is easier from plant suspension culture medium due to the 
reduction of contaminating proteins (Doran, 2013; Xu et al., 2011; Huang and McDonald, 2009; 
Ma et al., 2003; Okushima et al., 2000; Schillberg et al., 2013). To date, many 
biopharmaceuticals have been produced in suspension plant cells such as monoclonal antibodies 
and their derivatives, cytokines, hormones and enzymes (De Muynck et al., 2010; Whaley et al., 
2011; Schillberg et al., 2013; Fischer et al., 1999; Hong et al., 2002; James et al., 2001; Kwon et 
al., 2003; Magnuson et al., 1998). The tobacco suspension culture BY-2 cell line has been 
established from fragile callus tissues (Nagata et al., 1992) and been used as a bioreactor for 
production of various biopharmaceuticals (Huang et al., 2009; Schillberg et al., 2013; Fischer et 
al., 1999). 
I.1.1 Restrictions of plant cell cultures in biopharmaceutical production 
Although plant cell cultures have shown several advantages for production of biopharmaceuticals 
(I.1), there are some disadvantages of using this system. Minor differences have been seen in 
post-translational modification of proteins produced in mammalian and plant cells. The pattern of 
protein glycosylation through the secretory pathway is different between animal and plant cells 
(Figure I-1). The terminal galactose and sialic-acid residues are found in mammalian proteins 
(Figure I-1A), whereas these residues are absent in plant counterparts (Figure I-1B). Moreover, 
the carbohydrate group α(1,3)fucose and β(1,2)xylose are only present in plant proteins (Figure I-
1B). These slight differences in glycosylation pattern might cause pharmacokinetic differences. 
The possibility of allergic responses of plant-specific glycan structure has been studied (Lerouge 
et al., 2000; Gomord et al., 2010) and active antibodies against these residues have been found in 
human serum. These findings may indicate that α(1,3)fucose and β(1,2)xylose residues may have 
adverse reactions in humans (Bardor et al., 2003) and that the  presence of IgE antibodies 
directed against these epitopes may cause an allergic reaction (Gomord et al., 2010). 
Interestingly, from clinical trials of ElelysoTM it is obvious that a recombinant human 
glucocerebrosidase produced in carrot cells has no safety issues for clinical usage. This 
recombinant protein takes advantage of plant specific glycosylation pattern including mannose 
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terminated glycan, which is required for uptake by macrophages (Schillberg et al., 2013). 
However, several studies have been done to humanize the glycosylation patterns of plant derived 
pharmaceutical proteins (PDPs) (Nagels et al., 2011; Downing et al., 2006; Warner et al., 2000; 
Blixt et al., 2002; Bakker et al., 2001).  
(A)                                                                                   (B) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure I-1: Comparison of protein N-glycosylation in plants and mammalians. Schematic illustration 
of glycan structure in mammalian-derived proteins (A) and plant-derived proteins (B). The galactose, 
sialic-acid, and α(1,6) fucose residues are only found in glycan structure of mammalian-derived proteins, 
whereas the α(1,3) fucose and β(1,2) xylose residues are present in glycan structure of plant-derived 
proteins. N-acetylglucosamine and mannose residues are commonly seen in glycan structure of both plants 
and mammalian cells (green residues). Green residues are universal to plants and humans. Red and black 
residues are present in human and not plants. Yellow and purple residues are found in plants, not humans. 
Fuc, fucose; Gal, galactose; GlcNAc, N-acetylglucosamine; Man, mannose; NeuAC, acetylneuraminic 
acid (sialic acid); Xyl, xylose. (Ma et al., 2003; modified picture). 
 
The major drawback of plant cell cultures is low expression level of heterologous proteins such 
as biopharmaceuticals. This is due to the presence of proteases and potential occurrence of 
transcriptional and post-transcriptional gene silencing (Circelli et al., 2010). Plant proteases can 
degrade biopharmaceuticals either intracellularly along the secretory pathway and vacuole or 
extracellularly during secretion into culture medium (Sharp et al., 2001; Outchkourov et al., 
2003; Benchabane et al., 2008; Calinski et al., 2009; Doran, 2013; Schiermeyer et al., 2005). 
Moreover, biopharmaceuticals might be influenced by proteolytic degradation during extraction 
and downstream processing (Rivard et al., 2006).  
I.2 Plant proteases 
Proteases break down proteins by splitting peptide bonds between amino acid residues that can be 
internal (endopeptidases), N-terminal (aminopeptidases), or C-terminal (carboxypeptidases) (Van 
der Hoorn, 2008). Proteases play important roles in all aspects of plant growth and development. 
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They are involved in protein turn over and act as housekeepers to remove damaged proteins. 
Moreover, they function in cell division and differentiation, germination, senescence, 
programmed cell death and plant immunity (Shindo et al., 2012; Schaller, 2004; Shindo and van 
der Hoorn, 2008; Schiermeyer et al., 2009; Song et al., 2009). More than 700 proteases have 
been documented in the genome for Arabidopsis thaliana according to MEROPS database (Van 
der Hoorn, 2008), which are categorized over nearly 60 families. Proteases cleave peptide bond 
between amino acid residues with polarization of carbonyl groups using activated nucleophiles 
(Figure I-2). Accordingly, proteases have been grouped in seven catalytic classes based on 
catalytic residues acting as nucleophile: aspartic; asparagine; cysteine; glutamine; serine; metallo; 
and thereonine proteases (Rawlings et al., 2011). The major classes of plant proteases are 
aspartic, cysteine, serine, and matalloproteases. Serine proteases are the largest class of plant 
proteases including 200 members (Van der Hoorn, 2008). 
(A)                                                                                     (B) 
 
Figure I-2: Schematic illustration of hydrolysis mechanisms of different classes of proteases. A:  The 
proteases (black) bind to substrate proteins (red) to cleave peptide bond between amino acids. This 
process is mediated via substrate pockets (S) of proteases and amino acid residues (R) of substrate 
proteins. The proteases polarize scissile bonds by stabilizing an oxyanion hole, which causes the carbonyl 
group to be susceptible for the nucleophilic attack. B: The proteases have been classified in seven major 
classes according to the nature of the nucleophile (Van der Hoorn, 2008; modified picture). 
 
It was previously reported that the metalloprotease activity causes degradation of recombinantly 
produced DSPA-α1 (Desmodus rotundus salivary plasminogen activator alpha 1) in tobacco BY-
2 cells culture media (Schiermeyer et al., 2005). To better understand the influence of the plant 
proteolytic machinery in degradation of biopharmaceuticals produced in BY-2 cells, other 
endogenous tobacco proteases were cloned as follow: aspartic (NtAP1), cysteine (NtCP1), and 
serine (NtSP1) proteases. The biochemical characterization and subcellular localization of those 
proteases were done in the present thesis. This information can be helpful to increase the 
accumulation level of heterologous proteins in tobacco BY-2 cells. In the following subsections, 
the previous studies of these particular plant proteases will be reviewed. 
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I.2.1 Aspartic proteases 
Plant aspartic proteases (APs) have been categorized in five families according to MEROPS 
proteases database; A1, A3, A11 and A12, and A22. They are the second-largest class of 
proteases in the plant kingdom (Van der Hoorn, 2008). The majority of plant APs is placed in the 
A1 family. The members of the A1 family are active at acidic pH, their proteolytic activity is 
sensitive to pepstatin A (except the Arabidopsis AP encoded by the CDR-1 gene) and their 
catalytic domain consists of two aspartic residues which activate a water molecule as nucleophile 
(Dunn et al., 2002; Hill et al., 1997; Rawlings et al., 2012). The cleavage of peptide bonds 
commonly occurs between two hydrophobic residues (Phe, Val, Ile, Leu) or after one 
hydrophobic residue (Castanheira et al., 2005; Beyer et al., 2005; Bhatt et al., 2000; Turner et al., 
2001). In 1997, the name phytepsin was suggested to designate all related plant APs and was 
accepted by the NC-IUBMB (Nomenclature Committee of the International Union of 
Biochemistry and Molecular Biology) (Barrett et al., 1997). However, various names are found in 
the literature to denote plant APs based on the plant species or specific tissue from which enzyme 
is purified (Kervinen and Wlodawer, 2013). To date, several phytepsins have been purified and 
described from rice (Doi et al., 1980; Asakura et al., 1997), buckwheat (Belozerskii et al., 1984), 
squash and cucumber seeds (Polanowski et al., 1985), wheat (Belozersky et al., 1989), cardoon 
plant (Faro et al., 1995; Verissimo et al., 1996; Llorente et al., 2004; Sidrach et al., 2005), barley 
(Runeberg-Roos et al., 1991), Arabidopsis (Mutlu et al., 1998), potato (Guevara et al., 2001) 
sunflower (Park et al., 2000), from Centaurea calcitrapa (Raposo and Domingos, 2008), from 
Cirsium vulgare (Lufrano et al., 2012).  In vitro analysis showed that phytepsins cleave Brassica 
2S albumin (D’Hondt et al., 1993) and lectin (Runeberg-Roos et al., 1994; Mutlu et al., 1998). 
Therefore, it has been suggested that they might be involved in seed development and 
germination (Törmäkangas et al., 1994; Tamura et al., 2007). Moreover, phytepsins have 
functions in different plant physiological aspects such as programmed cell death (Runeberg-Roos 
and Saarma, 1998), flower development (Brodelius et al., 2005), and pathogen defense (Xia et 
al., 2004; Mendieta et al., 2006; Munoz et al., 2010). The milk clotting activity of two phytepsins 
(cyprosins and cardosins) from cardoon (Cynara cardunculus L.) flowers was described 
(Cordeiro et al., 1992 and 1994; Fernandez-Salguero et al., 2003). Flowers of cardoon have been 
traditionally used in cheese production in Spain and Portugal.  
 
Primary structure 
The general structure of plant APs (phytepsins) is typically similar to APs from microbial 
(bacterial and yeast) and mammalian cells. The primary structure of phytepsins comprises a 
signal peptide, propeptide of about 40 residues followed by the catalytic domain, which contains 
the plant-specific insert (PSI) domain (Kervinen and Wlodawer, 2013). The majority of 
phytepsins are produced as single-chain zymogens and then processed to the mature form. The 
mature phytepsins can be single or two-chain enzymes (Simoes and Faro, 2004). The propetide 
domain exists in all phytepsins, functioning in the activation process and correct folding of the 
enzymes (Koelsch et al., 1994). The PSI is an additional insertion of around 100 amino acids that 
is only found in plant APs and has high similarity with saposin and saposin-like proteins 
(Guruprasad et al, 1994; Runeberg-Roos et al., 1991; Frazao et al., 1999; Glathe et al., 1998; 
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Ramalho-Santos et al., 1998). However, it is known that the PSI is absent in some of plant APs, 
including a phytepsin-like AP from tobacco chloroplast nucleoids (Nakano et al., 1997) and 
nucellin from barley ovaries (Chen and Foolad, 1997). The biological roles of the PSI have not 
been completely known but it has been suggested that it might facilitate vacuolar targeting 
(Guruprasad et al, 1994; Kervinen et al., 1999; Terauchi et al., 2006; Duarte et al., 2008; Pereira 
et al., 2013). It has been shown that the PSI has a certain function in vacuolar targeting but the 
extra C-terminal extension is also essential for this process (Pereira et al., 2013). In addition, the 
two conserved catalytic residues (Asp-Thr-Gly and Asp-Ser-Gly) are found in the primary 
structure of numerous phytepsins belonging to the A1 family. 
 
Tertiary structure 
The X-ray crystal structure of two phytepsins have been determined including prophytepsin from 
barley (PDB code: 1QDM) (Kervinen et al., 1999) (Figure I-3) and mature cadosin A from C. 
cardunculus (PDB code: 1B5F) (Frazao et al., 1999). The mature form of both enzymes consists 
of two-polypeptide chains that are held together using hydrophobic interaction and hydrogen 
bonds. The structure of mature enzymes is bilobal with two similar glycosylated β-barrel 
domains. The catalytic sequence motifs (DTG/DSG) are located in each β-barrel domain in such 
a way that the two catalytic aspartic residues are accessible in the interdomain cleft for activation 
of the water molecule as nucleophile. Three conserved disulfide bridges are present to stabilize 
the overall structure of the enzymes. The propeptide and the first 13 residues of the N-terminus of 
the mature enzyme cover the catalytic site to keep the enzyme inactive. The PSI domain is 
inserted into the C-terminal extension to form an independent domain. The structure of PSI is 
composed of five α-helices that are folded into a compact entity using three disulfide bridges.  
 
Figure 1-3: Three-dimensional structure of prophytepsin from barley. Stereo ribbon diagram of the 
prophytepsin (PDB code: 1QDM). Catalytic aspartic residues are green, conserved Lys residue at the N-
terminal part of the mature enzyme is orange, plant specific domain (PSI) is pink, and six disulfide bridges 
are yellow (Kervinen et al., 1999, modified picture). 
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Processing and activation mechanism 
The phytepsins are initially produced as zymogen and then undergo N-terminal processing. Some 
of them undergo further internal processing to render mature enzymes. The PSI domain is 
commonly eliminated partially or completely during enzyme maturation resulting in two 
polypeptide chains (Glathe et al., 1998; Ramalho-Santos et al., 1998; White et al., 1999). The 
activation process of the enzymes relies on acidic conditions. The acidic condition triggers 
disruption of salt bridges between two highly conserved residues at the N-terminus of the mature 
enzyme (Lys and Tyr) and catalytic aspartic residues. This leads to detachment of the propeptide 
from the active site. Therefore, the acidic condition plays a role in activation and subsequent self-
processing of phytepsins (Kervinen et al., 1999; Park et al., 2001; Castanheira et al., 2005). 
Nevertheless, both autocatalytic and heterocatalytic steps are required for enzyme activation. The 
activation process probably relies upon both prevailing pH and the presence of processing 
peptidases in the endomembrane system (Kervinen and Wlodawer, 2013). In addition, processing 
of phytepsins occurs sequentially so that signal peptide, propeptide and the PSI are cleaved. 
However, the order of processing is different between cardosin A and barley phytepsins. In case 
of cardosin A, the propeptide is first removed (Ramalho-Santos et al., 1998; Castanheira et al., 
2005), whereas the PSI is first cleaved off in case of the barley phytepsin (Glathe et al., 1998). 
 
Intracellular transportation 
Phytepsins are predominantly destined to the vacuole (Guruprasad et al., 1994; Paris et al., 1996; 
Kervinen et al., 1999; Schaaf et al., 2004), but they have also been found in other intracellular 
compartments and in the extracellular matrix (Radlowsk et al., 1996; Kuwabara and Suzuki, 
1995; Prasad et al., 2009; Devaraj et al., 2008). Nascent phytepsins are translocated to the 
endoplasmic reticulum (ER) using a signal peptide. After cleavage of the signal peptide, these 
enzymes proceed to the Golgi apparatus where they are directed to their final destination. 
Vacuolar transportation of phytepsins is mainly mediated by the Golgi apparatus, trans-Golgi 
network (TGN), and prevacuolar compartment (PVC). For barley phytepsin, the NPLR-peptide in 
the propetide and also some regions in the PSI domain have been suggested as vacuolar sorting 
signal. The C-terminal extension also has been shown to function in vacuolar targeting 
(Dombrowski et al., 1993; Pereira et al., 2013). 
I.2.2 Cysteine proteases 
The Arabidopsis thaliana genome encodes around 140 cysteine proteases (CPs) that are grouped 
in 15 families in five clans (CA, CD, CE, CF, and CP) according to the MEROPS classification 
of peptidases (Rawlings et al., 2013). Clan CA and CE proteases have papain-like tertiary 
structure, but CD proteases have a caspase-like structure. These enzymes play important roles in 
plant physiology (programmed cell death, senescence, abscission, flowering, pollen or embryo 
development and germination) as well as plant immunity (pathogen defense) (Grudkowska and 
Zagdanska 2004; Van der Hoorn 2008; Martinez et al, 2012). The majority of plant CPs belongs 
to subfamily C1A and is explained here. 
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Plant C1A cysteine-proteases  
C1A cysteine proteases or papain-like proteases function in diverse processes of plants like 
senescence, abscission, programmed cell death (PCD), seed reserve mobilization, fruit ripening, 
and pathogen defense (Grudkowska and Zagdanska 2004; Van der Hoorn 2008; Martinez et al, 
2012). These proteases share universal features as follows. (1) Cysteine residues act as 
nucleophile; (2) they contain three conserved amino acid residues with the order of Cys, His, and 
Asn; (3) their activity requires normally an acidic pH optimum; (4) they have wide substrate 
specificity and are sensitive to cysteine proteases inhibitors e.g., E-64 and leupeptin (Diaz and 
Martinez, 2013). 
 
Primary structure 
The zymogen of C1A proteases contains a signal peptide, an inhibitory propeptide, a catalytic 
domain and a C-terminal region. The inhibitory propeptide comprises of 130-160 amino acids 
and the mature enzyme is around 220-270 residues long. The propeptide region includes an 
ERFININ signature observed in cathepsins L- and H-like or ERFNAQ found in cathepsin F-like 
proteases. The function of aforementioned motifs is not known and they are not found in 
cathepsin B-like proteases (Martinez and Diaz, 2008). Furthermore, some of the cathepsin L-like 
proteases have a C-terminal extension sequence, which contains a proline-rich region and a 
granulin domain (Yamada et al., 2001). This granulin domain presumably functions in activation 
and solubility of protease (Beers et al., 2004). The catalytic domain includes three highly 
conserved amino acids residues Cys, His and Asn and a Gln residue. Moreover, C1A proteases 
contain three disulfide bridges that are indispensable for correct folding.  
 
Tertiary structure 
The three-dimensional structure of plant C1A proteases is similar to the animal counterparts with 
globular protein structure. This structure includes two distinct domains forming a cleft at the 
surface. This cleft functions as substrate binding site (Kamphuis et al., 1985) (Figure I-4). 
 
Figure I-4: Three-dimensional structure plant C1A/ papain proteases. Stereo ribbon diagram was 
prepared from the Protein Data Bank entry (9PAP) using PyMOL software. Catalytic residues are located 
in cleft at surface of enzyme. This cleft acts as substrate binding site. 
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Processing and intracellular trafficking 
Plant C1A cysteine proteases are synthesized as zymogen and directed to the endoplasmic 
reticulum (ER) using an N-terminal signal peptide. The signal peptide is cleaved off and then 
these enzymes are transported via Golgi apparatus (G) and trans-Golgi network (TGN) to the 
vacuole or externally secreted (Martinez et al., 2009; Herman and Larkins, 1999). The C1A 
proteases activation occurs by limited intra-or-inter-molecular proteolysis to remove the 
propetide (Wiederanders et al., 2003). The C1A protease processing might occur auto-
catalytically in the acidic organelles (Martinez et al., 2012). Experimental evidence has  
demonstrated that the N-terminal propeptide of sweet potato sporamin and barley aleurain 
contain conserved amino acid residues (NPIRL/P) as sequence-specific vacuolar sorting signals 
(ssVSS) (Matsuoka and Nakamura, 1991). In addition, some members of C1A proteases carry 
H/KDEL as the C-terminal ER retrieval signal. An example is the cysteine protease from mung 
bean that plays an important role in seed germination (Toyooka et al., 2000). 
I.2.3 Serine proteases 
The Arabidopsis genome encodes more than 200 serine proteases (SPs), which are grouped in 14 
families of nine clans. SPs are the largest class of peptidases in plants. The majority of plant SPs 
belongs to families S8, S9, S10, and S33. These enzymes play important roles in all aspects of 
plant life. As an example, some of the subtilases (family S8, clan SB) have function in regulation 
of stomata density and distribution within the epidermis (SDD1) and are responsible for cuticle 
development during embryogenesis (ALE1). The members of serine carboxypeptidases-like 
proteases SNG1 and SNG2 (family S10, clan SC) act as acyltransferases in the biosynthesis of 
sinapoyl esters, which are involved in the protection against UV-radiation (Van der Hoorn, 
2008). The plant subtilases (Family S8, clan SB) are discussed below. 
 
Plant subtilases  
The name subtilases is derived from two subtilisins that are bacterial serine proteases from the 
Carlsberg and BPN’ strains of Bacillus subtilis (Smith et al., 1966). Plant subtilases are generally 
active at alkaline pH with broad substrate specificity (Schaller, 2013). However, a handful of 
plant subtilisins have an acidic pH optimum e.g., ARA12 (Hamilton et al., 2003). The plant 
subtilases are grouped in family S8 of clan SB (Rawlings et al., 2013). The cucumisin is the first 
purified and cloned plant subtilase gene from the sarcocarp of melon (Kaneda et al., 1975). The 
second identified plant subtilase is P69 from tomato leaves (Solanum lycopersicum) with a 
molecular mass of approximately 69 kDa. Experimental evidence indicated that this enzyme is 
induced during infection with tomato pathogens (Granell et al., 1987; Fischer et al., 1989; Christ 
and Mösinger, 1989). Further investigations revealed that six p69 isoforms are also present in 
tomato including P69A-F. P69A is expressed constitutively in all vegetative organs except 
flowers, whereas P69D is expressed in flowers and leaves. P69B and C are pathogenesis-related 
(PR) proteins, which are induced during pathogen infection (Pseudomonas syringe) or treatment 
with salicylic acid. P69E and F have different expression pattern in specific tissues and might be 
involved in basic metabolic functions (Jorda et al., 2000). To date, several plant subtilases have 
been identified in plant species including bryophyte (Physcomitrella patens, 23 members), 
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Arabidopsis (56 members), rice (63 members) and poplar (90 members) (Schaller, 2013). Various 
plant subtilases have been purified from plant tissues such as macluralisin from fruits of Maclura 
pomifera (Rudenskaya et al., 1995), taraxalisin from dandelion Taraxacum (Rudenskaya et al., 
1998), plantagolisin from leaves of common plantain (Bogacheva et al., 2001), subtilases from 
green malt (Fontanini and Jones, 2002), bean (Popovic et al., 2002), soybean (Beilinson et al., 
2002; Boyd et al., 2002), and Arabidopsis (Hamilton et al., 2003). These subtilases share 
universal features such as broad substrate specificity and are tremendously abundant. Therefore, 
it was estimated that they are involved in general protein turnover (Bogacheva, 1999). 
 
Primary structure 
All characterized plant subtilases are predominantly synthesized as zymogen, except AtSBT6.2. 
The zymogen consists of a signal peptide, a propeptide, a catalytic domain and a C-terminal 
domain. The N-terminal cleavable signal peptide targets the pre-pro-enzyme to the secretory 
pathway (Schaller, 2013). The propeptide acts as an intra-molecular inhibitor of enzyme activity 
as well as a chaperon needed for correct folding of the catalytic domain (Nakagawa et al., 2010; 
Zhu et al., 1989; Li et al., 1995). The catalytic domain contains catalytic residues (Asp, His, and 
Ser) in a typical subtilases order (Dodson and Wlodawer, 1998) and includes a protease-
associated (PA) domain with around 130 amino acids between the His and the Ser residues. The 
PA domain plays a role in ligand-substrate binding and protein-protein interaction (Luo and 
Hofmann, 2001; Lawrence et al., 1999). Experimental evidence indicated that this domain is 
required for enzyme activity of SBT3 from tomato and intracellular trafficking through the 
secretory pathway (Cedzich et al., 2009). The C-terminal fibronectin (Fn III)-like domain is 
attached to the catalytic domain functioning in activity of a few plant subtilases (Cedzich et al., 
2009).  
 
Tertiary structure 
The three-dimensional structure of two plant subtilases has been determined; tomato subtilases 3 
(SBT3) (Ottmann et al., 2009) and melon cucumisin (Murayama et al., 2012). These two 
enzymes show high similarity in terms of the tertiary structure. Both enzymes are folded into 
three domains; catalytic domain, protease-associated (PA), and C-terminal fibronectin (Fn III)-
like domain. The catalytic domain of both enzymes shows subtilase-like-folding including highly 
conserved twisted β-sheets flanked by α-helices. The PA domain contains three α-helices and 
nine β-strands. The crystal structure of SBT3 revealed that the PA domain has an important 
function in homodimerization. In case of cucumisin, the PA domain does not contribute to homo-
dimer formation. The C-terminal fibronectin (Fn III)-like domain consists of a stranded β-
sandwich structure (Figure I-5). 
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Figure I-5: Three-dimensional structure of plant subtilases (SBT3 and cucumisin). A: Stereo ribbon 
diagram of the tomato subtilase 3 (SBT3) monomer. The catalytic domain is red, and protease-associated 
(PA) domain is yellow, (Fn III)-like domain is dark blue (Ottmann et al., 2009; modified picture). B: 
Stereo ribbon representation of the cucumisin monomer (Murayama et al., 2012). The catalytic domain is 
green, protease-associated (PA) domain is yellow, and (Fn III)-like domain is blue (Murayama et al., 
2012, modified picture). 
 
Processing and intracellular trafficking 
In general, maturation of plant subtilases requires at least two processing steps to remove the 
signal peptide and propeptide. The propeptide of plant subtilases is cleaved off through auto-
catalysis (Cedzich et al., 2009). Some of the plant subtilases have to be further processed at the N 
and C-termini to render the mature form. Experimental evidence indicated that cucumisin is C-
terminally processed to produce a truncated version with a 116 amino acids deletion, whereas it 
retains activity (Yamagata et al., 1994). In case of SBT1, N-terminal processing was observed to 
eliminate 21 amino acids, and was shown to be essential for enzyme activity. This cleavage 
occurs auto-catalytically in acidic compartments and thus it is dependent on pH (Janzik et al., 
2000). From previous studies it is evident the tomato SBT3 secretes to the apoplast and its C-
terminal domain contains a secretion signal (Cedzich et al., 2009). 
 
Most of the therapeutic proteins produced in plant cell cultures pass through the plant secretory 
pathway and secrete into the culture medium. The plant secretory pathway consists of 
intracellular compartments including endoplasmic reticulum (ER), Golgi apparatus, trans-Golgi 
network (TGN), plasma membrane, and the vacuole (Kim and Brandizzi, 2014). The recombinant 
pharmaceutical proteins are degraded by the plant endogenous proteases while they travel along 
the secretory pathway, after secretion into the culture medium or when missorted to the vacuole 
(Pillay et al., 2014; Callis, 1995; Doran, 2006; Sharp and Doran, 2001; Schiermeyer et al., 2005; 
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Stevens et al., 2000; Yang et al., 2005; Hadlington et al., 2003). The activity of plant proteases is 
pH dependent and the plant cellular compartments have different pH (Martiniere et al., 2013). 
Therefore, a detailed elucidation of intracellular transport of proteases is desirable to determine 
the favourable cellular compartments for their activity. Here, the protein transport and 
intracellular trafficking in plant cells will be reviewed. 
I.3 Protein transport and intracellular trafficking in plant cells 
Plant intracellular trafficking has similar features as other eukaryotic cells including the same 
system for vesicle formation and fusion (the formation of coated protein I (COPI) vesicles 
contiguous with Golgi cisternae and the COPII vesicles required for ER export) (Nebenfuhr et 
al., 2000; Phillipson et al., 2001). However, the plant endomembrane system has unique 
characteristics such as abundant discrete Golgi stacks (Staehelin and Moore, 1995), several types 
of vacuoles (Jurgens, 2004; Jolliffe et al., 2005; Robinson et al., 2005; Mo et al., 2006), 
formation of transient compartments during cell division (Jurgens, 2004), the lack of transitional 
ER (Pavelka and Robinson, 2003), and the absence of an ER-Golgi intermediate compartment 
(ERGIC) (Neumann et al., 2003). The cargo proteins transport from ER to Golgi via bulk flow 
while cargo carrying H/KDEL attached protein retain in the ER (Boulaflous et al., 2009). Golgi 
apparatus functions as sorting station to separate receptor-mediated trafficking to the lytic 
vacuole from bulk flow to the plasma membrane. Plasma membrane proteins are recycled via the 
endocytic pathway from early endosomes (EE), which appear to be identical with the trans-Golgi 
network (TGN) in plant cells. Moreover, late endosomes (LE) correspond to the prevacuolar 
compartment (PVC), acting as an intermediate organelle between Golgi and vacuole (Jurgens, 
2004; Contento and Bassham, 2012). The function of different organelles in tobacco BY-2 cells 
membrane trafficking is described here.  
I.3.1 The endomembrane system of tobacco BY-2 cells 
The compartmentalization of plant cell requires the exchange of proteins, polysaccharides and 
lipids between different organelles using transport intermediates (Jurgens, 2004). The 
endomembrane system of tobacco BY-2 cells is composed of distinct membrane compartments 
including the endoplasmic reticulum (ER), Golgi apparatus (G), endosomes, and vacuole.  
 
Endoplasmic reticulum 
The plant endoplasmic reticulum (ER) is the first and the largest compartment involved in 
membrane trafficking. The nascent proteins are targeted to this cellular compartment by the N-
terminal hydrophobic signal peptide. After that, the signal peptide is eliminated by a luminal 
signal peptidase and soluble proteins are folded. The soluble and membrane-bound proteins are 
glycosylated in the ER. The proper folded proteins exit from the ER to the Golgi. ER-resident 
proteins are held or are recycled from the Golgi (Vitale and Denecke, 1999). Moreover, the ER 
isolates oil, rubber, and storage proteins by using ER-derived membrane compartments (termed 
ER bodies). The ER-bodies are delivered to the plant storage vacuole. This ability is unique 
distinct feature of the plant ER compared to the other eukaryotes (Chrispeels and Herman, 2000). 
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However, plant storage vacuole does not seem to be present in tobacco BY-2 cells (Robinson and 
Ritzenthaler, 2006; Jurgens, 2004).  
 
Golgi apparatus  
The plant Golgi apparatus is the key membrane compartment with multiple functions such as the 
cell wall polysaccharides and membrane glycolipids synthesis, proteins glycosylation, and 
proteins sorting towards the final destinations (Neumann et al., 2003). The Golgi stacks are 
passively mobile within the plant cells. This movement is essential for ER-to-Golgi transport 
(Boevink et al., 1998; Nebenfuhr and Staehelin, 2001). Three models have been suggested for 
proteins transport between ER and Golgi stacks: (1) vacuum cleaner, (2) stop-and-go, and (3) 
mobile export sites. In the vacuum cleaner model, Golgi stacks travel around the surface of the 
ER to capture cargo and thus the whole ER can export products to the Golgi (Boevink et al., 
1998). In the stop-and-go model, the ER contains fixed export sites in which the Golgi halts 
transiently and takes up cargo from the ER (Nebenfuhr et al., 1999). In the mobile export sites 
model, the Golgi and ER export sites travel together and exchange products during this 
movement (Brandizzi et al., 2002). In animal cells, ER-to-Golgi transport is mediated via the ER-
Golgi intermediate compartment (ERGIC). For this vesicular trafficking, cargo proteins travel 
between ER-to-ERGIC by using vesicular coat proteins (COPII) and then the periphery of 
ERGIC fuses to cis-Golgi cisternae for delivery. The GTPase Rab1 acts in the final step of cargo 
delivery and fusion to Golgi. The other set of protein-coated vesicles (COPI) function in 
retrograde transport between Golgi and ER (Schindler et al., 1993; Neumann et al., 2003). In 
plant cells, the ERGIC compartment has not been seen so far. Previous studies showed that the 
ER-to-Golgi transport is mediated via direct fusion of the ER and the cis-face of Golgi stacks in 
tobacco leaf cells. These results suggested that vesicular coat proteins might not be involved in 
protein transport between ER and Golgi (Brandizzi et al., 2002; Neumann et al., 2003). 
Nevertheless, the components of COPII vesicles were characterized in plant cells (Andreeva et 
al., 1998) and experimental evidence indicated that COPII vesicles are essential for protein 
transport to the Golgi (Andreeva et al., 2000; Phillipson et al., 2001; Neumann et al., 2003). It 
was therefore suggested that COPII vesicles function in Golgi transport by determining the site of 
ER-to-cis-Golgi-connections, and COPII vesicles are not imperative for transport (Hawes et al., 
2000). The Golgi stacks are categorized into cis-, medial-, and trans- cisternae subdivisions based 
on enzyme activities. For instance, it is hypothesized that mannosidase II performs N-glycan 
modification in a medial subdivision of the Golgi. Several fluorescent Golgi-localized markers 
have been used such as UDP-glucose transporter (GONST1), mannosidase I (GmManI), β 1,2-N-
acetylglucosaminyltransferase I (GnTI or NAGTI), β 1,2-xylosyltransferase, and mammalian 
sialyltransferase (ST) (Jurgens, 2004; Nelson et al., 2007). In tobacco BY-2 cells, the Golgi 
apparatus shows a similar structure and behavior like other plant species. It has been estimated 
that hundred Golgi stacks exist in BY-2 cells. They are highly mobile, but not in continuous 
motion. Each Golgi stack start to move and then stop, they do a type of ‘’wiggling’’ before 
resuming of movement. To visualize the Golgi apparatus in BY-2 cells, various fluorescent 
markers have been used such as GFP/RFP-tagged GmManI (cis-cisternae), YFP-tagged GONST1 
(trans cisternae), RFP-tagged sialyl teransferase (trans cisternae) and GFP-tagged 
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xylosyltransferase (medial cisternae). Moreover, Golgi stacks have been visualized by 
immunostaining with COPI, AtArf1, and AtSec21 antibodies (Robinson and Ritzenthaler, 2006).  
 
Endosomes 
Endosomes are a composition of different organelles that function in the sorting and delivery of 
internalized materials from the cell surface, recycling of plasma membrane cargo as well as 
delivery of materials from Golgi to lysosomes or vacuoles (Contento and Bassham, 2012). 
Endosomes are involved in trafficking of both biosynthetic (secretory) and endocytic cargo. In 
plant cells, endocytosis plays an important roles in different key plant processes such as embryo 
differentiation (Geldner et al., 2003; Goh et al., 2007; and Jaillais et al. 2008; Tamura et al., 
2007), gravitropism (Silady et al., 2004), epidermis differentiation (Shen et al., 2003), guard cell 
movement (Shope et al., 2003), cell wall remodeling (Baluska et al., 2002), the regulation of 
auxin transport (Geldner et al., 2003; Jaillais et al., 2007), and plant pathogen defense (Robatzek 
et al., 2006). Endosomes are grouped into four classes in animal cells: early (EE), recycling (RE), 
intermediate (IE), and late endosomes (LE). Early endosomes (EE) and late endosomes (LE) are 
two endosomal compartments which have been characterized in plant cells, but other types of 
endosomes have not been seen (Contento and Bassham, 2012). EE is the first compartment in the 
endocytic pathway, collecting internalized cargo from the cell surface. This compartment is 
rapidly labeled with the membrane styryl FM4-64 dye in plant cells. Experimental evidence 
indicated that the trans-Golgi network (TGN) corresponds to early endosomes (EE) in plant cells 
and it is the first compartment for delivery of internalized cargo (Joachim and Robinson, 1984; 
Tanchak et al., 1988; Lam et al., 2007). Fluorescent labeling experiments showed that vacuolar 
ATPase localizes to the TGN/EE. The colocalization studies with FM4-64 as hallmark for EE and 
fluorescent marker for vacuolar ATPase confirmed that trans-Golgi network (TGN) is equivalent 
to early endosomes (EE) in plant cells. Moreover, inhibition of the vacuolar ATPase using a 
vesicular trafficking inhibitor (concanamycin A) led to the accumulation of biosynthetic and 
endocytic cargo at the TGN, showing both routes merged in this compartment (Dettmer et al., 
2006). Specific marker proteins, in particular endosomal Rab GTPases, can also characterize 
endosomal compartments. These proteins have important functions in intracellular trafficking 
such as vesicle formation, transport and fusion. There are some differences between animal and 
plant Rab GTPases in terms of subcellular location. Rab11 and Rab4 GTPases are found in the 
RE in animal cells, whereas Rab 11 orthologs localized into EE/TGN in plant cells (Ueda et al., 
1996; Inaba et al., 2002; Preuss et al., 2006). Rab5 members are localized to early endosomes 
(EE) in animal cells, but Rab5-like proteins (AtRabF2a, AtRabF2b, and AtRabF1) resided to late 
endosome (LE/PVC) in plant cells (Haas et al., 2007; Kotzer et al., 2004). Experimental evidence 
showed that Rab5-like proteins play an important role in protein transport between LE/PVC and 
vacuole (Kotzer et al., 2004; Sohn et al., 2003; Bolte et al., 2004). Electron microscopy and 
FM4-64 uptake studies in tobacco BY-2 cells demonstrated that multi-vesicular bodies (MVB) 
corresponds to LE/PVC (Tse et al., 2004). Moreover, LE/PVC comprise vacuolar sorting 
receptors (VSRs) and vacuolar proteins, suggesting it as an intermediate compartment in 
biosynthetic and endocytic trafficking to the vacuole (Tse et al., 2004; Mo et al., 2006; Miao et 
al., 2008; Jaillais et al., 2008; Bottanelli et al., 2011). Colocalization studies with RabGTPases 
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markers located in LE/PVC showed that MVB is functionally equivalent to LE/PVC in plant cells 
(Haas et al., 2007; Miao et al., 2008) (Figure I-6). 
 
Figure I-6: Biosynthetic and endocytic routes converge at the trans-Golgi network. Schematic 
diagram of protein trafficking in tobacco BY-2 cells. The internalized endosomal marker FM4-64 is 
delivered to the central vacuole via the endocytic route. After uptake from medium, it reaches early 
endosomes or the trans-Golgi network (EE/TGN). The late endosomes or the prevacuolar compartment 
(LE/PVC) functions as an intermediate organelle to transport FM4-64 from EE/TGN to the tonoplast of 
the vacuole. Proteins with vacuolar sorting signals (VSS) end up to the central vacuole through the Golgi, 
EE/TGN, and LE/PVC/MVB via the biosynthetic route. Biosynthetic and endocytic routes merged at the 
at trans-Gogi network (Lam et al., 2007, modified picture). 
 
Plant vacuole 
The vacuole is the largest organelle that occupies approximately 90% of plant cell volumes 
(Toyooka and Matsuoka, 2006). The main role of vacuoles is the production of the osmotic 
pressure that adds mechanical stability of plant tissues. The vacuole regulates osmotic pressure in 
plants with accumulation and exchange of solutes. The vacuole contains different kinds of solutes 
including primary metabolites (carbohydrates, amino acids and organic acids), secondary 
metabolites, proteases, and inorganic ions (chloride, nitrate, potassium and sodium). Vacuoles 
also contain defense-related enzymes such as chitinases, showing the important role of this 
organelle in plant immune response (Neuhaus and Paris, 2005). To date, at least two functional 
types of vacuoles have been identified including lytic and protein-storage vacuoles. These 
vacuoles can co-exist in same cell or merge to form a large central vacuole (Paris et al., 1996). 
The lytic vacuole (LV) has an acidic pH and corresponds to animal lysosomes or yeast vacuoles, 
acting in protein decomposition due to the presence of catabolic enzymes. For intracellular 
trafficking studies, multiple markers for the lytic vacuole have been used including the γ-form of 
tonoplast intrinsic protein (γ-TIP), sporamin, and aleurain (Matsuoka et al., 1995; Paris et al., 
1996). The protein-storage vacuole (PSV) contains storage proteins that are normally used during 
seed germination such as 2S albumin (Jurgens, 2004). The α-form of the tonoplast intrinsic 
protein (α-TIP) is one of the unique proteins located in membrane of PSV.  
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Vacuolar trafficking 
In plant cells, proteins are targeted to LV and PSV via different routes. Three main routes have 
been reported in literature: classical, non-classical, and autophagic (Figure I-7).  
 
Figure I-7: Vacuolar transportation routes in plant cells. Three vacuolar pathways have been 
described in plant cells. (A) The classical route that is mediated via the Golgi apparatus, clathrin-coated 
vesicles (CCV), and prevacuolar compartments (PVC). (B) The non-classical route that is mediated by 
ER-derived vesicles and ends up to the central vacuole. These vesicles contain KDEL retention signals, so 
they are called KDEL vesicles (KV) (Okamoto et al., 2003). (C) The autophagic route which is mediated 
by the autophagosome and then fused to the vacuole. Autophagosome is formed by the engulfment of 
cytoplasmic portion in double-membrane bound (Surpin and Raikhel, 2004). 
 
Though most, if not all, of vacuolar proteins are produced, enter the ER, and pass through the 
Golgi apparatus. The vacuolar glycoproteins are separated from secreted proteins (bulk flow) 
probably at the trans-Golgi network (EE/TGN), where vacuolar soring receptors (VSRs) 
recognize vacuolar sorting signals (VSSs) and direct vacuolar proteins into clathrin-coated 
vesicles (CCVs). These vesicles deliver vacuolar proteins to the LE/PVC which functions as an 
intermediate organelle for delivery to the central vacuole. This is a classical route and well 
characterized in tobacco BY-2 cells as a signal-and-receptor-mediated process (Matsouka, 2004) 
(Figure I-7A). Three major types of vacuolar sorting signals (VSSs) have been characterized in 
plant cells including the sequence specific (ssVSSs) (Nakamura and Matsuoka, 1993), the C-
terminal sequence (ctVSS) (Nakamura and Matsuoka, 1993; Neuhaus and Rogers, 1998), and the 
physical structure (psVSS) (Neuhaus and Rogers, 1998; Jolliffe et al., 2003). The ssVSS group 
consists of a conserved motif residing at the N-terminal domain of proteins. This conserved motif 
contains a common sequence NPIRL/P or similar ones without the major alterations. The ctVSS 
group is composed of the C-terminal VSS. These sorting signals are not conserved, although they 
share similar features in terms of amino acids composition and topology. They are normally 
composed of hydrophobic acid residues and are required to be surface-exposed. The psVSS 
group depends on the physical structure of the proteins. They consist of one or more motifs, 
which are located in the center of the protein. These central motifs are exposed to the surface 
when proteins form their final tertiary structure. Behind this default vacuolar protein transport, 
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the non-classical route has been found in developing seed cells. For example cysteine protease 
(SH-EP) and α-TIP are transported to the protein-storage vacuole (PSV) via the non-classical 
route (Toyooka et al., 2000; Jiang and Rogers, 1998). In the case of SH-EP, the C-terminal ER 
retention signal (KDEL signal) acts as vacuolar sorting signal (VSS). The precursor form of SH-
EP containing KDEL signal sequestered into an ER-derived vesicle and these cargo proteins 
transport directly to the storage vacuole.  
 
 
The autophagic route is the engulfment of cytoplasmic components in double-membrane-
bounded structure, followed by transportation to the vacuole for degradation (Klionsky and 
Ohsumi, 1999) (Figure I-7C). Experimental evidence indicated, when the cultured tobacco BY-2 
cells are transferred to sucrose-free culture and treated with cysteine proteases inhibitors (E-64, 
leupeptin, and antipain), the degradation of sequestered parts of the cytoplasm (autophagosomes) 
is inhibited and caused the accumulation of cytoplasmic components in vesicles, so-called 
autolysosomes in plant cells. These experiments suggest that the degradation of cytoplasmic 
components takes place in ‘’autolysosomes’’, which are produced upon autophagy in BY-2 cells 
(Moriyasu and Ohsumi, 1996; Yamada et al., 2005; Moriyasu and Inoue, 2008). Toyooka (2006) 
and his colleagues described that the autophagosome is delivered to the central vacuole via two 
distinct pathways. One pathway is the direct transport of the autophagosome to the central 
vacuole and the other is the invagination of autophagosomes in small vacuolar structures that is 
supposed to be the autolysosome. Autolysosomes were isolated from BY-2 cells and elucidated 
containing vacuolar H+-ATPase and cysteine proteases (Takatsuka et al., 2011). Moreover, it was 
indicated that the autophagic pathway merges with the endocytic pathway in tobacco BY-2 cells. 
These data suggest that the autolysosome is resided in the endocytic pathway, downstream of the 
plasma membrane and upstream from the central vacuole (Yano et al., 2004; Yamada et al., 
2005). Therefore, it seems that the autolysosome is equivalent to the EE/TGN due to the presence 
of vacuolar H+-ATPase (Dettmer et al., 2006) and the acidic environment of EE/TGN (Martiniere 
et al., 2013). Table I-1 provides some of the inhibitors that hamper distinct steps in the 
biosynthetic, endocytic, and autophagic pathways to dissect trafficking routes and to characterize 
proteins potentially involved in these pathways. 
 
Table I-1: Some of the inhibitors used to study vesicular trafficking in plant cells. 
Inhibitor Effect on plant cells References 
Brefeldin A Causes re-translocation of Golgi proteins to ER 
Inhibits transport from endosomes to the plasma  
membrane 
Induce formation of BFA compartment 
Gelender et al., 2003;  
Nebenführ et al., 2002;  
Richter et al., 2007;  
Robinson et al., 2008; 
Tse et al., 2006 
Concanamycin A Blocks vacuolar ATPase 
Inhibits transport out of TGN 
Prevents vacuolar degradation 
Dettmer et al., 2006; 
Matsuoka et al., 1997 
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Inhibitor Effect on plant cells References 
E-64 
Leupeptin  
Antipain 
Inhibits cysteine proteases  
Causes formation of autolysosomes 
Moriyasu and Ohsumi, 1996
Moriyasu and Inoue, 2008 
Wortmannin Blocks PI3K 
Causes enlarged PVC 
Jaillais et al., 2006;  
Kasai et al., 2001;  
Matsuoka et al., 1995;  
Miao et al., 2006; 
Tse et al., 2004;  
Vermeer et al., 2006 
I.4 Aim of this thesis 
The main drawback of the plant production system is the fairly low accumulation level of foreign 
proteins compared with bacterial and mammalian production systems. Yields are mainly 
dependent on protein stability, which is significantly affected by the proteolytic degradation 
process. It has been found that the therapeutic proteins produced in tobacco BY-2 cells are 
degraded by the plant endogenous proteases (Schiermeyer et al., 2005). Proteases from four 
different enzymatic classes was identified and cloned from the tobacco BY-2 cells, including 
metallo (NtMMP1), aspartic (NtAP1), serine (NtSP1) and cysteine (NtCP1) proteases. The 
characterization and subcellular localization of NtMMP1 has been previously done (Schiermeyer 
et al., 2009; Mandal et al., 2010). The aim of this PhD thesis is the characterization and 
subcellular localization of other endogenous proteases cloned from the tobacco BY-2 cells; 
NtAP1, NtCP1, and NtSP1 proteases. To achieve this, the available cDNA sequences of the BY-2 
proteases shall be cloned and expressed as fusion proteins in a plant system (Nicotiana tabacum 
or Nicotiana benthamiana). To facilitate the detection and the purification of proteases the C-
termini will be fused to EmGFP (emerald green fluorescent protein) and the Strep-II tag. The 
expression of recombinant proteases will be characterized by immunoblot. When the expression 
has been confirmed by immunoblot, the recombinant proteases can be purified by affinity 
chromatography via anti-GFP antibody coupled to magnetic beads or via immobilized Strep-
Tactin. The purified enzymes should be analyzed for functionality by using fluorescent or 
chromogenic synthetic substrates. Subsequently, the proteolytic activity of purified enzymes will 
be evaluated towards pharmaceutical proteins. M12 antibody and human serum albumin can be 
tested as model proteins. The subcellular localization should be analyzed with GFP constructs by 
laser scanning confocal microscopy in transgenic BY-2 cells. Intracellular trafficking of these 
endogenous proteases will be monitored in transgenic BY-2 cells by using protein trafficking 
studies tools like papain family proteases inhibitor (E-64), the fungal toxin brefeldin A (BFA), 
and the fluorescent endocytosis marker (FM4-64). This information can be helpful to better 
understand the proteolytic degradation process of recominantly produced proteins in BY-2 cells. 
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PCR amplification of the cDNA sequence of 
aspartic (NtAP1)-, cysteine (NtCP1)- and serine 
(NtSP1) proteases as well as EmGFP and Strep II-
tag as fusion proteins  
Cloning of plant expression vector for the 
production of recombinant proteases  
Transformation of 
tobacco BY-2 cells with 
recombinant proteases 
expression constructs 
Generation of 
transgenic tobacco BY-2 
cell lines    
Expression analysis of 
stably transformed 
tobacco BY-2 cells by 
Western blot using anti-
GFP and Strep-Tactin 
Expression analysis of 
transiently transformed plants 
by Western blot using anti-GFP 
antibody and Strep-Tactin 
Transient expression of 
recombinant proteases in a 
plant system (N. tabacum and 
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Purification of recombinantly 
produced proteases by using 
affinity chromatography method 
via immobilized Strep-Tactin 
and immobilized anti-GFP 
antibody 
Functionality assay of purified 
enzymes using fluorescent or 
chromogenic synthetic 
substrates 
Analysis of the 
subcellular localization 
of the proteases using 
laser scanning confocal 
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Analysis of the 
transport and 
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tobacco BY-2 cells 
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activity of recombinant 
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Figure  I-8: Schematic overview of the work presented in this thesis. 
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II Materials and Methods 
II.1 Materials 
II.1.1 Chemicals and consumables 
The following companies supplied chemicals: 
AppliChem GmbH (Darmstadt), Biotrend (Köln), Bio-Rad (München), Fluka (Neu-Ulm),  
Sigma-Aldrich (Taufkirchen), Bio-Rad (München), Fluka (Neu-Ulm), GE Healthcare (Freiburg), 
Gibco BRL (Eggenstein), Life Technologies GmbH (Darmstadt), Merck (Darmstadt), Roche 
(Mannheim), Roth (Karlsruhe), Serva (Heidelberg). The consumables were from: Amicon 
(Witten), Biozym (Hess. Oldendorf), Eppendorf (Hamburg), Greiner (Solingen), Millipore 
(Eschborn), Nunc (Bieberach), Schott Glaswerke (Mainz), Serva (Heidelberg), Whatman 
(Dassel) and Zeiss (Oberkochem). 
 
II.1.2 Special chemicals 
Protease inhibitors such as E-64, Pepstatin A and Antipain were purchased from AppliChem 
GmbH. Complete® protease inhibitor cocktail tablets with or without EDTA were purchased 
from Roche Diagnostics. FM4-64 was purchased from Biotrend. LysoTracker® Red was 
supplied from Life Technologies GmbH. 
 
II.1.3 Buffers, media and solutions 
All standard solutions, buffers, and media were prepared according to the fourth edition of 
Sambrook and Russell (2012) using deionized water. Compositions of non-standard solutions or 
buffers are listed at the end of the respective method section. All media and some solutions were 
prepared and sterilized by autoclaving (25min/121°C/2bar). Heat-sensitive components, such as 
antibiotics, were prepared as stock solutions, filter-sterilized (pore size: 0.2 μm) and added to the 
medium after autoclaving following cooling down to 50°C. 
 
II.1.4 Matrices and membranes 
GFP fusion proteins were purified from transgenic BY-2 cell lines (II.2.2.2) using the µMACSTM 
GFP isolation kit from Miltenyi Biotech GmbH (Bergisch Gladbach). Strep-Tactin® Sepharose 
from IBA GmbH (Goettingen) was used for purification of recombinant Strep-tag® proteins from 
transiently transformed N. benthamiana leaves. ImmobilonTM-P transfer membrane (PVDF, 
0.45μm) from Millipore, Roti® PVDF from Roth, Protran® nitrocellulose membrane from 
Whatman, HybondTM-C-nitrocellulose membrane (0.45μm) from GE Healthcare and Whatman 
no.1 paper from Whatman were used in immunoblot analysis (II.2.3.3).  
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II.1.5 Enzymes and reaction kits 
The restriction enzymes from New England Biolabs (NEB) (Frankfurt am Main) were used for 
DNA digestion. Home-made Taq polymerase was used in colony-PCRs (II.2.1.17). Other used 
kits are listed in table II-1. 
 
Table  II-1: Reaction kits and suppliers. 
 
II.1.6 Antibodies and substrates 
Primary antibody mouse anti-GFP (Roche Diagnostics, Mannheim) and secondary antibody goat 
anti-mouse IgG (Fc specific) conjugated to alkaline phosphatase (AP) (Dianova, Hamburg) were 
used to detect GFP fusion proteins in immunoblot (II.2.3.3). Strep-Tactin (IBA, Goettingen) 
conjugated to alkaline phosphatase (AP) was used to detect StrepII-tagged proteins in 
immunoblot (II.2.3.3). Human serum albumin (HSA) and the plant-produced vitronectin-specific 
antibody M12 (kindly provided by Dr. Nicole Raven, Fraunhofer IME, Aachen) were used as 
substrates for purified NtAP1 fusion proteins (II.2.2.4) in protease activity assays (II.2.4.2). To 
detect human serum albumin (HSA), goat anti-HSA antibodies (Bethyl Laboratories, Hamburg) 
were used as primary antibody followed by rabbit anti-goat antibody (Fc specific) conjugated to 
alkaline phosphatase (AP) (Dianova, Hamburg). Heavy and light chains of M12 antibodies were 
detected by the goat anti-human IgG (Fc specific) antibody conjugated to alkaline phosphatase 
(AP) (Dianova, Hamburg) and the goat anti-human lambda (λ chain specific) conjugated to 
alkaline phosphatase (AP)  (Sigma-Aldrich), respectively. The heavy chain of the 2F5 antibody 
was detected by the goat anti-human IgG (Fc specific) antibody conjugated to alkaline 
phosphatase (AP) (Dianova, Hamburg). NBT/BCIP (Bio-Rad, Munich) was used as substrate for 
alkaline phosphatase in immunoblots. Fluorogenic and chromogenic synthetic substrates were 
used for protease activity assays (II.2.4.1) and were purchased from Enzo Life Sciences 
(Lörrach). 
 
II.1.7 Oligonucleotides 
Oligonucleotides used for DNA amplification using polymerase chain reaction (PCR) (II.2.1.17), 
splicing by overlapping extension PCR (SOE-PCR) (II.2.1.18) and sequence analysis (II.2.1.19) 
are listed in the following tables. All oligonucleotides were synthesized by Eurofins MWG 
Operon (Ebersberg).  
  
Reaction kit Supplier 
Expand high fidelity PCR system Roche 
Nucleospin Plasmid kit for mini-preparation of plasmids Macherey-Nagel (Düren) 
NucleoSpin Extract II Kit for DNA fragment purification Macherey-Nagel (Düren) 
CloneJET PCR cloning Kit  
Thermo Scientific 
(Braunschweig) 
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Table  II-2: Primers used for generation of aspartic protease fusion constructs. Introduced 
restriction sites are shown in italic.  
 
 
 
Table  II-3: SOE-PCR primers used for generation of cysteine protease fusion construct. Introduced 
restriction sites are shown in italic.   
 
  
Primer name Restriction site at 5’ Primer sequence (5’→3’) 
Forward primer NtAP1-Cterm CTC GAG (XhoI) TCGAGGCAACTCGAGAACCAG
GC 
Reverse primer NtAP1-rev-508 CCT GCA (SdaI) CCTGCAGGAGCAGCTTCA 
GCAAAACCAACTCTCG 
Reverse primer NtAP1-rev-474 CCT GCA (SdaI) CCTGCAGGCACGTCTAAA 
GCTGTAAATCCACTG 
Reverse primer NtAP1-rev-417 CCT GCA (SdaI) CCTGCAGGCAATCGGTCA 
CACAGCTGATTAAC 
Reverse primer NtAP1-rev-299 CCT GCA (SdaI) CCTGCAGGTCCTGCCAAT 
AAGGATGTTCCAGAATC 
Forward primer EmGFP - AGCAAGGGCGAGGAGCTGTTC 
Reverse primer EmGFP-StrepII GGATCC (BamHI)  
GGATCCTTATTTTTCGAA 
CTGCGGGTGGCTCCACTT 
GTACAGCTCGTCCATG 
Primer name Overhang region 
Restriction 
site at 5’ 
Primer sequence 
(5’→3’) 
Forward primer NtCP1-
Cterm 
 
CCATGG 
(NcoI) 
CAACACTCCCATGGAT
GTAAACC 
Reverse SOE primer-
NtCP1 
CTCCTCGCCCTT 
GCT 
 
CTCCTCGCCCTTGCTGG
CAACGACAGGGTAGGA 
TGC 
Forward SOE primer-
EmGFP 
TAC CCT GTC 
GTT  GCC 
 
TACCCTGTC GTT  
GCCAGCAAG GGC 
GAGGAGCTG TTC 
Reverse primer-EmGFP-
StrepII 
 
GGATCC 
(BamHI) 
GGATCCTTATTTTTC 
GAACTC 
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Table  II-4: Primers used for generation of serine protease fusion constructs. Introduced restriction 
sites are shown in italic.   
 
 
Table  II-5: Primers used for DNA sequencing. 
 
II.1.8 Vectors 
The pJET1.2 from Thermo Scientific (St. Leon-Rot) was exploited as intermediate vector for all 
sub-cloning steps prior to DNA sequencing. This vector comprises the beta-lactamase (bla) gene 
for selection with ampicillin. The vector pTRAkt (Sack et al., 2007) was used for transformation 
of the plants (N. tabacum and N. benthamiana) and tobacco BY-2 suspension culture via 
Agrobacterium-mediated transformation. The pTRAkt vector is an optimized plant expression 
vector which is composed of the Cauliflower mosaic virus 35S promoter, the 5’-untranslated 
region from Tobacco etch virus (TEV) and the CaMV 35S transcriptional terminator. Scaffold 
attachment regions (SAR) were introduced next to the right and left border of the T-DNA to 
optimize gene expression. On the T-DNA part of this vector the kanamycin (nptII) resistance 
gene as a plant selection marker and on the vector backbone ampicillin (bla) resistance gene as a 
bacterial selection marker is located. 
 
Primer name 
Restriction site 
at 5’ 
Primer sequence (5’→3’) 
forward primer NtSP1-Cterm GGT ACC(KpnI) CAACATTATTTCGGGTACCTCTAT
G 
reverse primer NtSP1-rev-753 CCT GCA (SdaI) CCTGCAGGTGTTTCAGACTCTTGT
AGAATAAC 
reverse primer NtSP1-rev-555 CCT GCA (SdaI) CCTGCAGGAGACCAAGTGGGGTG
CGCGCT 
forward primer EmGFP __ GAGCAAGGGCGAGGAGCTGTTC
ACC 
reverse primer EmGFP-StrepII 
GGATCC 
(BamHI)  
GGATCCTTATTTTTCGAACTGCG
GGTGGCTCCACTTGTACAGCTCG
TCCATG 
Primer name Primer sequence (5’→3’) 
pSS 5′ ATCCTTCGCAAGACCCTTCCTCT 
pSS 3′ AGAGAGAGATAGATTTGTAGAGA 
pJET1.2 Forward CGACTCACTATAGGGAGAGCGGC 
pJET1.2 Reverse AAGAACATCGATTTTCCATGGCAG 
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II.1.9 Bacterial and yeast strains 
E. coli strains DH5α and XL1-Blue were used as host cells for all intermediate cloning steps 
(Table II-6). A. tumefaciens GV3101 (pMP90RK GmR, KmR, RifR (Koncz and Schell, 1986) was 
used for plant transformation.  
 
Table  II-6: Names, suppliers and genotypes of E. coli strains used throughout the work. 
 
II.1.10 Plants and animals 
The tobacco BY-2 suspension culture (Nicotiana tabacum L. cv. Bright Yellow 2) (Nagata et al., 
1992) was used for stable transformation (II.2.2.2). Nicotiana tabacum L. cv. Petite Havana SR1 
(Maliga et al., 1973) and Nicotiana benthamiana were used for transient protein expression 
(II.2.2.1). 
 
II.1.11 Equipment and applications 
AIDA Image analyzer (Straubenhardt) 
Centrifuges: Avanti
TM 
30 and Avanti
TM
J-25 from Beckman (Brea, California, USA), Biofuge A 
from Heraeus (Hanau), Eppendorf 5415D. Rotors: F0650, F2402H, JLA 10.500 and JA 25.50 
from Beckman, #1140 and #11222 from Sigma, RLA-300, SS-34 and GS-3 from DuPont 
Instruments (Bad Homburg).  
Clean bench: Kojair (Nideggen).  
DNA-sequencing machine: 3700 DNA analyzer and BigDye
TM 
cycle-sequencing terminator 
chemistry (V 3.0) from Applied Biosystems.  
DNA gel electrophoresis apparatus: Wide mini and mini cells for DNA agarose electrophoresis 
from Bio-Rad, and the power supplies from Bio-Rad.  
Electroporation apparatus: Multiporator from Eppendorf and 0.2 cm or 0.4 cm cuvettes from 
Bio-Rad.  
Synergy HT Multiplate Reader: BioTek Instruments GmbH 
Innova
TM 
4340 incubator shaker: Eppendorf (Hamburg). 
LAS Imager: LAS3000 from Fujifilm (Duesseldorf). 
Mini-PROTEAN Tetra Cell:  Bio-Rad 
Microscopes: Leica (Wetzlar). 
PCR Thermocyclers: Primus and Primus 96 plus from MWG-Biotech, Mastercycler Personal 
from Eppendorf, DNA Engine from Bio-Rad (Munich, Germany).  
Strain Source Genotype 
DH5α 
Invitrogen 
(Ausubel et 
al., 1995) 
F- (f80d Lac 2ΔM15) Δ(LacZYA-argF) U169end A1 
rec1hsdR17(rk- mk+) deoR thi-1 supE44 gyrA96 relA1 λ- 
XL1-Blue Stratagene 
recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F′ proAB 
laclIq ZΔM15 Tn10 (Tetr)] 
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Photometers: Biophotometer from Eppendorf and Cuvettes # 67.742 from Sarstedt 
(Nürmbrecht). Nanodrop, ND1000 from Thermo Scientific. 
Protein gel electrophoresis equipment: Mini PROTEAN II
TM 
from Bio-Rad.  
Software: Microsoft Office 2010 (Microsoft); Adobe Photoshop CS5 (Adobe); Clone manager 9 
functions as an expert system to help with cloning simulation, enzyme operations and graphic 
map drawing, AIDA (Raytest, Straubenhardt). 
UV-Transilluminators: Wavelength 302nm and UVT-20M from Herolab (Wiesloch). UV-
chamber from Bio-Rad.  
Vacuum filtration unit: Sartorius (Goettingen). 
 
 
II.2 Methods 
II.2.1 Recombinant DNA technologies 
All experiments related to cloning procedures performed for the purposes of this PhD thesis were 
carried out according to general recombinant DNA techniques protocols described in the fourth 
edition of Sambrook and Russell (2012) such as PCR (polymerase chain reaction), SOE-PCR 
(splicing by overlap extension), DNA extraction, DNA precipitation, restriction enzyme 
digestion, DNA ligation, and DNA agarose gel electrophoresis. 
II.2.1.1 Construction of plant expression vectors 
The binary vector pTRAkt containing a double 35S promoter of the Cauliflower mosaic virus 
(CaMV) was used to construct fusion proteases; the C-terminal part of the full-length and 
truncated versions of tobacco aspartic protease NtAP1-, cysteine protease NtCP1-, and serine 
protease NtSP1 fused to GFP protein and Strep II-tag. For generation of pTRAkt vectors 
encoding the full-length of aspartic protease NtAP1 and its three C-terminal deletion mutants 
fused to GFP protein and Strep II-tag (Table II-7), the cDNA encoding the NtAP1 (GenBank: 
DQ648018.1) and GFP/StrepII-tag were amplified by PCR (II.2.1.17) using the specific primers 
(Table II-2) from plasmid backbones (pTRAkt-NtAP1-Str and pJET-GFP-Str). These PCR 
products were primarily sub-cloned into pJET1.2/blunt cloning vector (II.1.8) and then placed 
downstream of the CaMV 35S promoter using the XhoI, SdaI and BamHI restriction sites in the 
binary vector pTRAkt.  
 
Table II-7: Plant expression vectors carrying tobacco aspartic protease fusion constructs. 
 
No. Name Description 
1 pTRAkt-AP1508-GFP-Str The full-length of NtAP1 (508 aa) fused to GFP and Strep II-tag 
2 pTRAkt-AP1474-GFP-Str The C-terminal truncated version of NtAP1 (474 aa) fused to GFP and Strep II-tag 
3 pTRAkt-AP1417-GFP-Str 
The C-terminal truncated version of NtAP1 (417 aa) fused to GFP 
and Strep II-tag 
4 pTRAkt-AP1299-GFP-Str The C-terminal truncated version of NtAP1 (299 aa) fused to GFP and Strep II-tag  
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To generate plant expression vector carrying the full-length of cysteine protease fused to GFP 
and Strep II-tag (pTRAkt-CP1-GFP-Str), the cDNA encoding the full-length of NtCP1 
(GenBank: ABW71226.1) and GFP/StrepII were amplified and joined by SOE-PCR (II.2.1.18) 
using designed primers (Table II-3) from the plasmid backbones (pTRAkt-NtCP1-Str and pJET-
GFP-Str). The SOE-PCR products were sub-cloned into the pJET1.2/blunt cloning vector (II.1.8) 
and finally put downstream of the CaMV 35S promoter using NcoI and BamHI restriction sites in 
the binary vector pTRAkt. To construct plant expression vectors (pTRAkt-NtSP753-GFP-Str and 
pTRAkt-NtSP555-GFP-Str) (Table II-8), the cDNA encoding the full-length of NtSP1 (GeneBank: 
DQ648019.1) and GFP/StrepII were amplified by PCR (II.2.1.17) using designed primers (Table 
II-4). These PCR products were sub-cloned into pJET1.2/blunt cloning vector and then placed 
downstream of CaMV35S promoter using the KpnI, SdaI and BamHI restriction sites in the 
binary vector pTRAkt. 
 
Table II-8: Plant expression vectors carrying tobacco serine protease fusion constructs. 
No. Name Description 
1 pTRAkt-SP1753-GFP-Str The full-length of NtSP1 (753 aa) fused to GFP and Strep II-tag 
2 pTRAkt-SP1555-GFP-Str  The C-terminal truncated of NtSP1 (555 aa) fused to GFP and Strep II tag 
II.2.1.2 Preparation of chemically competent E. coli  
A single colony of E. coli strain of XL1-Blue grown on LB-agar plate was inoculated into 5 ml 
LB medium in a 15 ml test tube and incubated overnight (o/n) at 37ºC. One ml of the o/n culture 
was transferred into 100 ml of LB medium containing 20 mM MgSO4, 10 mM KCl and grown 
for approximately 3 h until reaching the OD600 nm of 0.5. The cells were transferred to an ice-cold 
test tube, placed for 10 min on ice and then centrifuged for 10 min (3500g/4°C). Subsequently the 
cell pellets were resuspended in 15 ml ice-cold TfBI-buffer and kept on ice for 10 min. The cells 
were recovered by centrifugation as described above and resuspended in 4 ml ice-cold TfBII-
buffer. One hundred μl aliquots of the suspension were dispensed into pre-chilled 1.5 ml 
microcentrifuge tubes, frozen immediately in liquid nitrogen and stored at -80°C. 
TfB-I, pH 5.8:  
Potassium acetate 30 mM
MnCl2 50 mM
CaCl2 10 mM
Glycerol 15% (v/v)
 
MOPS 30 mM
CaCl2 75 mM
RbCl 10 mM
Glycerol 15% (v/v)
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II.2.1.3 Transformation of E. coli by heat-shock 
Frozen aliquots (100 µl) of the chemically prepared competent E. coli cells (II.2.1.2) were thawed 
on ice for 5-10 min and plasmid DNA (up to 200 ng) or ligation products were carefully added as 
described by Sambrook and Russell (2012). Incubated cells with DNA were kept for 30 min on 
ice and suddenly heat shock was given for 90 S at 42ºC. After heat shock, the bacteria were 
transferred on ice for additional 3 min and 800 µl of pre-warmed (37°C) SOC medium was added 
and incubated at 37°C for 1 h. After incubation, 200 μl of cells were streaked out onto a LB-agar 
plate supplemented with ampicillin and incubated at 37°C for 16 h. The remaining 600 µl were 
also centrifuged and supernatant was decanted. The bacteria were resuspended in the remaining 
fluid, streaked out on LB containing ampicillin and then incubated at 37°C for 16 h. 
 
II.2.1.4 Preparation of electrocompetent E. coli 
Electrocompetent E. coli were prepared from strains DH5α and XL1-blue as described by Dower 
et al. (1988). A single colony of bacteria from an LB plate was inoculated in 5 ml LB-medium 
and cultured at 37°C o/n. Five ml of fresh o/n culture was transferred into 500 ml of LB medium 
and incubated for 3-4 hours at 37°C until the mid-log phase (OD600 nm= 0.5-0.6). Subsequently 
the cells were kept on ice for 15-20 min and then harvested by centrifugation (3000g/4°C/10 
min). Cells were washed three times with sterile cold water while the volume of water  was 
reduced by half in each washing step and resuspended in ice-cold 10% (v/v) glycerol to a 300-
fold concentration from the original culture volume (at >1010 cells/ml). Sixty microliter (60 µl) 
aliquots were frozen directly in liquid nitrogen and stored at -80°C. 
 
II.2.1.5 Transformation of E. coli by electroporation 
Transformation via electroporation was carried out according to the protocol provided by 
Stratagene. Frozen aliquots of electrocompetent E. coli cells (II.2.1.4) were kept on ice for 5-10 
min and mixed with either 100 pg of plasmid DNA or 100-200 ng of desalted ligation product 
(desalting was performed using dialysis membrane). The cell/DNA mixture was transferred into a 
prechilled sterile electroporation cuvette (0.2 cm or 0.1 cm gap) and placed in the safety chamber. 
After application of a 5 ms electric pulse (2.5 kV for 0.2 cm and 1.7 kV for 0.1 cm gap 
electrocuvette), 900 µl of pre-warmed (37°C) SOC medium was added immediately to the cells 
and incubated at 37°C with shaking for 1 h. Eventually, 200 μl of the cells were plated onto LB-
agar plates containing suitable antibiotics and incubated at 37°C over night. 
 
II.2.1.6 Preparation of electrocompetent A. tumefaciens 
A single colony of A. tumefaciens strain GV3101::pMP90RK grown on a YEB-agar plate 
comprising 25 g/ml rifampicin (Rif) and 25 g/ml kanamycin (Km) (YEB-Rif-Km) was 
exploited to inoculate 10 ml of YEB-Rif-Km medium in a 100 ml Erlenmeyer flask and kept at 
28°C for two days with shaking (160 rpm). One ml of the culture was transferred into 100 ml of 
YEB-Rif-Km medium and incubated at 28°C for 15-20 h with shaking (160 rpm) until the OD600 
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nm reached 1-1.5. In the next step, the cells were placed on ice for 15 min and harvested by 
centrifugation (4000 g/4°C/5 min). The culture medium was decanted and the cells were washed 
three times with 100 ml of ice-cold ddH2O and once with 100 ml of ice-cold sterile 10% (v/v) 
glycerol. After each washing step the cells were spun down by centrifugation (4000 g/4°C/5 min) 
and eventually they were resuspended in 500 l of sterile 10% (v/v) glycerol. Around 50 l 
aliquots of the suspension were dispensed into prechilled 1.5 ml microcentrifuge tubes, frozen 
immediately in liquid nitrogen and stored at -80°C. 
YEB-Rif-Km medium: 
Nutrient broth  0.5% (w/v)
Yeast extract 0.1% (w/v)
Peptone 0.5% (w/v)
Sucrose 0.5% (w/v)
The following compounds were added after autoclaving and cooling to 55°C: 2 mM MgSO4, 25 
g/ml rifampicin and 25 g/ml kanamycin. 
 
II.2.1.7 Transformation of A. tumefaciens by electroporation 
About 0.2-0.4 g of plasmid DNA (II.2.1.13) in sterile ddH2O was added to a thawed aliquot of 
electrocompetent agrobacteria cells (II.2.1.6) and kept on ice for 5 min. The cell/DNA mixture 
was transferred into a prechilled electroporation cuvette (0.2 cm) and put into the safety chamber. 
After application of the pulse (2.5 kV, 5ms), 900 µl of SOC medium was added to the cells and 
they were transferred into a 15 ml test tube and incubated at 28°C for 1 h with shaking (160 rpm). 
Eventually, 1-10 l of the cells were plated on YEB-agar containing 25 g/ml rifampicin (Rif), 
25 g/ml kanamycin (Km) and 50 g/ml carbenicillin (Carb) (YEB-Rif-Km-Carb) and incubated 
at 28°C for 2-3 days. As a negative control, transformation of Agrobacterium cells with H2O was 
performed. 
 
II.2.1.8 Determination of the transformation efficiency of competent bacteria  
The efficiency of transformation for each new batch of competent cells was analysed by test 
transformations with known concentrations (100 pg) of supercoiled plasmid pUC19 for E. coli 
and pTRAkc for A. tumefaciens cells. The following equation was used to calculate the 
transformation efficiency (CFU/µg): 
 
 
Transformation efficiency = colonies/µg/dilution (Colonies = the number of colonies counted on 
the plate, µg = the amount of DNA transformed expressed in µg, dilution = the total dilution of 
the DNA before plating) 
 
The transformation rates were calculated; for heat-shock competent E. coli 106/g pUC19, 
electrocompetent E. coli 108/g pUC19 and A. tumefaciens >103/g pTRAkc.   
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II.2.1.9 Culturing of E. coli and glycerol stock preparation 
Single colonies of all strains were obtained by streaking the corresponding strain on LB agar 
plates. To select recombinant bacteria, LB agar containing 100 g/ml ampicillin was used. 
Incubation was carried out at 37°C. For short term storage (around 2 weeks), the plates were 
stored at 4°C and for long term storage, 5 ml LB medium comprising the appropriate antibiotics 
and 2% (w/v) glucose was inoculated with a single recombinant colony and grown overnight at 
37°C with vigorous shaking (160 rpm). Glycerol stocks were prepared by mixing 800 µl of a 
fresh overnight culture with 200 µl of 80% (v/v) sterile glycerol in water. Bacterial glycerol 
stocks were stored at -80°C.  
 
II.2.1.10 Culturing of A. tumefaciens and preparation of glycerol stocks 
Positive recombinant Agrobacterium colonies comprising the plasmid of interest were inoculated 
in 10 ml of YEB-Rif-Km-Carb medium and incubated at 28°C for 2 days with vigorous shaking 
(160 rpm). The culture was transferred to 15 ml test tubes and cells were spun down by 
centrifugation (4000 g/15°C/10 min). The supernatant was discarded and cells were resuspended 
in a 1:1 volume of fresh YEB Rif-Km-Carb medium and glycerol stock media (GSM). The 
suspension was stored at -80°C in 500 l aliquots and used for further experiments. 
Glycerol stock medium (GSM): 
Glycerol 50% (v/v)
MgSO4 100 mM
Tris-HCl, pH 7.4 25 mM
 
II.2.1.11 Isolation of plasmid DNA 
Plasmids were isolated in high quality from recombinant E. coli according to the alkaline lysis 
method (Sambrook and Russell, 2012) using Nucleospin Plasmid kit Mini and Midi (Macherey-
Nagel). Plasmid DNA was analyzed in terms of purity and yield either by reading the UV 
absorbance at 260 and 280 nm via the NanoDrop spectrophotometer according to Sambrook and 
Russel (2012) or by analytical agarose gel electrophoresis (II.2.1.12). Isolated DNA samples 
were stored at -20°C and used for cloning and sequencing purposes. 
 
II.2.1.12 Agarose gel electrophoresis of DNA 
Plasmid DNA (II.1.8), PCR fragments (II.2.1.16) and enzymatically digested DNA (II.2.1.14) 
were fractionated using 0.8-1.2% (w/v) agarose gels prepared in TBE buffer comprising ethidium 
bromide as described by Sambrook and Russel (2012). The DNA molecular markers such as 1 kb 
(Thermo Scientific) and 100 bp (Roth) DNA ladder were used for analysis of sample size, 
integrity and determination of DNA concentration. The DNA was visualized on an UV 
transilluminator by illumination at 302 nm. The gel pictures were captured by using a universal 
hood II for Gel Doc XR (BioRad). 
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10X TBE electrophoresis buffer (pH 8.3):                                      
Tris-base 890 mM
Boric acid 890 mM
EDTA 20 mM
 
 
II.2.1.13  Preparative agarose gel electrophoresis of DNA 
Preparative gel electrophoresis was exploited for isolation of DNA fragments after restriction 
enzyme digestion (II.2.1.14) or PCR-amplified DNA (II.2.1.17) before cloning into a suitable 
vector. After electrophoresis, the desired DNA fragments were excised from the gel and purified 
using the “NucleoSpin
 
Extract II Kit l” (Macherey-Nagel) according to the manufacturers’ 
instruction. 
 
II.2.1.14 Restriction digest of DNA and preparative agarose gel electrophoresis 
Restriction endonucleases, appropriate buffers and BSA solution were supplied from New 
England Biolabs. Single or double restriction digests of DNA fragments were carried out at 
suitable buffer and temperature according to the manufacturers’ instruction. 
 
II.2.1.15  Quantification of DNA 
The concentration of plasmids and DNA fragments were determined either by using NanoDrop 
spectrophotometer according to the manufacturers’ instruction or by preparative agarose gel 
electrophoresis (II.2.1.13) followed by quantification of band intensity using AIDA software 
(according to the manufacturers’ instruction). The 1:3 molar ratio of vector: insert was used for 
ligation. The following formulation illustrates the conversion of molar ratios to mass ratios. 
 
 
 
 
 
II.2.1.16 Ligation of the DNA fragments 
Digested DNA fragments (II.2.1.14) containing insert and vector were ligated in a 3:1 molar ratio 
to obtain the desired final vector using 80 U of T4 DNA ligase or 1 µl Quick T4 DNA ligase 
(NEB) in buffer supplied with the enzyme. The final volume of ligation mixture was adjusted to 
20 µl. Sticky and blunt end ligations were performed at 22°C for at least 3 hours or at 15°C for 
overnight. Ligation product was used for E. coli transformation (II.2.1.5). 
 
ng of vector X kb of size of insert                                   insert 
----------------------------------------- X molar ratio of  --------------- 
Kb size of vector                                                             vector 
Chapter II                                                                                                       Materials and Methods 
 
-31- 
II.2.1.17  PCR amplification 
Polymerase chain reaction (PCR) was used for amplification of NtAP1, NtCP1 and NtSP1 from 
plasmid backbones previously described in section II.2.1.1. DNA fragments were amplified 
according to the protocol of Sambrook and Russell (2012) using ExpandTM high fidelity PCR 
system (Roche). The reactions were carried out in 0.2 ml PCR reaction tubes using a DNA 
thermal cycler. The cycler contained a heated lid to abolish evaporation of the reaction mixture.  
For screening of recombinant E. coli and agrobacteria, colony-PCR was carried out to confirm 
the presence of plasmids as described by Jesnowski et al. (1995). Selected colonies were picked 
using sterile tips and suspended in 20 l of sterile distilled water in PCR tubes. The suspension 
was boiled for 10 min and cell debris was spun down by centrifugation (13000 g/RT/5 min). 
Eventually, 10 l of the supernatant was used for PCR reactions in a total volume of 25 l.  
The optimal annealing temperature (Tm) of the primers was experimentally optimized or 
calculated based on the empirical formula of Wu et al. (1991): 
 
Tm = {22 + 1.46 [2× (G + C) + (A + T)]} 
PCR reactions were performed in a total volume of 25 l as described below: 
 
Table  II-9: PCR master mix. 
 
Amplification was carried out under the following conditions: 
                                                          Step1: 5 min 95°C 
                                                          Step2: 1 min 95°C 
                                                          Step3: 1 min 55°C    
                                                          Step4: 1 min 72°C 
                                                          Step5: Go to Step2; repeat 24-34 cycles 
                                                          Step6: 10 min 72°C 
The annealing temperature and the time for denaturation were changed according to Tm value of 
primers and the length of the amplicon. 
 
Components Volume Final concentration 
10X PCR buffer 2.5 µl 1X 
50 mM MgCl2 1.0 µl 1.5 mM 
10 mM dNTPs 0.5 µl 0.2 mM each 
10 pmol forward Primer 1.0 µl 0.0004 mM 
10 pmol backward primer 1.0 µl 0.0004 mM 
Template DNA 2.0 µl 0.1-10 ng 
Taq DNA polymerase (5U/ml) 0.25 µl 1.25 units 
dd H2O to 25 µl  
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II.2.1.18  Splicing by overlapping extension PCR 
SOE-PCR (Horton et al., 1989) was used to join the 3’ end of NtCP1 with the DNA constructs 
expressing GFP/StrepII fusion proteins (II.2.2.2). The SOE-primers (Table II-3) were designed so 
that the ends of the PCR products carry complementary sequences. When these PCR products 
were mixed, denatured and annealed, the strands having the matching sequences at their 3’ends 
overlapped and acted as primers for each other. Extension of this overlap by DNA polymerase 
created a molecule in which the original sequences are spliced together. 
SOE-PCR reaction was performed in three steps. The first step was the amplification of the DNA 
fragments (NtCP1 and GFP-Str) individually using designed SOE primers (Table II-3). This step 
of the SOE-PCR program was the same as the PCR program described in section II.2.1.17. The 
second step was the fusion of individual amplified DNA fragments using the SOE reaction. The 
SOE-PCR reaction was performed by mixing equimolar amounts of two overlapping PCR 
fragments in a total reaction volume of 25 l (2.5 l 10x PCR buffer, 1.75 mM MgCl2, 20 pmol 
of each dNTP, and 0.2 units ExpandTM high fidelity DNA polymerase mix). The program for 
SOE reaction comprised 5 min at 96˚C for pre-heating, followed by four cycles of denaturation at 
94˚C for 1 min, annealing at 37˚C for 1 min, extension at 72˚C for 1 min. Third step of SOE-PCR 
was re-amplification of joined DNA fragments (NtCP1 and GFP-Str) using designed terminal 
forward primer for NtCP1-Cterminal part and reverse primer for GFP-Str (Table II-3). To this 
end, the reaction mixture from the SOE-PCR was mixed with 25 l of PCR cocktail containing 
2.5 l 10x PCR buffer, 1.75 mM MgCl2, 20 pmol of each dNTP, 10 pmol of forward and 
backward terminal primers, 0.2 units ExpandTM high fidelity DNA polymerase mix and again 
another normal PCR was performed as described in section (II.2.1.17). The performance of each 
PCR reaction was examined by running 5 μl of each reaction on agarose gels (II.2.1.13) with a 
suitable DNA marker. 
 
II.2.1.19  DNA sequencing 
Dye termination sequencing based on chain termination method described by Sanger et al. (1977) 
was carried out using the Applied Biosystems 3730 DNA analyzer and BigDyeTM terminator 
U3.1 sequencing kit. Chromas software package (Technelysium Pty Ltd) was used for displaying 
the chromatogram files. For assessment of sequencing data the Vector NTI advance10 software 
package and Clone manager software professional suit version 9 (Sci-Ed software) were used. 
 
II.2.2  Expression and purification of recombinant protein 
Recombinant proteins were transiently expressed in a plant system (N. tabacum and N. 
benthamiana or stably in tobacco BY-2 cells. Two different plant species were used for transient 
expression since the Strep II tag was C-terminally cleaved in N. tabacum, but not in N. 
benthamina. For purification, affinity chromatography method was used either by immobilized 
anti-GFP antibodies or Strep-Tactin sepharose. 
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II.2.2.1  Transient expression in N. tabacum or N. benthamina by using agroinfiltration 
A. tumefaciens-mediated infiltration of N. tabacum and N. benthamiana was performed according 
to a modified protocol as described in the literature (Sparkes et al., 2006). Different recombinant 
agrobacteria harboring fusion constructs (II.2.1.1) or the p19 construct as gene silencing 
suppressor (Voinnet et al., 2003) were co-transformed in N. tabacum and N. benthamiana leaves. 
To this end, they were individually inoculated in 50 ml fresh YEB-Km-Rif-Carb in a ratio of 
1:100 from glycerol stocks (II.2.1.10). The cells were incubated at 28ºC o/n with shaking at 160 
rpm (pre-culture). Next day, the cells were spun down by centrifugation (4,000g/RT/15min) and 
supernatant was decanted. Subsequently, the cells were resuspended in 50 ml of YEB-Km-Rif-
Carb medium supplemented with 20 µM acetosyringone, 10 mM glucose, and 10 mM MES (pH 
5.6). The day after, suspensions of recombinant agrobacteria were diluted to the OD600 nm of 1 
using infiltration medium. Prior to agroinfiltration, recombinant agrobacteria carrying the fusion 
constructs (II.2.1.1) or the p19 construct were mixed in a ratio of 4:1 and maintained at room 
temperature for 2-3 h. The respective plants were removed from the greenhouse and placed under 
a white fluorescence lamp for 1 h and leaves were sprayed with water to open stomata fully to aid 
the infiltration. To infiltrate the plant leaves (N. tabacum and N. benthamiana), the prepared 
agrobacteria mixture was injected into tobacco leaves using a 1 ml disposable syringe without 
needle. For injection, it was pressed down gently on the plunger while directly supporting the 
upper side of the leaf by fingers. After agroinfiltration, plants were incubated in a growth 
chamber at 22ºC with 16 h / 8h light/dark photoperiod.  
Infiltration medium:                             
MS basic salt mixture 0.43% (w/v)
MES, pH 5.6 10 mM
Sucrose 2% (w/v)
 
200 M of acetosyringone was added directly before use. 
 
II.2.2.2  Sable transformation of tobacco BY-2 cells  
Stable transformation of tobacco BY-2 cells was performed by co-cultivation of BY-2 suspension 
cultured cells with A. tumefaciens carrying fusion constructs (II.2.1.1) according to the protocol 
previously described (An, 1985). To screen transgenic tobacco BY-2 calli expressing fusion 
constructs (II.2.1.1), the expression of GFP was analysed by Schott cold light source (KL 2500) 
in combination with filters (blue filter for excitation and yellow for emission). Selected 
transformed BY-2 calli were cultured in MS medium (Sigma-Aldrich, Taufkirchen, Germany) 
supplemented with 0.15 µg/ml thiamin-HCl, 0.02 µg/ml KH2PO4, and 3% (w/v) sucrose (pH 5.6) 
to establish transgenic tobacco BY-2 cell lines. For all experiments, the BY-2 cells were 
maintained by subculturing weekly into fresh culture medium using a 5% (v/v) inoculum for 
transgenic and 2% (v/v) inoculum for wild type cells. The cells were incubated in an orbital 
shaker (Eppendorf, Hamburg) at 180 rpm, 26˚C in the dark. 
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II.2.2.3  Expression and purification of NtCP1 from N. benthamiana leaves 
The recombinant NtCP1 was transiently expressed and purified from N. benthamiana leaves 
using Strep-Tactin sepharose matrix (IBA GmbH, Goettingen) according to the manufacture’s 
instruction. Briefly, total soluble protein (TSP) was extracted as mentioned below (II.2.2.5) from 
25 g of syringe infiltrated young leaves (II.2.2.1). Before application of cell extract on the Strep-
Tactin sepharose matrix, the column was equilibrated by adding 2 CV (CV=column volume) of 
equilibration buffer (0.1 M Tris-HCl pH 8.0, 0.15 M NaCl, 1 mM EDTA). After column 
equilibration, the plant cell extract (50 ml) was applied onto the column at 4°C. After the cell 
extract has been completely entered the column, it was washed by adding five CV washing 
buffer. Elution was done by adding six CV elution buffer and elution fractions were collected. To 
regenerate the column it was washed by adding three CV regeneration buffer. The regeneration 
buffer contains the yellow azo dye HABA (2- [4’-hydroxy-benzeneazo] benzoic acid) that was 
added to displace desthiobiotin from the binding pocket. Once HABA binds to the binding site, 
the color turns to red indicating that regeneration process occurred properly and intensity of color 
is an indicator of the column activity status. 
Washing buffer (pH 8.0):          
Tris-HCl 1M
NaCl 1.5 M
EDTA 10 mM
 
Elution buffer (pH 8.0):    
Tris-HCl 1M
NaCl 1.5 M
EDTA 10 mM
Desthiobiotin 25 mM
 
Regeneration  buffer (pH 8.0):       
Tris-HCl 1M
NaCl 1.5 M
EDTA 10 mM
HABA 
 
10 mM
II.2.2.4 Purification of NtAP1 and NtSP1 from transgenic BY-2 cell lines 
The full-length proteins NtAP1 and NtSP1 both fused to GFP protein and Strep II-tag (II.2.2.2) 
were purified from transgenic BY-2 cells using the µMACSTM isolation kit according to 
manufacturer’s instruction (Miltenyi Biotec, Bergisch Gladbach). For this purpose, the transgenic 
BY-2 cell lines expressing the full-length proteins NtAP1 and NtSP1 both fused to GFP were 
harvested after five days post-subculture. The BY-2 cells were separated from culture medium by 
using a vacuum filtration unit (Sartorius, Goettingen). Total soluble protein (TSP) was extracted 
as described (II.2.2.5). The cell extract was transferred to a fresh 1.5 ml tube and 50 µl of anti-
GFP microbeads added to magnetically label the epitope-tagged target protein. After the labeling 
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incubation has finished apply the cell lysate onto the column and let lysate run through. The 
column was washed four times with 200 µl of washing buffer I and once with washing buffer II. 
The bonded proteins to matrix were eluted by shifting pH.  
 
Washing buffer I (pH 8.0): 
Tris-HCl 50 mM 
NaCl 150 mM 
Sodium deoxycholate                   0.5% (w/v) 
Triton X-100 1% (v/v) 
 
Washing buffer II (pH 7.5) 
Tris-HCl 20 mM 
 
Acidic elution buffer (pH 3.0) 
 
                                      
 
Alkaline elution buffer (pH 11.0) 
 
 
 
II.2.2.5 Preparation of total soluble proteins from plant leaves and BY-2 cells 
Total soluble protein (TSP) was extracted from transiently transformed N. tabacum and N. 
benthamiana leaves (II.2.2.1) by using liquid nitrogen and mortar and pestle to convert leaves to 
powder and then 2 ml of extraction buffer was added per gram of leaf material. For clarification, 
cell debris was removed by centrifugation (20,000 g/4°C/30 min) and the supernatant was used 
for purification of NtCP1 fusion proteins via Strep-Tactin sepharose matrix (II.2.2.3). To extract 
NtAP1 and NtSP1 fusion proteins from stably transformed BY-2 cell lines, the transgenic BY-2 
cells were separated from culture medium by vacuum filtration. Total soluble protein (TSP) was 
extracted as described above and clarified supernatant was used for purification via the 
µMACSTM isolation kit (II.2.2.4). 
Extraction buffer (pH 8.0):    
Tris-HCl 100 mM 
EDTA 5 mM 
NaCl 150 mM 
DTT 10 mM 
Triton X-100 0.5% (v/v) 
 
Extraction buffer was supplemented with a tablet of protease inhibitor cocktail EDTA-free 
(Roche, Mannheim) according to the manufacturer’s recommendation.  
 
Glycine-HCl 100 mM 
CAPS 100 mM 
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II.2.3 Protein analysis 
II.2.3.1 Quantification of proteins  
Purified recombinant proteases were prepared from N. benthamiana and tobacco BY-2 cell lines 
(II.2.2.3 and II.2.2.4). Defined amounts of purified standard proteins (BSA) and purified 
proteases were separated by SDS-PAGE, visualized by Coomassie blue or silver staining 
(II.2.3.2). Purified proteases were quantified by AIDA image analysis software. BSA protein 
dilution series served as a standard to quantify purified protein amount. 
II.2.3.2 SDS-PAA gel electrophoresis and staining of gel 
After protein purification (II.2.2.3 and II.2.24), the purity of purified recombinant proteases was 
analyzed by discontinuous SDS-polyacrylamide gel electrophoresis (for the stacking gel: T = 4%, 
C = 2.6%, pH 6.8; for the separating gel: T = 12%, C = 2.6%, pH 8.8) (Ausubel et al., 1995) 
under reducing and/or non-reducing conditions (Laemmli, 1970) using a Mini-PROTEAN Tetra 
Cell apparatus (Bio-Rad). Prior to loading onto the gel, protein samples were mixed with proper 
5x sample buffer depending on reducing or non-reducing conditions. For reducing conditions, 
samples were denatured by boiling for 5 min in the presence of β-Mercaptoethanol and then 
separated by constant 120 V for 70 min. Purified proteases were visualized either by staining gels 
(Coomassie brilliant blue or silver staining (Shevchenko et al., 1996) or by transferring to 
nitrocellulose membrane for immunoblotting analysis (II.2.3.3). Staining and de-staining of the 
gels were carried out with Fairbank solutions followed by boiling with microwave and constant 
rocking (Wong et al., 2000). For mass spectrometry (MS) analysis, protein bands were cut out 
from sensitive Coomassie blue stained gel (Kang et al., 2002). 
SDS-PAGE running buffer (pH 8.3):                                     
Tris base 25 mM
Glycine 192 mM
SDS 0.1% (w/v)
 
Coomassie staining solution: 
Coomassie brillant blue R-250 0.25% (w/v)
Methanol 50% (v/v)
Glacial acetic acid 9% (v/v)
 
 
Coomassie destaining solution:                           
Methanol 5% (v/v)
Glacial acetic acid 7.5% (v/v)
 
Sensitive Coomassie blue staining solutions: 
Staining solution:  
Aluminium sulfate  5% (w/v)
Ethanol 10% (v/v)
Coomassie Brilliant Blue 0.02% (w/v)
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(CBB-G250) 
Phosphoric acid  2% (v/v)
 
Destaining solution: 
Ethanol 10% (v/v)
Phosphoric acid 2% (v/v)
 
Silver staining solutions: 
Fixation solution:   
Ethanol 50% (v/v)
Glacial acetic acid 5% (v/v)
 
Sensitizer:  
Sodium thiosulfate  0.02% (v/v)
 
Silver stain solution: 
Silver nitrate 0.1% (v/v)
 
Developing solution:  
Formalin 0.05% (v/v)
Sodium bicarbonate 2% (v/v)
Stop solution:  
Acetic acid  5% (v/v)
 
II.2.3.3  Immunoblot analysis 
Separated proteins (II.2.3.2) were transferred from an SDS-PAA gel to a PVDF or Hybond™-C 
nitrocellulose membrane (0.45 μm) electrophoretically using the BioRad Mini Protean II tank 
blot device. The membrane was blocked with 1x PBST buffer containing 5% (w/v) skim milk 
powder. Primary antibody anti-GFP (0.4 µg/ml) and secondary antibody goat anti-mouse IgG (Fc 
specific) conjugated to alkaline phosphatase (0.12 µg/ml) were used to detect GFP fusion 
proteins. Strep-Tactin (0.046 µg/ml)) conjugated to alkaline phosphatase (AP) was used to detect 
proteins containing a Strep II-tag. To detect human serum albumin (HSA), goat anti HSA (0.33 
µg/ml) was used as primary antibody followed by rabbit anti goat Fc-AP (0.12 µg/ml) as 
secondary antibody. For detection of heavy and light chains of the M12 antibody, goat anti-
human IgG (Fc)-AP antibody (0.2 µg/ml) and goat anti-human lambda-AP (0.46 µg/ml) were 
used, respectively. Bound secondary antibodies were finally revealed by addition of substrate 
BCIP/NBT in AP buffer. 
PBST buffer (pH 7.4):                                   
NaCl 137 mM
KCl 2.7 mM
Na2HPO4 8.1 mM
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KH2PO4 1.5 mM
Tween 20 0.5-1.0% (v/v)
Transfer buffer (pH 8.3):                                      
Tris-HCl 25 mM
Glycine 192 mM
Methanol 20% (v/v)
 
AP buffer (pH 9.6): 
Tris-HCl, pH 9.6 100 mM
NaCl 100 mM
MgCl2 5 mM
 
II.2.3.4 Mass spectrometry (MS) 
The NtAP1 fusion protein was purified from transgenic BY-2 cell lines (II.2.2.4), separated by 
SDS-PAGE (II.2.3.2) and visualized by sensitive Coomassie blue staining (Kang et al., 2002). 
The stained bands in sensitive Coomassie blue staining were excised from the SDS-PAGE 
(II.2.3.2) and then digested by trypsin to produce a complex mixture of peptides, preferential for 
MS analysis and with basic residues at the carboxyl terminus of the peptides (Arg or Lys 
residues). The peptide mixter was separated using RP chromatography and respective peptides 
were directly sprayed into mass spectrometer. To find matching proteins, generated MS/MS 
peptide spectra were used for the search in a Swiss-Prot using sophisticated software (Mascot).  
II.2.4 Protease activity assay  
II.2.4.1 Activity assay using synthetic substrates 
The quenched fluorogenic substrate for cathepsin D and cathepsin E (Enzo Life Sciences, 
Lörrach,) was used as specific substrate for activity assay of the purified NtAP1 protease 
(II.2.2.4). The substrate is one decapeptide Mca-Gly-Lys-Pro-Ile-Leu-PhePhe-Arg-Leu-Lys 
(Dnp)-D-Arg-NH2 [Mca = (7-methoxycoumarin-4-yl) acetyl; Dnp=dinitrophenyl] in which the 
Mca fluorescence is quenched by the Dnp group until cleavage occurs between two residues with 
hydrophobic side chains (PhePhe) (Yasuda et al., 1999). The activity assay was performed in a 
total volume of 100 µl; the standard assay contained 20 µM of substrate and 300 ng of purified 
NtAP1 in 50 mM Tri-sodium citrate, pH 3.1. Cleavage of quenched substrate was monitored over 
60 min using the Synergy HT Multiplate Reader (BioTek Instruments GmbH, Bad Friedrichshall) 
with 360 excitation and 460 nm emission at 37ºC. To inhibit activity of the NtAP1 protease, 5 
µM of Pepstatin A was added in a total volume of 100 µl. Water was used as negative control in 
the assay. 
 
Aspartic protease reaction buffer (pH 3.1):                                     
Tri Na-citrate 50 mM 
NaCl 200mM 
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For activity assay of purified NtCP1 (II.2.2.3), fluorogenic substrate for cathepsin B and L and 
papain was used, Z-Phe-Arg-AMC [Z: benzyloxycarbonyl; AMC: 7-Amino-4-methyl 
coumarin] (Tchoupe et al., 1990). The activity assay was carried out in a total volume of 100 µl; 
the standard assay contained 10 µM of substrate and 500 ng of purified NtCP1 in 100 mM 
sodium acetate buffer, pH 4.5. Cleavage of the substrate was monitored over 60 min using the 
Synergy HT Multiplate Reader with 380 nm excitation and 460 nm emission at 37ºC. To inhibit 
the activity of NtCP1, 10 µM of E-64 was added in a total volume of 100 µM. Water was used as 
negative control in assay.  
Cysteine protease reaction buffer (pH 4.5):                                     
Sodium acetate 100 mM
EDTA 
DTT 
4 mM
8 mM
II.2.4.2 Proteolytic activity of NtAP1 using biopharmaceuticals 
The degradation of valuable biopharmaceutical proteins by active NtAP1 was assayed (II.2.2.4). 
For this purpose, human serum albumin (HSA), the vitronectin-specific human antibody M12, 
and the human anti-HIV antibody 2F5 were selected as model proteins. The proteolytic activity 
assay was performed in a total volume of 100 µl; the standard assay contained 1 µg of each 
biopharmaceutical protein as mentioned above and 300 ng of purified NtAP1 (II.2.2.4) in 50 mM 
Tri-sodium citrate, pH 3.1. This reaction mixture was incubated o/n at 28ºC. After incubation, 0.4 
µg of these biopharmaceutical proteins were separated by 12% (w/v) SDS-PAGE (II.2.3.2) and 
analyzed by immunoblot (II.2.3.3). Pepstatin A (5 µM) was used in total volume of 100 µl to 
inhibit degradation of biopharmaceutical proteins by purified NtAP1 (II.2.2.4). Aspartic protease 
reaction buffer was used as negative control in the proteolytic activity assay. 
Aspartic protease reaction buffer (pH 3.1):                                     
Tri Na-citrate 50 mM 
NaCl 200mM 
 
II.2.5 Subcellular localization study of recombinant proteases in BY-2 cells 
II.2.5.1 Laser scanning confocal microscopy 
Laser scanning confocal microscopy was performed to study transgenic BY-2 cell lines over-
expressing proteases fused to GFP (II.2.1.1). Images were acquired using Leica TCS-SP spectral 
confocal microscope equipped with an argon ion laser using a 40× oil immersion PLAN-APO 
objective (Leica, Wetzlar). GFP was excited at 488-nm wavelengths by the argon laser line, and 
the resulting fluorescence filtered through 500-570-nm emission filters to the photomultiplier 
tube (PMT) detector. FM4-64 was excited at 561-nm and images were taken at 575-nm emission. 
Images were captured using Leica TCS-SP software, converted to TIFF format for export, and 
images were overlaid by Adobe Photoshop CS5 software.  
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II.2.5.2 Application of endocytosis marker FM4-64 and vesicular trafficking inhibitors 
Transgenic BY-2 cell lines expressing fusion constructs (II.2.1.1) were used in the FM4-64 
uptake and trafficking inhibitor studies. The transgenic BY-2 cell lines were harvested four days 
after post subculture, followed by addition of FM4-64 (20 µM), E-64 (10 µM), and BFA (35.6 
µM) to 2 ml of cultured cells and incubated o/n at 26ºC with 180 rpm. The treated cells were 
transferred onto slides and observed by laser scanning confocal microscopy (II.2.5.1). 
 
II.3 Activity-based protein profiling 
II.3.1 In vivo labeling of tobacco BY-2 cells suspension culture 
The transgenic BY-2 cell lines expressing the full-length NtAP1 fusion were harvested after four 
days subculture. Labeling experiments were performed using 2 ml of cell culture for each 
experiment; the solution was transferred to a 12-well cell culture plates. Symplostatin was added 
to this solution and its derivatives as activity based probes (10 µM final concentration) (provided 
by Dr. Renier van der Hoorn, MPIPZ) and incubated o/n at 26ºC with shaking (180 rpm). After 
the labeling, the cells were separated from medium and ground with liquid nitrogen. Total soluble 
protein (TSP) was extracted using extraction buffer (100 mM tris-HCl, pH 8.0, 10 mM DTT). 
The cell extract was clarified using centrifugation (16,000 g /4ºC/10min). Supernatant was passed 
through a PD-10 column (Bio-Rad, Munich). The biotinylated probe was used to enrich the target 
proteases with avidin-agarose beads.  The reaction was stopped using SDS-PAGE loading buffer 
and boiling samples to 95ºC for five minutes. The proteins were fractionated by SDS-PAGE 
(II.2.3.2) and visualized using immunoblot (II.2.3.3). For immunoblot, the proteins were blotted 
onto nitrocellulose membrane after SDS-PAGE separation and detected using streptavidin-
horseradish-peroxidase (HRP). 
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III   Results 
 
The result section is divided into three parts to describe molecular characterization and 
subcellular localization of three endogenous proteases cloned from tobacco BY-2 cells: 
phytepsin-like aspartic (NtAP1), aleurain-like cysteine (NtCP1), and subtilisin-like serine 
(NtSP1) proteases. To this end, cDNAs encoding these proteases were fused to cDNAs of GFP 
and Strep II-tag proteins, cloned into the plant expression vector pTRAkt and then transformed 
stably in tobacco BY-2 cells or transiently in tobacco/N. benthamiana leaves, respectively. The 
expression of these recombinant proteases was analyzed by immunoblot. After that, recombinant 
proteases were purified from transgenic BY-2 cell lines via an anti-GFP antibody coupled to 
magnetic beads or from transiently transformed tobacco/N. benthamiana leaves via immobilized 
Strep-Tactin. Protease activity was determined by using specific synthetic substrates. In addition, 
the proteolytic activity of aspartic protease fusion protein (NtAP1) was evaluated towards 
pharmaceutical proteins used as model such as human serum albumin (HSA) and M12 antibody.  
To determine the subcellular localization of the tobacco endogenous proteases, BY-2 cells 
producing NtAP1-GFP-Str, NtCP1-GFP-Str, and NtSP1-GFP-Str fusion proteins were analyzed 
using laser scanning confocal microscopy (LSCM). In addition, the intracellular trafficking of 
these proteases was studied using the protein transport inhibitors. Two chemical inhibitors (the 
cysteine proteases inhibitor E-64 and Brefeldin A) were used to perturb specific parts of the 
trafficking pathway for better understanding of the proteases transport through the intracellular 
compartments. Using a biotinylated cysteine protease inhibitor the target protease of E-64 were 
purified and identified with mass spectrometric analysis. As the biosynthetic and the endocytic 
pathways merge within endosomal system in tobacco BY-2 cells, the colocalization studies of 
aforementioned fusion proteases were performed with an endocytic tracer FM4-64 for a detailed 
elucidation of proteases transport.  
 
III.1  Characterization of NtAP1 from tobacco BY-2 cells 
III.1.1   Expression and purification of the recombinant NtAP1  
III.1.1.1 Expression of the NtAP1 in N. benthamiana  
The cDNA sequence of NtAP1 is 1830 bp long with a 1524 bp ORF encoding 508 amino acids. 
In silico analysis using SignalP 4.0 (Petersen et al., 2011) and multiple sequence alignment (refer 
to appendix VII.2) with various aspartic proteases (APs) from other plant species like Cirsium 
vulgare, Centaurea calcitrapa, Arabidopsis thaliana, Helianthus annuus, and Hordeum vulgare 
predicted that the primary structure of NtAP1 is composed of different domains as follows. (1) a 
signal peptide (aa 1-24), (2) a propeptide (aa 25-69), (3) the catalytic domain (aa 69-315) with the 
two catalytic aspartic acid residues D103 and D290, (4) the PSI (aa 315-417) and (5) the C-
terminal domain (aa 418-508). The N-terminal part of catalytic enzyme (aa 69-81) plays an 
important role in inactivation mechanism of enzyme (Kervinen et al., 1999). Four potential N-
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glycosylation sites were also predicted in NtAP1 using the NetNGlyc 1.0 Server (Blom et al., 
2004): one in the catalytic domain (aa 139-141) one in the PSI (aa 399-401) and two in the C-
terminal domain (aa 435-437 and 442-444) (Figure III-1). 
 
(A) 
 
(B) 
 
Figure  III-1: Primary structure of tobacco phytepsin-like aspartic protease NtAP1. A: The different 
domains of NtAP1 are shown in a schematic illustration. SP: signal peptide (aa 1-24); PP: propeptide (aa 
25-69); CD: catalytic domain (aa 69-315); PSI: plant-specific insert (aa 315-417); C-T: c-terminal domain 
(aa 418-508). N-glycosylation sites (NGT: aa 139-141; NET: aa 399-401; NVS: aa 435-437; NQT: aa 
442-444). B: The deduced amino acid sequence of the NtAP1 cDNA clone is shown. The hydrophobic N-
terminal signal peptide is green underlined. The propeptide is highlighted in orange color. The N-terminus 
part of mature enzyme (the first 11 residues) is highlighted in cyan color. The highly conserved Lys78 and 
Tyr80 residues are marked with asterisks. The two catalytic sequence motifs; Asp-Thr-Gly (DTG) and 
Asp-Ser-Gly (DSG) are highlighted in light blue color. Plant specific insert (PSI) is purple underlined. 
Four potential N-glycosylation sites are broken-lined.  
 
Multiple alignment of NtAP1 (GenBank: DQ648018.1) with other published APs amino acid 
sequences using the BLAST database search tool (http://blast.ncbi.nlm.nih.gov/Blast.cgi) shows 
over 60% similarity with other APs in plant species. It shows similarity with preprocirsin 
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(GenBank: AFB73927.2, 77% identity), cenprosin (GenBank: CAA70340.1, 75% identity), the 
Ha-AP (GenBank: BAA76870.1, 73% identity), the At-AP (GenBank: AAC49730.1, 73% 
identity), phytepsin (PDB accession: 1QDM_A, 68% identity), and cardosin A (PDB accession: 
1B5F_A, 69% identity). It also shows less than 60% similarity with human cathepsin E (PDB 
accession: 1TZS_A, identities: 52%) (Table III-1). 
 
Table  III-1: Percentage of identity and similarity of NtAP1 amino acid sequence with other APs. 
GenBank accession 
No. (protein) Organism 
Name of 
protease 
Percentage 
of identical 
residues 
Percentage 
of similar 
residues 
AFB73927.2 Cirsium vulgare Preprocirsin 77 88 
CAA57510.1 Cynara cardunculus Cyprosin 76 87 
CAA70340.1 Centaurea calcitrapa Cenprosin 75 87 
BAA76870.1 Helianthus annuus Ha-AspP 73 86 
AAC49730.1 Arabidopsis thaliana At-AspP 73 84 
1QDM_A (PDB) Hordeum vulgare Phytepsin 68 82 
1B5F_A  (PDB) Cynara Cardunculus  Cardosin A 69 66 
1TZS_A (PDB) Homo sapiens Cathepsin E 52 66 
 
All above-mentioned peptidases belong to the A1 family according to MEROPS classification of 
proteases (Rawlings et al., 2012). To generate the plant expression vector pTRAkt-NtAP1-GFP-
Str (Figure III-2), the cDNA encoding the full-length of the NtAP1 was fused to the cDNAs of 
GFP and the Strep II-tag proteins and then cloned into pTRAkt vector (II.1.8). The expression of 
NtAP1 fusion protein was under the control of CaMV 35S promoter. GFP and Strep II-tag were 
used to facilitate detection and purification of the NtAP1. 
 
 
Figure  III-2: Schematic illustration of the T-DNA of the binary vector pTRAkt-NtAP1-GFP-Str. 
Left and right borders (LB and RB) are 25 bp imperfect repeats that delimit the T-DNA. Pnos is the 
promoter and pAnos is the terminator of the nopaline synthase gene nptII. SAR is the scaffold attachment 
region. P35S is promoter and pA35S is terminator of Cauliflower mosaic virus (CaMV) 35S gene. The 
NtAP1 is the endogenous tobacco aspartic protease. SP is signal peptide sequence of the NtAP1. GFP is 
green fluorescent protein. Str is strepII affinity tag. The number below shows the size of open reading 
frame of the NtAP1 encoding 508 amino acid residues. 
 
The plant expression vector pTRAkt-NtAP1-GFP-Str was transformed to A. tumefaciens 
(II.2.1.7) for subsequent transient expression. Three to four young leaves of N. benthamiana were 
syringe infiltrated with recombinant Agrobacteria (II.2.2.1). To enhance the yield of expression, 
the NtAP1 fusion protein was co-expressed with the p19 protein of the Tomato bushy stunt virus 
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to abolish onset of post-transcriptional gene silencing (PTGS) (Voinnet et al., 2003). Infiltrated 
plants were incubated for 72 h. Subsequently, total soluble protein (TSP) was extracted by mild 
detergents (II.2.2.5), and analysed by immunoblot (II.2.3.3) using an anti-GFP antibody and 
Strep-Tactin. Immunoblot analysis confirmed expression of NtAP1-GFP-Str in N. benthamiana 
leaves (Figure III-3). In immunoblot, four prominent protein bands (~100, ~50, ~28, and ~19 
kDa) were detectable using an anti-GFP antibody (Figure III-3A), whereas only one band was 
visible using Strep-Tactin (~100 kDa) (Figure III-3B). 
 
Figure  III-3: Immunoblot analysis of NtAP1-GFP-Str produced transiently in N. benthamiana. Total 
soluble protein (TSP) was extracted (II.2.2.5) from a transiently transformed N. benthamiana producing 
the NtAP1-GFP-Str (II.2.2.1). Fourty µl of plant cell extract was separated by 12% (w/v) SDS-PAGE 
(II.2.3.2), blotted onto nitrocellulose membrane (II.2.3.3), and probed either by (A) a primary antibody 
mouse anti-GFP (0.4 µg/ml) followed by detection with secondary antibody goat anti-mouse AP-labeled 
Fc-specific antibody (0.12 µg/ml) or (B) by Strep-Tactin AP-labeled (0.046 µg/ml). The membranes were 
incubated with NBT/BCIP solution to develop color. M is prestained protein marker. 
 
The highest molecular mass band (~100 kDa) corresponds to proprotein (detected by an anti-GFP 
antibody and Strep-Tactin) (Figure III-3A, B). The middle band in Figure III-3A represents 
processing intermediate with a molecular mass of ~50 kDa and the lower bands with molecular 
masses of ~28 kDa and ~19 kDa might be free GFP and its degradation product (detected by an 
anti-GFP antibody). This study indicated that the full-length NtAP1 fusion protein is subjected to 
the C-terminal processing during enzyme maturation, which caused the proteolytic cleavage of 
the strep II-tag (Figure III-3B). 
 
III.1.1.2 Expression and purification of NtAP1-GFP-Str from BY-2 cells  
Wild type BY-2 cells were used to produce the NtAP1-GFP-Str protein. Initially the wild type 
cells were stably transformed with the Agrobacterium (II.2.1.7) harbouring pTRAkt-NtAP1-GFP-
Str (II.2.1.1). After three to four weeks the expression of GFP in transgenic BY-2 calli was 
analysed using schott cold light source (KL 2500) in combination with filters (blue filter for 
excitation and yellow for emission). Two transgenic BY-2 calli (#16 and #42) which had high 
levels of GFP expression were selected for the establishment of suspension cultures. The 
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expression of the NtAP1 fusion protein was analysed by immunoblot. To this end, total soluble 
protein (TSP) was extracted (II.2.2.5) from BY-2 cell line number #16 and then visualized by 
immunoblot (II.2.3.3) using an anti-GFP antibody (Figure III-4A) or Strep-Tactin (Figure III-4B), 
respectively. 
 
Figure  III-4: Immunoblot analysis of NtAP1-GFP-Str produced stably in tobacco BY-2 cells. Total 
soluble protein (TSP) was extracted from tobacco BY-2 cell line #16 (II.2.2.2) producing NtAP1-GFP-Str 
(II.2.2.1) after five days subculture (II.2.2.5). Fourty µl of cell extract was fractionated by 12% (w/v) 
SDS-PAGE (II.2.3.2), blotted onto nitrocellulose membrane (II.2.3.3), and probed either by (A) a primary 
antibody mouse anti-GFP (0.4 µg/ml) followed by secondary antibody goat anti-mouse AP-labeled Fc-
specific antibody (0.12 µg/ml) or (B) by Strep-Tactin AP-labeled (0.46 µg/ml). The membranes were 
incubated with NBT/BCIP solution to develop color. M is prestained protein marker. 
 
 
Seven prominent protein bands were revealed in immunoblot probed by an anti-GFP antibody 
(Figure III-4A). The upper band might be proprotein with a molecular mass of ~100 kDa. The 
middle bands with molecular masses of ~70 kDa, ~50 kDa, and ~40 kDa are probably processing 
intermediates. The lower bands (~28 kDa and ~19 kDa) might be free GFP and its degradation 
product. Immunoblot analysis using Strep-Tactin indicated the elimination of Strep II-tag when 
NtAP1-GFP-Str stably expressed in tobacco BY-2 cells (Figure III-4B). From this study it was 
assumed that the Strep II-tag was eliminated by the proteolytic machinery of tobacco BY-2 cell.  
 
The NtAP1-GFP-Str was purified from transgenic BY-2 cell line #16 using an anti-GFP antibody 
coupled to magnetic beads (II.2.2.4). Proteins retained in magnetic field were eluted by shifting 
the pH to 3.0. The eluted proteins were separated on a SDS-PAA gel and silver stained (II.2.3.2) 
(Figure III-5B). Beside this, the eluted proteins were analyzed by immunoblot using an anti-GFP 
antibody (II.2.3.3) (Figure 5A). 
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(A)                                                     (B) 
 
Figure  III-5: Analysis of purified NtAP1-GFP-Str overexpressed in tobacco BY-2 cells. The NtAP1-
GFP-Str was purified from transgenic tobacco BY-2 cell line #16 (II.2.2.2) using an anti-GFP antibody 
coupled to magnetic beads (II.2.2.4). Total soluble protein (TSP) was extracted from 5-day-old BY-2 cell 
line producing NtAP1-GFP-Str (II.2.2.5). The lysate was incubated with an anti-GFP antibody conjugated 
to magnetic beads to magnetically label the NtAP1-GFP-Str. (II.2.2.4). Proteins retained in the magnetic 
field were eluted by dropping pH to 3.0 using elution buffer (0.1 M glycine, pH 3.0). A: Immunoblot 
analysis (II.2.3.3) of elution fraction from anti-GFP IgG affinity chromatography purification of NtAP1-
GFP-Str. Fourty µl of elution fraction was separated by 12% (w/v) SDS-PAGE (II.2.3.2), blotted onto 
nitrocellulose membrane (II.2.3.3), and probed by a primary antibody mouse anti-GFP (0.4 µg/ml) 
followed by detection with secondary antibody goat anti-mouse AP-labeled Fc-specific antibody (0.12 
µg/ml). The membrane was incubated with NBT/BCIP solution to develop color. B: Silver staining 
(II.2.3.2) of elution fraction from an anti-GFP IgG affinity chromatography purification of the NtAP1-
GFP-Str. Different amounts of BSA (100, 50, 25 ng) and 40 µl of elution fraction were separated by 12% 
(w/v) SDS-PAGE (II.2.3.2) and stained with silver nitrate. BSA is bovine serum albumin.  
 
The immunoblot analysis showed 6 distinct bands (Figure III-5A). The band with the highest 
molecular mass (~100 kDa) may be the full-length NtAP1-GFP-Str, while the 76 kDa band 
represents the fusion protein without the propeptide. The ~50 kDa band represents processing 
intermediate and the ~28 kDa band is likely free GFP. The bands with molecular masses of ~25 
kDa and ~19 kDa are most likely GFP degradation products.  
In silver stained SDS PA gel (Figure III-5B) 4 bands were visible with molecular masses of ~55 
kDa, ~35 kDa, ~20 kDa, and ~16 kDa, which were not detected in immunoblot analysis using an 
anti-GFP antibody (Figure III-5A). The most prominent band at ~55 kDa may represent mature 
NtAP1 without propetide, PSI, and GFP. The lower bands at ~35 kDa, ~20 kDa, and ~16 kDa are 
probably NtAP1 degradation products. To get further insight about NtAP1-GFP-Str maturation, 
the bands with molecular masses of ~100 kDa, ~76 kDa, ~55 kDa, and ~19 kDa were isolated, 
digested with trypsin and subjected to mass spectrometric analysis (III.1.3). The yield of purified 
NtAP1-GFP-Str was determined to be around 50 µg/kg fresh weight of harvested transgenic BY-
2 cells.  
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III.1.2  Proteolytic activity assay of the NtAP1-GFP-Str  
III.1.2.1 Proteolytic activity assay by using synthetic substrate  
The activity of purified NtAP1 fusion protein from BY-2 cell line number #16  was determined 
using the synthetic fluorogenic substrate for Cathepsin D/E (Mca-Gly-Lys-Pro-Ile-Leu-PhePhe-
Arg-Leu-Lys (Dnp)-D-Arg-NH2) (Yasuda et al., 1999). This synthetic substrate has been 
generated based on the hydrolytic specificity of Cathepsins D/E, thereby the cleavage occurs 
between two residues with hydrophobic side chains (PhePhe). The reactions were prepared as 
described in the material and methods section (II.2.4.1). The fluorogenic substrate (20µM) was 
mixed with activity assay buffer (0.5 M tri-sodium citrate, 0.1 M NaCl, pH 3.1), followed by 
adding a constant amount of the purified enzyme (~300 ng). After that, the level of fluorescence 
was measured using the synergy HT Multiplate reader. As the majority of proteases in family A1 
are most active at acidic pH (Rawlings et al., 2012), the NtAP1 fusion protein was eluted by 
acidic buffer (0.1 M glycine, pH 3.0). To rule out the possible activity of NtAP1 at alkaline pH, 
the fusion protein was eluted by alkaline buffer (0.1 M CAPS, pH 11.0). The pepstatin A was 
used as an inhibitor of the majority of aspartic proteases (Mutlu et al., 1999). As expected the 
purified NtAP1-GFP-Str eluted by alkaline buffer could not hydrolyze synthetic substrate, while 
the eluted protein by acidic buffer was active (Figure III-6). The activity of protein was inhibited 
in the presence of pepstatin A. These results indicated that the processing of NtAP1 fusion 
protein is pH dependent. The preprotein converts to active form via autocatalytic process at acidic 
pH.  
 
Figure  III-6: Proteolytic activity assay of the NtAP1-GFP-Str using synthetic substrate. The NtAP1-
GFP-Str was purified using an anti-GFP antibody coupled to magnetic beads (II.2.2.4) and then eluted 
either by acidic buffer (0.1 M glycine, pH 3.0) or alkaline buffer (0.1 M CAPS, pH 11.0). The elution 
fractions were incubated with the fluorogenic substrate for Cathepsin D/E (20 µM) in activity assay buffer 
(0.5 M tri-sodium citrate, 0.1 M NaCl, pH 3.1) at 37 ºC for 60 min (II.2.4.1).  
 
III.1.2.2 Proteolytic activity assay by using pharmaceutical proteins as a substrate  
Over the last decades, the plant cells have been used as a platform for the production of valuable 
biopharmaceuticals (Huang et al., 2009; Schillberg et al., 2013; Fischer et al., 1999). The major 
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challenge in plant cell bioproduction platform is low accumulation level of foreign proteins. As 
previously reported in the literature, the endogenous metalloproteases might participate in 
degradation of DSPAα1 produced in tobacco BY-2 cells (Schiermeyer et al., 2004). 
An in vitro assay was performed for a better understanding of the influence of NtAP1 on 
degradation of foreign proteins. To this end, purified NtAP1 fusion protein (II.2.2.4) was 
incubated for 20 h with selected recombinant proteins (II.2.4.2) and then analyzed by 
immunoblot (II.2.3.3). Two pharmaceutical proteins were used as model for this assay: (1) the 
human serum albumin (HSA) which derived from serum with >95.0% purity (EMD Chemical, 
Darmstadt) and (2) the vitronectin-specific M12 antibody (kindly provided by Dr. Nicole Raven, 
Fraunhofer IME). 
Human serum albumin (HSA) consists of 585 amino acids with a molecular mass of 66.5 kDa. It 
has been used for treatment of critical ill patients (Nicholson et al., 2000). Immunoblot analysis 
indicated the degradation of HSA protein in the presence of purified NtAP1-GFP-Str (Figure III-
7, lane 2), whereas proteolysis was significantly reduced by adding the AP inhibitor pepstatin A 
(Figure III-7, lane 3). The HSA protein is roughly stable when incubated in activity assay buffer 
lacking the NtAP1-GFP-Str (Figure III-7, lane 1).  
 
Figure  III-7: Immunoblot analysis of human serum albumin (HSA) in the presence of purified 
NtAP1-GFP-Str. The purified NtAP1-GFP-Str (300 ng) was incubated with one microgram of HSA 
overnight at 28˚C in activity assay buffer (0.5 M tri-sodium citrate, 0.1 M NaCl, pH 3.1) (II.2.4.2). 
Around 0.4 µg of HSA was separated by 12% (w/v) SDS-PAGE (II.2.3.2), blotted onto nitrocellulose 
membrane (II.2.3.3), probed by a primary antibody goat anti HSA (0.33 µg/ml) followed by detection with 
rabbit anti goat (Fc)-AP labeled (0.12 µg/µl). The membrane was incubated with NBT/BCIP solution to 
develop color. M: prestained protein marker; 1, HSA incubated with activity assay buffer (II.2.4.2) in the 
absence of purified NtAP1-GFP-Str; 2, HSA incubated with activity assay buffer (II.2.4.2) in the presence 
of purified NtAP1-GFP-Str  (300 ng); 3, HSA incubated with activity assay buffer (II.2.4.2) in the 
presence of purified NtAP1-GFP-Str  (300 ng) and pepstatin A (5µM). Arrow indicates the full-length of 
HSA.  
 
The vitronectin-specific antibody M12 is a diagnostic and therapeutic humanized antibody 
(Wong et al., 2001). The stability of M12 antibody against purified NtAP1-GFP-Str was studied 
in vitro. To this end, purified enzyme and M12 antibody were incubated for 20 h in activity assay 
buffer (II.2.4.2). Subsequently, reaction buffer was analyzed by immunoblot (II.2.3.3) to 
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visualize potential degradation products. Immunoblot analysis (Figure III-8) indicated that 
purified NtAP1 fusion protein could degrade the heavy chain (HC) of the M12 antibody and form 
four visible degradation products (~50, ~45, ~38, and ~37 kDa) (Figure III-8, lane 2). The 
degradation of the M12 antibody was reduced in the presence of pespstain A (Figure III-8, lane 
3). In addition, the M12 antibody standard was stable whilst incubated in activity assay buffer 
(Figure III-8, lane 1) without the presence of the purified NtAP1 fusion protein. 
 
Figure  III-8: Immunoblot analysis of M12 antibody in the presence of purified NtAP1-GFP-Str. The 
purified NtAP1-GFP-Str (300 ng) (II.2.2.4) was incubated with one microgram of M12 antibody overnight 
at 28˚C in activity assay buffer (0.5 M tri-sodium citrate, 0.1 M NaCl, pH 3.1) (II.2.4.2). About 0.4 µg of 
M12 antibody was separated by 12% (w/v) SDS-PAGE (II.2.3.2) and then blotted onto nitrocellulose 
membrane (II.2.3.3). The heavy and light chain of M12 antibody was probed by goat anti-human AP-
labeled Fc-specific antibody (0.2 µg/ml) and goat anti-human AP-labeled lambda specific antibody (0.46 
µg/ml) and then developed with NBT/BCIP solution. M: prestained protein marker; 1, M12 antibody 
incubated with activity assay buffer in the absence of purified NtAP1-GFP-Str; 2, M12 antibody incubated 
with activity assay buffer in the presence of purified NtAP1-GFP-Str (300 ng); 3, M12 antibody incubated 
with activity assay buffer in the presence of purified NtAP1-GFP-Str and pepstatin A (5µM). Arrows 
indicate heavy and light chains of the M12 antibody. 
 
From these results it is obvious that the NtAP1 fusion protein can degrade two 
biopharmaceuticals used as model proteins in vitro. These data strengthen the speculation of 
pharmaceutical proteins degradation by the endogenous NtAP1 protease in tobacco BY-2 cells. 
 
III.1.3 Processing of NtAP1-GFP-Str 
Autocatalytic processing of NtAP1-GFP-Str was studied by mass spectrometric (MS) analysis 
(II.2.3.4). The total soluble protein (TSP) was extracted (II.2.2.5) from a 5-day-old culture of 
transgenic BY-2 cell line (#16) producing NtAP1-GFP-Str (Figure III-2). After that, NtAP1 
fusion protein was purified using an anti-GFP antibody conjugated to magnetic beads. Proteins 
retained in magnetic field were eluted by shifting the pH to 3.0 (II.2.2.4). The eluted protein was 
separated by SDS-PAGE (II.2.3.2) and then visualized by sensitive Coomassie blue staining 
(II.2.3.2). Four bands with molecular masses of ~100 kDa, ~76 kDa, ~55 kDa and ~19 kDa were 
excised from the polyacrylamide gel, digested by trypsin, and analysed by MS analysis. Protein 
database searching using search engine (Mascot) found matching proteins to the identified 
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peptides after chromatographic separation (refer to appendix VII.5). These results indicated that 
the ~100 kDa band corresponds to proprotein, while ~76 kDa is fusion protein without 
propeptide. The ~55 kDa is mature NtAP1 enzyme excluding propeptide, part of PSI, and GFP. 
As the ~19 kDa band contains GFP peptide fragments it is most likely a GFP degradation 
product. From this study it is evident that the NtAP1-GFP-Str converts to a mature form after 
deletion of propetide, part of PSI, and GFP. 
                  (A)                                                                (B) 
   
 
 
 
 
 
 
 
 
Figure III-9: Autocatalytic processing analysis of NtAP1-GFP-Str produced in tobacco BY-2 cells. 
A: Sensitive Coomassie blue staining (II.2.3.2) of elution fraction from  an anti-GFP bounded to magnetic 
beads purification of NtAP1-GFP-Str. Around 40 µl of elution fraction was fractionated by 12% (w/v) 
SDS-PAGE (II.2.3.2) and stained with Coomassie blue (II.2.3.2). Numbers indicate excised bands, which 
were digested by trypsin and analyzed by mass spectrometry (II.2.3.4). B: The results of mass 
spectrometric analysis (refer to appendix VII.5).  
 
 
III.1.4 Subcellular localization of NtAP1 in BY-2 cells 
In silico studies with Plant-mPloc (http://www.csbio.sjtu.edu.cn/bioinf/plant-multi/) predicted 
that the endogenous NtAP1 accumulates within the central vacuole. This prediction is based on 
the sequence similarity search of NtAP1 protein with 978 different plant protein sequences stored 
in Plant-mPloc database. These proteins are distributed among 12 subcellular locations of plants. 
To find out the subcellular location of the NtAP1 in vivo, tobacco BY-2 cells were stably 
transformed (II.2.2.2) with the full-length NtAP1-GFP-Str (II.2.1.1) (Figure III-2) and then 
analyzed by laser scanning confocal microscopy (LSCM) (II.2.5.1). When the BY-2 cell line 
number #16 producing NtAP1-GFP-Str was observed in three, five and seven days after 
subculture (Figure III-10B-D), GFP signals were detected within the central vacuole. In contrast, 
GFP signals were not observed in wild type BY-2 cells (Figure III-10A). These data 
demonstrated that the full-length NtAP1 fusion protein targets to the central vacuole.  
Protein 
bands 
no. 
Identified peptides molecular weight (kDa) 
1 Precursor form without signal peptide ~100 
2 Precursor form without propeptide ~76 
3 Mature form after partial deletion of the PSI  ~55 
4 Further processed form of GFP ~19 
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Figure III-10: Confocal images of transgenic tobacco BY-2 cells producing NtAP1-GFP-Str. Wild 
type BY-2 cells  and transgenic cell line (number #16) producing  NtAP1-GFP-Str (II.2.2.2) were 
analyzed by laser scanning confocal microscopy (II.2.5.1). A: The wild type tobacco BY-2 cells after three 
days sub-culturing.  B, C, D:  Tobacco BY-2 cell line #16 producing NtAP1-GFP-Str three, five and seven 
days after sub-culturing. White light transmission is represented on the left, green fluorescence in the 
middle, and the overlaid image on the right. Bar 50 µM. 
 
III.1.5 Vacuolar targeting of NtAP1  
To characterize the NtAP1 vacuolar transport, the BY-2 cell line (#16) producing NtAP1-GFP-
Str was studied by two technical approaches that made it possible to analyze more precisely the 
vacuolar transport of NtAP1. The first is the treatment of the transgenic tobacco BY-2 cells by 
inhibitors of vesicular trafficking (cysteine protease inhibitor E-64 and brefeldin A), which 
interrupted protein transport in specific parts for better understanding of the flow through the 
compartments.  The second is colocalization studies using red fluorescent markers for 
endocytosis (FM4-64 and LysoTracker® Red), because proteins cargo delivery to the vacuole is 
mediated by the same vesicles beyond trans-Golgi network/early endosome (TGN/EE) in both 
biosynthetic and endocytic pathways (II.2.5.2). 
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III.1.5.1 Study of vacuolar transport using vesicular trafficking inhibitors  
Vesicular trafficking inhibitors such as cysteine proteases inhibitors (E-64 and antipain) as well 
as Brefeldin A (BFA) were used in this study (II.2.5.2). Previous studies suggested that E-64 and 
antipain compounds abolish fusion of pre-vacuolar compartment/late endosome (PVC/LE) with 
the vacuole, resulting in the accumulation of aggregates in tobacco BY-2 cells (Yamada et al., 
2005). To monitor the influence of these compounds on vacuolar targeting of NtAP1, the tobacco 
BY-2 cells producing NtAP1-GFP-Str were treated by E-64 (10 µM) (Figure III-11B) and 
antipain (16.5 µM) (Figure III-11C) for 20 h. As a result, the accumulation of aggregates was 
induced and intensity of GFP signals from the vacuole declined compared to untreated transgenic 
BY-2 cells (Figure III-11A). These data showed that cysteine proteases inhibitors interrupt 
vacuolar targeting of NtAP1 in tobacco BY-2 cells. According to previous studies (Yamada et al., 
2005), it was assumed that E-64- and antipain-induced aggregates are probably PVC/LE. 
Moreover, BFA was used to inhibit vesicular trafficking from ER to the Golgi apparatus 
(Nebenfuhr et al., 1999 and Ritzenthaler et al., 2002) and to block vacuolar protein transport 
(Holwerda et al, 1992; Gomez et al., 1993). When the tobacco BY-2 cells producing NtAP1-
GFP-Str were treated by BFA (35.6 µM) for 20 h, vacuolar targeting of NtAP1 was not inhibited. 
As shown in Figure III-11D, intensity of GFP signals in treated BY-2 cells with BFA are the 
same as untreated transgenic BY-2 cells. These results demonstrated that vacuolar targeting of 
NtAP1 is insensitive to BFA in tobacco BY-2 cells.  
 
Figure III-11: Inhibitor studies of tobacco BY-2 cells producing NtAP1-GFP-Str. Tobacco BY-2 cells 
producing NtAP1-GFP-Str (II.2.2.2) were treated with vesicular trafficking inhibitors (II.2.5.2) and then 
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analyzed by laser scanning confocal microscopy (LSCM) five days after sub-culturing (II.2.5.1). A: 
Untreated transgenic tobacco BY-2 cells. B: Transgenic tobacco BY-2 cells treated by E-64 (10 µM) for 
20 h. C: Transgenic tobacco BY-2 cells treated by antipain (16.5 µM) for 20 h. D: Transgenic tobacco 
BY-2 cells treated by BFA (35.6 µM) for 20 h. White light transmission is shown on the left, green 
fluorescence in the middle, and the overlaid images on the right. Arrows indicate aggregates induced by 
PLCPs inhibitors. Bar 50 µM. 
 
III.1.5.2 The colocalization study with fluorescent markers for endocytosis   
Previous studies suggested that endocytic and biosynthetic routes converge beyond the TGN/EE 
where protein trafficking is mediated by PVC/LE to the central vacuole (Tse et al., 2004). To 
determine the position of E-64 induced aggregates in endocytic and vacuolar biosynthetic 
pathways, colocalization studies were done with red fluorescent dyes for endocytosis (FM4-64 
and LysoTracker® Red). FM4-64 is a useful tool for labeling TGN/EE and PVC/LE along the 
endocytic pathway from plasma membrane to the vacuole (Geldner et al., 2003; Tse et al., 2004). 
To perform FM4-64 uptake studies, the tobacco BY-2 cells producing NtAP1-GFP-Str were co-
incubated with both E-64 and FM4-64 for 20 h (Figure III-12B and C) (II.2.5.2). Confocal 
microscopy analysis (II.2.5.1) showed that FM4-64 labels E-64 induced aggregates in tobacco 
BY-2 cells producing NtAP1-GFP-Str (Figure III-12C). As recent studies indicated that the 
TGN/EE is the most acidic compartment in tobacco cells (Martiniere et al., 2013), a red-
fluorescent dye for labeling acidic organelles (LysoTracker®Red) was used to characterize E-64 
induced aggregates. To this end, tobacco BY-2 cells producing NtAP1-GFP-Str were treated with 
E-64 for 20 h and then LysoTracker Red was added 30 min prior to visualization according to 
manufacturer’s recommendation (Life Technologies). As shown in the microscopic images 
(Figure III-12F-H), LysoTracker®Red fluorescent dyes (Figure III-12G) were co-localized with 
E-64 induced aggregates (Figure III-12F). These results revealed that E-64-induced aggregates 
represent TGN/EE, where vacuolar biosynthetic and endocytic pathways merge at this 
compartment, not PVC/EE. Overall, inhibitor and colocalization studies demonstrated that ER, 
TGN/EE and PVC/LE are involved in vacuolar targeting of NtAP1. It was therefore concluded 
that the vacuolar transport of NtAP1 is mediated via classical route. 
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Figure III-12: Colocalization studies of tobacco BY-2 cell line #16 producing NtAP1-GFP-Str.  
Tobacco BY-2 cells producing NtAP1-GFP-Str (II.2.2.2) were treated with inhibitor E-64, endocytic 
tracer FM4-64, and an acidic organelle tracer LysoTracker Red (II.2.5.2) and then analyzed by laser 
scanning confocal microscopy (LSCM) five days after sub-culturing. A, B: Tobacco BY-2 cells producing 
NtAP1-GFP-Str were co-incubated with E-64 (10 µM) and FM4-64 (20 µM) for 20 h. D, E: Tobacco BY-
2 cells producing NtAP1-GFP-Str were incubated with E-64 (10 µM) for 20 h and then labeled with 
LysoTracker Red (50 nM) around 30 min prior to visualization with LSCM (II.2.5.2). Shown are the green 
channel ([A] [B]), the red channel ([D], [E]), and overlays of the separately recorded green and red 
channels ([D], [G]. Arrows indicate E-64 induced aggregates. Bar 50 µM. 
III.1.6 Identification of endosomal papain-like cysteine proteases in BY-2 cells 
The previous results (III-1.5) indicated that papain-like cysteine proteases (PLCPs) inhibitors (E-
64 and antipain) hamper the vacuolar transport of NtAP1 (II.2.5.2), while the aspartic protease 
inhibitor (pepstatin A) does not abolish this transport (Figure III-13).  
 
Figure III-13: Treatment of tobacco BY-2 cells producing NtAP1-GFP-Str with pepstatin A. 
Tobacco BY-2 cell line (#16) producing NtAP1-GFP-Str (II.2.2.2) were treated by pepstatin A for 20 h 
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(II.2.5.2) and then visualized by laser scanning confocal microscopy (LSCM) five days after sub-
culturing. A: Untreated transgenic tobacco BY-2 cells. B: Transgenic tobacco BY-2 cell line #16 treated 
by pepstatin A (5 µM). White light transmission is shown on the left, green fluorescence in the middle, 
and the overlaid images on the right. Bar 50 µM. 
 
From these results it is obvious that PLCPs are involved in vacuolar transport of NtAP1 in BY-2 
cells. To identify the target of PLCPs inhibitors in BY-2 cells, the activity-based protein profiling 
approach (ABPP) was used (II.3). ABPP is based on the employment of small molecule probe 
that reacts with the active site of protease, so it is called activity-based probe (ABP). The ABPs 
are normally conjugated to the reporter tag such as fluorophore or an affinity tag such as biotin. 
This conjugation makes feasible the display of labeled proteins on protein gels and the 
subsequent identification of the labeled proteins using mass spectrometry. The basic structure of 
ABP consists of three parts: a tag, linker, and the reactive group. In Figure III-14, the molecular 
structure of symplostatin 4 conjugated to biotin is shown as an example of ABP (Stolze et al., 
2012).  
 
Figure III-14: Molecular structure of symplostatin 4 tagged to biotin. The natural product 
symplostatin 4 (Sym4) is a PLCPs inhibitor that targets flacipain in P. falciparum.  Sym4 tagged to biotin 
was employed as an activity-based probe (ABP) for labeling PLCPs involved in vacuolar targeting. 
Biotinylated Sym4 facilitates visualization and purification of target proteases. The biotin tag is connected 
to the reactive group by a linker region. The reactive group is the Michael system in (4S)-amino-(2E)-
pentenoic acid moiety that binds to the active site of proteases. In Sym4, the reactive group is linked to 
methyl-methoxypyrrolinone (mmp-group) that affects likely on bio-reactivity and target specificity of this 
probe. The biotin-tag is in pink color, the linker is in green color, the reactive group is in yellow color, and 
mmp-group is in gray color.  
 
In this thesis, beside E-64 and antipain other PLCPs inhibitors were tested for their effectiveness 
to abolish vacuolar transport of NtAP1 (Figure III-16). Among them were symplostatin 4 (Sym4) 
with number #359 and derivatives thereof (Figure III-15) (Stolze et al., 2012). These derivatives 
include Sym4 tagged to biotin-rhodamine (#367) (Figure III-15A), the structural analog of Sym4 
without mmp-group (Sym4-neg) (#361), Sym4-neg tagged to alkyne (#362), Sym4-neg tagged to 
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biotin (#366), and Sym4-neg tagged to biotin-rhodamine (#368) (Figure III-15B). The respective 
derivatives were used to increase flexibility of profiling experiments. These probes were kindly 
provided by Dr. Van Der Hoorn from Plant Chemetics lab (http://www.plantchemetics.org/).  
 
Figure III-15: Symplostatin 4 (Sym4) and derivatives. A: Sym4 with mmp-group and derivatives 
thereof. The number #359 is the parent structure of Sym4, the number #367 is biotin-rhodamine-tagged 
derivative (Bio-Rho-Sym4); B: The analog structure of Sym 4 without mmp-group (Sym4-neg) and 
derivatives thereof. The number #361 is parent structure of Sym4-neg, the number #362 is alkyne-tagged 
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(Sym4-neg), the number #366 is biotin-tagged (Bio-Sym4-neg), and the number #368 is biotin-
rhodamine-tagged (Bio-Rho-Sym4-neg) derivatives. This modified image was obtained from PhD thesis 
of Sara Christina Stolze, 2012. 
As seen in Figure III-16, Sym4 (#359) (Figure III-16D) and derivatives thereof with number 
#361, #362, and #366 (Figure III-16E-G) evoked the same phenotype as E-64 (Figure III-16B) 
and antipain (Figure III-16C) in tobacco BY-2 cells producing NtAP1-GFP-Str. In contrast, the   
probe #367 (Figure III-16H) or #368 (Figure III-16I) did not block vacuolar transport of NtAP1. 
It was assumed that the large size of these probes is the main reason interfering with the uptake 
process from culture medium and the labeling reaction. The large size of these probes is due to 
the presence of both biotin and rhodamine tags (Figure III-15).  
Figure III-16: Screening the Sym4 and derivatives thereof. Tobacco BY-2 cell line (#16) producing 
NtAP1-GFP-Str were treated with E-64 (10 µM), antipain (16.5 µM), symplostatin 4 (Sym4) and its 
derivatives (10 µM) for 20 h (II.3), and then analyzed by laser scanning confocal microscopy on day 5 
(II.2.5.1). A: Untreated BY-2 cell line #16 producing NtAP1-GFP-Str. B-I: BY-2 cell line #16 producing 
NtAP1-GFP-Str were treated by (B) E-64 (C) antipain, (D) Sym4 (#359), (E) Sym4-neg (#361), (F) 
Sym4-neg (#362), (G) biotin-Sym4-neg (#366), (H) biotin-rhodamine-Sym4 (#367), and (I) biotin-
rhodamine-Sym4-neg (#368). Bar 50 µM 
 
A biotinylated version of Sym4-neg (Figure III-15B, number #366) was used to visualize the 
target proteases by immunoblot. The immunoblot analysis using Streptavidin-HRP indicated two 
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specific bands with molecular masses of 45 kDa and 35 kDa, respectively (Figure III-17, lane 2). 
Beside these prominent bands, additional bands with molecular masses of ~80 kDa, ~32 kDa and 
~30 kDa were visible on the gel. These detected bands are probably endogenous biotinylated 
proteins such as BCCP (the biotin carboxyl carrier proteins). The non-biotinylated version of 
sym4 (#362) (Figure III-17, lane 1) and the non-effective probes (#367 and #368) (Figure III-17, 
lane 3 and 4) were used as negative controls.  
 
Figure III-17: Immunoblot of the SDS-PAGE-resolved enzymes labeled by biotin-Sym4-neg. 
Tobacco BY-2 cell line #16 producing NtAP1-GFP-Str were collected four days after subculture, treated 
by Sym 4 (#362), biotin-Sym4-neg (#366), Bio-Rho-Sym4 (#367), or Bio-Rho-Sym4-neg (#368) for 20 
h (II.3). After that, the total soluble protein (TSP) was extracted from each treated cells using extraction 
buffer (II.2.2.5). Around 10 µl of cell extract was separated by 12% (w/v) SDS-PAGE (II.2.3.2), blotted 
onto nitrocellulose membrane (II.2.3.3) and probed by Streptavidin-HRP (0.33 µg/ml). M: prestained 
protein marker; Lane 1: tobacco BY-2 cell line #16 producing NtAP1-GFP-Str treated by Sym4-neg #362 
(10 µM); Lane 2: tobacco BY-2 cell line #16 producing NtAP1-GFP-Str  treated by biotin-Sym4-neg 
(#366); 3: tobacco BY-2 cell line #16  producing NtAP1-GFP-St treated by biotin-rhodamine-Sym4 
(#367); Lane 4; tobacco BY-2 cell line #16  producing NtAP1-GFP-St treated by biotin-rhodamine-Sym4-
neg (#368). Arrows indicate labeled proteins with biotinylated symplostatin 4. 
 
Subsequently, the biotinylated probe was used to enrich the target proteases with avidin-agarose 
beads (II.3.1). The enriched proteases were separated by SDS-PAGE and the 35 kDa and 45 kDa 
bands excised. After tryptic digest and elution from the gel the peptides were analyzed by mass 
spectrometry. The main targets proteins determined to be homologs of RD19C and RD21B (35 
kDa) and RD21B (45 kDa), which are papain-like cysteine proteases (PLCPs) containing a 
granulin domain.  
RD21-like proteases play a role in the plant defense and immunity (Shindo et al., 2012). From 
previous studies it is known that the processing of RD21 occurs auto-catalytically from 
intermediate stage (iRD21) to mature form without granulin domain (mRD21). As the maturation 
of RD21 is an autocatalytic process (Gu et al., 2012), the interruption of vacuolar targeting with 
PLCPs inhibitors suggest that the conversion of iRD21 to mRD21 might be signal transduction 
required for transport of NtAP1 to the central vacuole. 
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III.1.7  Type of NtAP1 vacuolar sorting signal  
Vacuolar sorting signals (VSS) of soluble proteins have been grouped into sequence specific 
(ssVSS), C-terminal hydrophobic (ctVSS), and protein structure-dependent sorting signals 
(psVSS) (Matsuoka et al., 1999). To determine the type of VSS in NtAP1, two technical 
approaches were used. The first was the construction of C-terminal deletion mutants (II.2.1.1) of 
the NtAP1 to study the influence of the C-terminal domain in the vacuolar targeting. The second 
was the comparison of NtAP1 sequence with the N-and C-termini domains of several known 
vacuolar proteins.  
As a first approach, three C-terminal deletion mutants of NtAP1 were generated and fused to 
GFP and Strep II-tag: (1) NtAP1474-GFP-Str with elimination of 34 amino acids from the C-
terminus domain (Figure III-18B); (2) NtAP1417-GFP-Str excluding the C-terminal domain 
(Figure III-18C), and NtAP1299-GFP-Str with deletion of the C-terminal domain, the PSI, and 
additional 18 amino acids from the catalytic domain (Figure III-18D). 
 
Figure III-18: The schematic representation of NtAP1 fusion protein and its C-terminal deletion 
mutants. A: The full-length sequence of NtAP1 fused to GFP and Strep II-tag (NtAP1-GFP-Str); B: The 
C-terminal deletion mutant of NtAP1 with 34 amino acids deletion from the C-terminus domain fused to 
GFP and Strep II-tag (NtAP1474-GFP-Str); C: The C-terminal deletion mutant of NtAP1 lacking the C-
terminus domain fused to GFP and Strep II-tag (NtAP1417-GFP-Str); D: The C-terminal deletion mutant of 
NtAP1 without C-terminal domain, PSI and additional 18 amino acids from the catalytic domain fused to 
GFP and Strep II-tag (NtAP1299-GFP-Str). SP: signal peptide; PP: propeptide; CD: catalytic domain; PSI: 
plant specific insert; GFP: green fluorescent protein; S: strep II-tag. 
 
Prior to stable transformation, they were transiently produced in tobacco leaves (II.2.2.1) and 
then analyzed by immunoblot using an anti-GFP antibody. (II.2.3.3). In immunoblot (Figure III-
19A), the precursor form of the NtAP1 fusion protein and its C-terminal deletion mutants were 
visible with molecular masses of ~100 kDa, ~89 kDa, ~83 kDa, and ~70 kDa. In addition, two 
prominant bands were detected at ~55 kDa and ~28 kDa. The ~55 kDa represents processing 
intermediate, while ~28 kDa is mostly likely free GFP. This result confirmed the expression of 
the NtAP1 fusion protein and its C-terminal deletion mutants.  
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To study the function of C-terminal domain in NtAP1 vacuolar sorting, generated contructs 
(Figure III-18) were stably transformed in tobacco BY-2 cells (II.2.2.2). Each tobacco BY-2 cell 
line producing NtAP1-GFP-Str (#16), NtAP1474-GFP-Str (#9), NtAP1417-GFP-Str (#7), or 
NtAP1299-GFP-Str (#15) was checked by immnunoblot using an anti-GFP antibody (II.2.3.3). 
This analysis confirmed the production of the fusion proteins in tobacco BY-2 cells (Figure III-
19B). The upper bands represent proprotein of the NtAP1-GFP-Str and its C-terminal deletion 
mutants with molecular masses of ~100 kDa, ~89 kDa, ~83 kDa, and ~70 kDa. The processing 
intermediate of NtAP1 or NtAP1474 fusion protein was detected at ~83 kDa (Figure III-19B, lane 
3, 4), while ~70 kDa or ~55 kDa represents the processing intermediate of NtAP1417-GFP (Figure 
III-19B, lane 2) or NtAP1299-GFP-Str (Figure III-19B, lane 1), respectively. In Figure III-19, lane 
4, the lower bands with molecular masses of ~70 kDa, ~50 kDa and ~38 kDa correspond to 
degradation products of the full-length of NtAP1 fusion protein.  
                               (A)                                                             (B) 
 
Figure III-19: Immunoblot analysis of NtAP1 fusion protein and its C-terminal deletion mutants. 
NtAP1 fusion construct and C-terminal deletion mutants (II.2.1.1) were transiently produced in tobacco 
leaves (II.2.2.1) and stably in tobacco BY-2 cells (II.2.2.2). Total soluble protein (TSP) was extracted 
from infiltrated tobacco leaves or transgenic BY-2 cells using extraction buffer (II.2.2.2). Around 40 µl of 
plant extract was separated by 12% (w/v) SDS-PAGE (II.2.3.2), blotted onto nitrocellulose membrane 
(II.2.3.3), and then probed by a primary antibody mouse anti-GFP (0.4 µg/ml) followed by detection with 
secondary antibody goat anti-mouse AP-labeled Fc-specific antibody (0.12 µg/ml). The membranes were 
incubated with NBT/BCIP solution to develop color. A: Immunoblot analysis of transiently produced 
NtAP1 fusion protein and its C-terminal deletion mutants in tobacco leaves; (1) NtAP1299-GFP-Str, (2) 
NtAP1417-GFP-Str, (3) NtAP1474-GFP-Str, and (4) NtAP1-GFP-Str. B: Immunoblot analysis of produced 
stably NtAP1 fusion protein and its C-terminal deletion mutants in tobacco BY-2 cells; (1) NtAP1299-GFP-
Str; (2) NtAP1417-GFP-Str, (3) NtAP1474-GFP-Str, and (4) NtAP1-GFP-Str. Arrows indicate the precursor 
of the NtAP1 fusion protein and its C-terminal deletion mutants. 
 
To study the subcellular localization of NtAP1 fusion protein and its C-terminal deletion mutants, 
transgenic tobacco BY-2 cell lines were analyzed using laser scanning confocal microscopy 
(II.2.5.1) (Figure III-20). The confocal images showed that the C-terminal deletion mutants were 
retained in the endoplasmic reticulum (ER) (Figure III-20B-D), while the full-length NtAP1 
fusion protein was targeted to the central vacuole (Figure III-20A). These results elucidated that 
vacuolar targeting determinant of NtAP1 resides within the C-terminus domain of NtAP1.  
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Figure III-20: Confocal microscopy of tobacco BY-2 cell lines producing NtAP1 fusion constructs 
and its C-terminal deletion mutants. Transgenic tobacco BY-2 cells producing the NtAP1-GFP-Str and 
its C-terminal deletion mutants were analyzed by laser scanning confocal microscopy (II.2.5.1) five days 
after sub-culturing. A: The tobacco BY-2 cell line #16 producing NtAP1-GFP-Str (Figure III-18A). B: 
The tobacco BY-2 cell line #9 producing NtAP1474-GFP-Str (Figure III-18B). C: The tobacco BY-2 cell 
line #7 producing NtAP1417-GFP-Str (Figure III-18C). D: The tobacco BY-2 cell line #15 producing 
NtAP1299-GFP-Str (Figure III-18D). White light transmission is shown on left, green fluorescence in the 
middle, and the overlaid images on the right. The scale bar indicated a distance of 50 µM. 
 
To decipher vacuolar sorting determinant residing in the C-terminal domain of NtAP1, C-
terminal domain of NtAP1 was compared with other protein families containing C-terminal 
vacuolar sorting signal (ctVSS) (Figure III-21). Amino acids alignment of NtAP1 C-terminal 
domain with other known ctVSS revealed that the four amino acids FAEA are conserved among 
them. From previous studies it is known that the C-terminal short peptide (FAEA) is sufficient 
for vacuolar targeting of chimeric proteins (Pereira et al, 2013). It was therefore concluded that 
the type of the NtAP1 vacuole sorting signals is ctVSS and the C-terminal peptide FAEA might 
be the responsible sorting signal for vacuolar targeting. 
  
Chapter III                                                                                                                               Results 
 
-62- 
TomatoAP           VG-FAEAA  
AtAP1              VG-FAEAA  
CardosinA          VG-FAEAA  
NtAP1              VG-FAEAA  
Barley-lectin      -GVFAEAI  
 
Figure III-21: Alignment of amino acid sequences of the NtAP1 C-terminal domain with other 
known C-terminal domains containing VSS. GenBank accession number: Tomato AP from Solanum 
lycopersicum (XM_004243437.1). AtAP1 from Arabidopsis thaliana (AAC49730.1). Cardosin A from 
Cynara Cardunculus (AJ132884). NtAP1 from Nicotiana tabacum (DQ648018.1). Lectin from 
Hordeum vulgare (M29280.1). The conserved amino acids in the C-terminal domain are shown in 
yellow. 
 
 
 
III.2  Characterization of NtCP1 from tobacco BY-2 cells 
III.2.1 Expression and purification of the recombinant NtCP1  
III.2.1.1 Transient expression of NtCP1 in N. benthamiana  
The cDNA of the aleurain-like (C1A) cysteine protease NtCP1 was cloned from the tobacco BY-
2 cells (kindly provided by Mrs. Verena Wahner, Fraunhofer IME) using degenerated primers. 
The cDNA sequence is 1345 bp long with a 1080 bp open reading frame (ORF) encoding 360 
amino acids. In silico analysis of the NtCP1 using SignalP 4.0 (Petersen et al., 2011) and multiple 
sequence alignment (refer to the appendix VII.4) with different cysteine proteases (CPs) from 
other plant species such as Nicotiana tabacum, Hordeum vulgare, Oryza sativa, and Solanum 
lycopersicum predicted that a preproprotein consists of four domains: a signal peptide (aa 1-22), 
an N-terminal propeptide (aa 23-143), a catalytic domain (aa 143-327), and a carboxy-terminus 
domain (aa 327-360). An N-terminal propeptide contains a vacuolar sorting signal (NPIR) and 
the non-contiguous ERFNIN motif. The catalytic domain comprises the catalytic amino acids 
C167, H307, and N327. In addition, two potential N-glycosylation sites were predicted in NtCP1 
(NCS: 127, NIT: 256) using the NetNGlyc 1.0 Server (Blom et al., 2004) (Figure III-22). 
 
(A)  
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(B) 
 
Figure III-22: Primary structure of tobacco aleurain-like protease NtCP1. A: Schematic 
representation of the different domains of the aleurain-like NtCP1 primary structure. SP: signal peptide; 
PP: propeptide containing vacuolar sorting signal (VSS); CD: catalytic domain; C-T: c-terminus domain. 
B: Deduced amino acid sequence of the aleurain NtCP1. The hydrophobic signal peptide is green 
underlined. An N-terminal propeptide is highlighted by dark blue. The putative vacuolar sorting signal 
(VSS) is highlighted by red colour (NPIR). The non-contiguous ERFNIN motif in the propeptide is 
marked with asterisks. Purple circles indicate the catalytic amino acid residues (C167, H307, and N327). 
Two potential N-glycosylation sites are shown with red broken-line (NCS: 127, NIT: 256). Black 
rectangles show the cysteine residues which function in formation of the disulfide bridges. 
 
Amino acids sequence similarity search of the NtCP1 (GenBank: ABW71226.1) with other 
published CPs using BLAST (http://blast.ncbi.nlm.nih.gov/Blast.cgi) shows 96% similarity to 
tobacco NtCP-23 (AAK07729.1), 96% to tobacco NbCP1 (AAZ32410.1), 89% to petunia P21 
(AAC49361.1), 86% to tomato SENU3 (CAA88629.1), and 78% to actindin (ABQ10199.1). In 
addition, it shows less than 75% similarity with barley aleurain (CAA28804.1, identities: 73%), 
rice oryzain gamma (BAA14404.1, identities: 69%), and human cathepsin H (GenBank: 
CAA30428.1, identities: 61%) (Table III-2).  
 
Table  III-2: Percentage of identity and similarity of NtCP1 amino acid sequence with other CPs. 
GenBank accession 
No. (protein) Organism 
Name of 
protease 
Percentage 
of identical 
residues 
Percentage 
of similar 
residues 
AAK07729.1 Nicotiana tabacum cv. Samsun NN NtCP-23 96 98 
AAZ32410.1 Nicotiana benthamiana NbCP1 96 98 
CAA88629.1 Solanum lycopersicum SENU3 86 93 
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ABQ10199.1 Actinidia deliciosa Actindin 78 85 
CAA28804.1 Hordeum vulgare Aleurain 73 83 
BAA14404.1 Oryza sativa Oryzain γ 69 82 
CAA30428.1 Homo sapiens  Cathepsin H 61 71 
 
The aleurain-like cysteine protease NtCP1 belongs to the C1A subfamily including papain-like 
cysteine proteases. To generate the plant expression vector pTRAkt-NtCP1-GFP-Str (Figure III-
23), the cDNA encoding the full-length of the NtCP1 was fused to the cDNAs of GFP and the 
Strep II-tag proteins and then cloned into pTRAkt vector (II.1.8). The expression of the NtCP1 
was under the control of the CaMV 35S promoter. For the purpose of visualization and 
purification, the cDNA of the NtCP1 was fused to GFP and Strep-II tag proteins. 
 
Figure III-23 Schematic image of the T-DNA of the binary Ti vector pTRAkt-NtCP1-GFP-S. LB and 
RB are left and right borders (25 bp imperfect repeats delimited the T-DNA), Pnos and pAnos are 
promoter and terminator of nopaline synthase gene (nptII) encoding sequence of the neomycin 
phosphotransferase gene, SAR is scaffold attachment region, P35S and pA35S are promoter and 
terminator of Cauliflower mosaic virus (CaMV) 35S gene. SP: signal peptide sequence of the endogenous 
the aleurain-like NtCP1; GFP: green fluorescent protein; Str: strep II-tag. The number below shows the 
size of open reading frame of the NtCP1 encoding 360 amino acid residues. 
 
For transient expression of the cysteine protease NtCP1, agrobacteria (II.2.1.7) carrying the plant 
expression vector pTRAkt-NtCP1-GFP-Str or p19, respectively, were co-expressed in N. 
benthamiana (II.2.2.1). The infiltrated leaves were kept for 72 h under amenable growth 
condition. Total soluble protein (TSP) was extracted from one-gram of infiltrated leaves (II.2.2.5) 
and then was analyzed by immunoblot using an anti-GFP antibody or Strep-Tactin, respectively 
(II.2.3.3). Five prominent bands with molecular masses of ~70 kDa, ~53 kDa, ~27 kDa, ~19 kDa, 
and ~17kDa were detected using an anti-GFP antibody (Figure III-24A), while only two bands 
with molecular masses of ~70 kDa and ~53 kDa were visualized by Strep-Tactin (Figure III-
24B). The highest band with a molecular mass of ~70 kDa represents preprotein, while ~53 kDa 
band is likely mature NCP1 fusion protein.  The ~28 kDa band corresponds to free GFP. The 
lower bands with molecular masses of ~19 kDa and ~17 kDa are most likely GFP degradation 
products. These results confirmed the production of NtCP1-GFP-Str in N. benthamiana.  
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Figure III-24: Immunoblot analysis of NtCP1-GFP-Str produced transiently in N. benthamiana. 
Two or three leaves of N. benthamiana were infiltrated by agrobacteria carrying the NtCP1-GFP-Str in 
combination with agrobacteria carrying the p19 construct (II.2.2.1). The infiltrated leaves were incubated 
for 72 h and total soluble leaf protein was extracted using extraction buffer (II.2.2.5). Around 40 µl of 
extract (TSP) was separated by 12% (w/v) SDS-PAGE (II.2.3.2), blotted onto nitrocellulose membrane 
(II.2.3.3), and probed either by (A) a primary antibody mouse anti-GFP (0.4 µg/ml) followed by detection 
with secondary antibody goat anti-mouse AP-labeled Fc-specific antibody (0.12 µg/ml) or (B) by Strep-
Tactin-AP (0.046 µg/ml). The membranes were incubated with NBT/BCIP solution to develop color. M: 
prestained protein marker. 
 
III.2.1.2 Purification of the NtCP1 fusion protein 
The Strep-tag® system (II.2.2.3) was used for the purification of the NtCP1-GFP-Str protein. The 
Strep-II affinity tag is an eight-residue peptide sequence (Trp-Ser-His-Pro-Gln-Phe-Glu-Lys) 
showing intrinsic affinity towards streptavidin. This technology allows the purification of 
recombinant proteins conjugated to the Strep-II affinity tag in one-step (Schmidt et al., 2007). For 
the purification of the NtCP1 fusion protein, it was transiently expressed in N. benthamina leaves 
using the syringe infiltration method (II.2.2.1). After three days incubation, infiltrated leaves (24 
gram) were harvested and total soluble protein (TSP) extracted using extraction buffer (II.2.2.5). 
The cell extract was applied to affinity column containing Strep-Tactin. Proteins coupled to 
matrix were eluted using elution buffer containing 2.5 mM destiobiotin as reversibly binding 
specific competitor (II.2.2.3). To visualize the purified NtCP1-GFP-Str, immunoblot analysis was 
performed using an anti-GFP antibody or Strep-Tactin, respectively (II.2.3.3). Four prominent 
bands were detected using an anti-GFP antibody (Figure III-25A). The upper band with a 
molecular mass of ~70 kDa is the proprotein. The middle band at ~53 kDa represents mature 
enzyme. The lower bands with molecular masses of ~28 kDa and ~19 kDa are free GFP and its 
degradation product, respectively. In immunoblot analysis using Strep-Tactin, two distinct bands 
were detected (Figure III-25B). The band with molecular mass of ~70 kDa represents proprotein, 
while ~53 kDa band is mature NtCP1 fusion protein.  
In addition, purity and yield of the purified fusion protein was determined using Comassie blue 
staining (II.2.3.2) and densitometry methods (II.2.3.1). The Comassie blue staining of purified 
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fusion protein shows purity around 60% on SDS-PAGE (Figure III-25C). The yield was 
determined to be approximately 1 mg/kg after purification.  
 
Figure III-25: Purification of the NtCP1-GFP-Str produced transiently in N. benthamiana. The 
NtCP1-GFP-Str was purified from transformed transiently N. benthamiana leaves via affinity 
chromatography on immobilized Strep-Tactin (II.2.2.3). Total soluble protein (TSP) was extracted form 
24 gram infiltrated leaves producing NtCP1-GFP-Str (II.2.2.5) (Figure III-23). The NtCP1-GFP-Str was 
purified via Strep-tag® system (II.2.2.3). The protein bounded to matrix was eluted by using elution 
buffer containing 2.5 mM desthiobiotin as reversible binding competitor (II.2.2.3). Around 20 µl of the 
eluted protein was separated by 12% (w/v) SDS-PAGE (II.2.3.2), blotted onto nitrocellulose membrane 
(II.2.3.3) and detected either by A: a primary antibody mouse anti-GFP (0.4 µg/ml) and then detection 
with secondary antibody goat anti-mouse AP-labeled Fc-specific antibody (0.12 µg/ml) or by B: Strep-
Tactin AP-labeled (0.046 µg/ml). The membranes were incubated with NBT/BCIP solution to develop 
color. C: Coomassie blue staining; around 20 µl of the purified NtCP1-GFP-Str and different amount of 
pure BSA were fractionated by 12% (w/v) SDS-PAGE (II.2.3.2) and then stained (II.2.3.2) to determine 
the yield, purity, and integrity of purified NtCP1-GFP-Str. M: prestained protein marker. 
 
III.2.2 Proteolytic activity assay by using synthetic substrate  
The fluorogenic synthetic substrate Z-Phe-Arg-AMC was used to determine the activity of 
NtCP1-GFP-Str produced in N. benthamiana (Tchoupe et al., 1991). The experiment was done as 
described in the material and methods section (II.2.4.1). To this end, 500 ng of the purified 
NtCP1fusion protein was incubated with 10 µM of fluorogenic substrate in activity assay buffer. 
To prevent oxidation of the active cysteine site, eight millimolar concentrations of DTT in 
combination with EDTA were added in the activity assay buffer. In addition, E-64 (10 µM) was 
used as a cysteine protease inhibitor in this experiment. In vitro proteolytic activity assay of the 
purified NtCP1-GFP-Str showed that it was able to cleave the synthetic substrate Z-Phe-Arg-
AMC, while E-64 inhibits its activity (Figure III-26). In addition, fluorogenic substrate was not 
cleaved in the absence of NtCP1-GFP-Str (blank). These results demonstrated that purified 
NtCP1-GFP-Str is active at acidic condition like most members of the C1 family proteases 
(Martinez et al., 2012). 
M 
(kDa) 
M 
(kDa) M
(kDa)
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Figure III-26. Activity assay of purified NtCP1-GFP-Str using fluorogenic substrate. The purified 
NtCP1-GFP-Str (500 ng) was incubated with the fluorogenic synthetic substrate Z-Phe-Arg-AMC (10 
µM) for 60 minutes at 37ºC in activity assay buffer (0.1 M sodium acetate, 8 mM DTT, 4 mM EDTA, pH 
4.5) (II.2.4.1). 
 
III.2.3  Subcellular localization of NtCP1 
The subcellular localization of NtCP1 was initially studied in silico using Plant-mPloc 
(http://www.csbio.sjtu.edu.cn/bioinf/plant-multi/). This study predicted that NtCP1 targets to the 
central vacuole. This prediction is based on the sequence similarity search of NtCP1 protein with 
978 different plant protein sequences stored in Plant-mPloc database. For in vivo studies, tobacco 
BY-2 cells were stably transformed (II.2.2.2) with NtCP1-GFP-Str (Figure III-23) and then 
analyzed using laser scanning confocal microscopy (LSCM) (II.2.5.1). Two transgenic BY-2 calli 
(#11 and #26) which had high levels of GFP expression were selected among six calli for the 
establishment of suspension cultures. Prior to the microscopy studies, production of NtCP1-GFP-
Str was studied in tobacco BY-2 cell line #11. To this end, total soluble protein (TSP) was 
extracted from five days old cell line (II.2.2.5) and then analyzed by immunoblot (II.2.3.3) using 
an anti-GFP antibody (Figure III-27). Eight distinct bands were detected with molecular masses 
of ~70 kDa, ~53 kDa, ~50 kDa, ~40 kDa, ~35 kDa, ~28 kDa, ~25 kDa, and ~19 kDa. The highest 
molecular mass band at ~70 kDa represents proprotein, while 53 kDa is mature enzyme. The 
middle bands (~50 kDa, ~40 kDa, and ~35 kDa) correspond to processing intermediates. The ~28 
kDa band is free GFP and the lower bands with molecular masses of ~25 kDa and ~19 kDa are 
GFP degradation products. From this result it is obvious that the NtCP1-GFP-Str is 
overexpressed in tobacco BY-2 cell line #11. This cell line was used for subsequent subcellular 
localization of NtCP1. 
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Figure III-27: Immunoblot analysis of the NtCP1-GFP-Str produced stably in tobacco BY-2 cells. 
Tobacco BY-2 cell line #11 producing NtCP1-GFP-Str was harvested five days after subculture and then 
total soluble protein (TSP) extracted using extraction buffer (II.2.2.5). Around 40 µl of cell extract was 
separated by 12% (w/v) SDS-PAGE (II.2.3.2), blotted onto nitrocellulose membrane (II.2.3.3) and probed 
by a primary antibody mouse anti-GFP antibody (0.4 µg/ml) followed by detection with secondary 
antibody goat anti-mouse AP-labeled Fc-specific antibody (0.12 µg/ml). The membrane was incubated 
with NBT/BCIP solution to develop color. M: prestained protein marker. 
 
The confocal images from the transgenic BY-2 cell line #11 in log and stationary phases of 
growth showed strong GFP signals in the central vacuole (Figure III-28B-D), whereas no signals 
were detected from wild type BY-2 cells (Figure III-28A). This observation indicated that the 
NtCP1-GFP-Str accumulates within central vacuole.  
 
Figure III-28: Confocal images of transgenic BY-2 cell line producing NtCP1-GFP-Str. Tobacco BY-
2 cell line #11 producing NtCP1-GFP-Str (II.2.2.2) was analysed by laser scanning confocal microscopy 
(II.2.5.1) at log and stationary phases of growth. A: The wild type tobacco BY-2 cells. B, C, D: transgenic 
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tobacco BY-2 cell line #11 producing NtCP1-GFP-Str in three, five and seven days after sub-culturing. 
White light transmission is shown on the left, green fluorescence in the middle, and the overlaid image on 
the right. Bar 50 µM. 
 
III.2.4  Vacuolar targeting of NtCP1 in BY-2 cells  
To elucidate the vacuolar targeting pathway of NtCP1, the transgenic BY-2 cells producing 
NtCP1-GFP-Str were studied by vesicular trafficking inhibitors and colocalization studies with 
the red fluorescence endocytosis marker FM4-64. 
III.2.4.1 Study of vacuolar targeting of NtCP1 by using vesicular trafficking inhibitors  
For this purpose, the transgenic tobacco BY-2 cell line #11 producing NtCP1-GFP-Str was 
treated with BFA (35.6 µM) for 20 h to inhibit vesicular trafficking at the early steps of the 
vacuolar biosynthetic route (Nebenfuhr et al., 1999 and Ritzenthaler et al., 2002). Confocal 
images of treated transgenic BY-2 cells demonstrated that NtCP1-GFP-Str was retained in the 
ER. As seen in Figure III-27B, in some of the transgenic BY-2 cells, vacuolar targeting of the 
NtCP1-GFP-Str was completely avoided and displayed pattern of the redistribution of NtCP1-
GFP-Str cargo to the ER (Figure III-27B, indicated by arrow), whereas some other cells 
represented GFP fluorescence signal in the ER as well as the central vacuole. However, the 
intensity of the GFP signal declined in BY-2 cell line #11 treated by BFA (Figure III-27B) 
compared to the untreated BY-2 cell line (Figure III-27A). These data showed that BFA 
treatment avoided vacuolar targeting of NtCP1 to some extent by inhibiting trafficking from the 
ER to the Golgi in tobacco BY-2 cells. As previously shown in this thesis (III-1-5-2), PLCPs 
inhibitors (E-64 and Antipain) abolish trafficking of vacuolar protein cargo from TGN/EE to 
PVC/LE. Based on these results, the tobacco BY-2 cell line #11 producing NtCP1-GFP-Str was 
treated by PLCPs inhibitors (E-64 or Antipain, respectively) for 20 h. Confocal images analysis 
displayed that E-64 or Antipain led to the accumulation of GFP fluorescence aggregates in 
transgenic BY-2 cell line (Figure III-29C-D). The intensity of the GFP fluorescence signal in the 
central vacuole of treated cells (Figure III-29C-D) was decreased compared to the untreated 
transgenic BY-2 cell line #11 (Figure III-29A). These data demonstrated that PLCPs inhibitors 
(E-64 and antipain) interrupt the NtCP1-GFP-Str cargo delivery to the central vacuole. It was 
therefore deduced that TGN/EE may participates in the vacuolar transport of endogenous and 
recombinant tobacco NtCP1. 
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Figure III-29: Inhibitor studies of tobacco BY-2 cells producing NtCP1-GFP-Str. Tobacco BY-2 cell 
line #11 producing NtCP1-GFP-Str was treated with BFA (35.6 µM) or PLCPs inhibitors (E-64 and 
Antipain) for 20 h (II.2.5.2) and then analyzed by laser scanning confocal microscopy (II.2.5.1) five days 
after sub-culture. A: Untreated BY-2 cell line #11 producing NtCP1-GFP-Str. B: Tobacco BY-2 cell line 
#11 producing NtCP1-GFP-Str treated with BFA (35.6 µM). C: Tobacco BY-2 cell line producing NtCP1-
GFP-Str treated with E-64 (10 µM). D: Tobacco BY-2 cell line #11 producing NtCP1-GFP-Str treated 
with Antipain (16.5 µM). White light transmission is shown on the left, green fluorescence in the middle, 
and the overlaid images on the right. Bar 50 µM. Arrows indicate redistributed vesicles carrying NtCP1-
GFP-Str to the ER (B) and aggregates induced by PLCPs inhibitors (C and D).  
 
III.2.4.2 The colocalization study with fluorescent markers for endocytosis   
To confirm the involvement of TGN/EE in vacuole transport of NtCP1, colocalization studies 
were performed using the red fluorescent endocytosis tracer FM4-64 (Geldner et al., 2003; Tse et 
al., 2004). To this end, the tobacco BY-2 cell line #11 producing NtCP1-GFP-Str were co-
icubated by E-64 (10 µM) and FM4-64 (20 µM) for 20 h (II.2.5.2) and then observed by laser 
scanning confocal microscopy (II.2.5.1). Confocal images showed that internalized FM4-64 
merged (Figure III-30E) with E-64-induced aggregates (Figure III-30D), while no colocalization 
was observed when BY-2 cell line #11 were treated only with FM4-64 (Figure III-30B). 
Accordingly, these data confirmed that E-64-induced aggregates are TGN/EE in tobacco BY-2 
cells. These results showed that NtCP1 transport to the central vacuole is mediated through the 
classical route, which is composed of ER, TG/EE and PVC/EE organelles.  
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Figure III-30: Colocalization study of tobacco BY-2 cell line #11 producing the NtCP1-GFP-Str. 
Tobacco BY-2 cell line #11 producing NtCP1-GFP-Str were harvested four days after subculture, co-
incubated with E-64 (10 µM) and FM4-64 (20 µM) for 20 h at 26ºC (II.2.5.2) and then analyzed by laser 
scanning confocal microscopy (II.5.2.1). A: Untreated tobacco BY-2 cell line #11 producing NtCP1-GFP-
Str. B: Tobacco BY-2 cell line #11 producing NtCP1-GFP-Str treated with FM4-64 (20 µM). C: Overlaid 
images of A and B. D: Treated BY-2 cell line #11 producing NtCP1-GFP-Str treated with E-64 (10 µM). 
E: Tobacco BY-2 cells producing NtCP1-GFP-Str co-incubated with E-64 (10 µM) and FM4-64 (20 µM). 
F: Overlaid images of D and E made by Adobe Photoshop CS2 software. Arrows indicate E-64 induced 
aggregates. Bar 50 µM. 
 
III.2.5  Type of NtCP1 vacuolar sorting signal  
Multiple sequence alignment of NtCP1 with other known proteins containing vacuolar sorting 
signal (VSS) revealed that the NPIR motif resides within the propeptide of NtCP1 (Figure III-31). 
Previous studies showed that vacuolar proteins containing the NPIR motif are transported 
through the Golgi to the TGN/EE, whereby a membrane-bound receptor such as VSR1 or BP-80 
recognizes this N-terminal motif. Niemes suggested that the interaction between vacuolar sorting 
receptor and NPIR motif might occur at the ER (Niemes et al., 2010). PVC/LE acts as a 
intermediate organelle to deliver protein cargo containing NPIR motif from TGN/EE to the 
central vacuole (Matsuoka et al., 1991; Dombrowski et al., 1993). From this study it is evident 
that the type of the NtCP1 vacuolar sorting signal is sequence specific (ssVSS). 
Aleurain        ADSNPIR  
Oryzain         DDSNPIR  
NTCP-23         ADENPIR  
NtCP1           AVENPIR  
 
Figure III-31: Alignment of amino acid sequences of the NtCP1 N-terminal propeptide with other 
known N-terminal propeptides containing VSS. GenBank accession number: Aleurain from Hordeum 
vulgare (CAA28804.1). Oryzain from Oryza sativa (AAC49730.1). NtCP-23 from Nicotiana tabacum 
(AAZ32410.1). NtCP1 from Nicotiana tabacum (ABW71226.1). The conserved amino acids in the N-
terminal propeptide are shown in yellow. 
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III.3 Characterization of NtSP1 from tobacco BY-2 cells 
III.3.1 Expression and purification of the recombinant NtSP1  
III.3.1.1 Expression of the recombinant NtSP1 in N. benthamina  
The cDNA of the subtilisin-like serine protease NtSP1 (S8A) was cloned from tobacco BY-2 
cells (kindly provided by Mrs. Gudrun Müller, Fraunhofer IME). The tobacco NtSP1 cDNA is 
2495 bp long including the open reading frame of 2259 bp. This ORF encodes a pre-pro-protein 
with 753 amino acids. In silico analysis using SignalP 4.0 (Petersen et al., 2011) and multiple 
sequence alignment with reported subtilases (refer to the appendix VII.4) from various plant 
species such as Arabidopsis thaliana, Cucumis melo, Solanum lycopersicum, and Oryza sativa 
revealed that the NtSP1 primary structure consists of four domains: a signal peptide (aa 1-23), a 
propeptide (aa 24-115), catalytic domain (aa116-593) and C-terminal domain (aa 593-753). The 
propetide acts as an intramolecular chaperon essential for correct folding (Zhu et al., 1989; Li et 
al., 1995) and enzyme activity (Nakagawa et al., 2010). The site of propeptide processing was 
deduced at the N-terminal site of a pair of threonine residues (Thr116 and Thr117) according to the 
published N-terminal sequence of mature cucumisin (Yamagata et al., 1994) and the presence of 
these conserved pair residues (TT) among all plant subtilases. The catalytic domain of the NtSP1 
contains three catalytic residues with specific arrangement for subtilases (D147, H203, and S533), 
the catalytically important asparagine residue (N306) which is responsible for stabilizing the 
transition state oxyanion in subtilisin (Robertus et al., 1972) and the protease-associated domain 
(PA) between the His and Ser catalytic residues (amino acids 362-464) which may affect the 
NtSP1 activity by interacting with the catalytic domain (Cedzich et al., 2009). The NtSP1 C-
terminal domain is presumably involved in activity and sorting of the NtSP1 (Cedzich et al., 
2009). Seven potential N-glycosylation sites were predicated in NtSP1 using the NetNGlyc 1.0 
Server (Blom et al., 2004) (Figure III-32). 
 
(A) 
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Figure III-32: Primary structure of subtilisin-like NtSP1. A: Schematic representation of different 
domains of the subtilisin-like NtSP1 SP: signal peptide; PP: propeptide; CD: catalytic domain; PA: 
protease-associated domain; C-T: c-terminus domain. B: Deduced amino acid sequence of the NtSP1 pre-
pro-protein. The hydrophobic N-terminal signal peptide is underlined in green. The pro-peptide is 
highlighted by light blue. The protease-associated domain (PA) is indicated by a yellow background. 
Black circles indicate the catalytic amino acid residues (D147, H204, and S533). The stabilizing Asn (N306) is 
highlighted in pink. The catalytic motifs of NtSP1 are in light and red background. Seven potential N-
glycosylation sites are shown with red dots (NFT: 176, NGT: 227, NLT: 369, NKT: 518, NPS: 595, NYT: 
621, NIT: 717). Arrow indicates the site of pro-peptide processing.  
 
The amino acid sequence of the tobacco NtSP1 (GeneBank: DQ648019.1) was compared with 
other reported plant subtilases via blast search in the MEROPS (Rawlings et al., 2012) and NCBI 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi) web-based databases. Sequence similarity search 
elucidated that the NtSP1 amino acid sequence has more than 70% similarity with p69 peptidases 
from tomato, 50-61% similarity with p69 peptidases from other plants such as grapevine, black 
cottonwood, lotus, castor oil plant, rice, sorghum, and maize. It also shows 44-45% similarity 
with different subtilases in Arabidopsis thaliana (Table III-3). 
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Table  III-3: Percentage of identity and similarity of NtSP1 amino acids with other SPs.  
GenBank accession 
No. (Protein) Organism 
Name of 
protease 
Percentage 
of identical 
residues 
Percentage 
of similar 
residues 
CAA76724.1 Solanum lycopersicum P69A 70 81 
CAA76725.1 Solanum lycopersicum P69B 71 82 
CAA06412.1 Solanum lycopersicum P69C 71 81 
CAA07250.1 Solanum lycopersicum P69D 71 83 
CAA06413.1 Solanum lycopersicum P69E 70 80 
CAA06414.1 Solanum lycopersicum P69F 73 82 
XP_002275452 Vitis vinifera V-P69 61 74 
XP_002325705 Populus trichocarpa P-P69 59 73 
BAF95753 Lotus japonicas L-P69-1 59 73 
BAF95754 Lotus japonicas L-P69-2 57 71 
BAF95755 Lotus japonicas L-P69-3 57 70 
EEF51043 Ricinus communis R-P69 57 70 
UNIPROT:Q8RVC2 Oryza sativa Ri-P69 53.65 50 
XP_002465042 Sorghum bicolor S-P69-2 50 63 
AAN13182.1 Arabidopsis thaliana At2g05920 45 61 
BAH20348.1 Arabidopsis thaliana At3g14067 45 59 
AED98332.1 Arabidopsis thaliana ARA12  44 60 
AEE86443.1 Arabidopsis thaliana At4g34980 45 59 
AEE27657.1 Arabidopsis thaliana SDD1 43 57 
BAA06905.1| Cucumis melo cucumisin 41 58 
 
To generate the plant expression vector pTRAkt-NtSP1-GFP-Str (Figure III-33), the cDNA 
encoding the full-length of the NtSP1 was fused to the cDNAs of GFP and the Strep II-tag 
proteins and then cloned into pTRAkt vector (II.1.8). The cDNA of NtSP1 fusion protein was put 
under the control of constitutive CaMV35 promotor and introduced to Agrobacterium (II.2.1.7).  
 
Figure III-33: Schematic illustration of the T-DNA of the binary Ti vector pTRAkt-NtSP1-GFP-Str. 
LB and RB are left and right borders (25 bp imperfect repeats delimited the T-DNA). Pnos and pAnos are 
promoter and terminator of nopaline synthase gene (nptII). SAR is scaffold attachment region.  P35S and 
pA35S are promoter and terminator of the Cauliflower mosaic virus (CaMV) 35S gene. SP is the signal 
peptide sequence of the subtilisin-like NtSP1. GFP is the cDNA of green fluorescent protein and Str is the 
cDNA of Strep II-tag. 
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Prior to stable transformation in tobacco BY-2 cells, the expression of NtSP1 fusion protein was 
checked by immunoblot in transiently produced N. benthamiana. To this end, N. benthamiana 
leaves were infiltrated with Agrobacteria carrying pTRAkt-NtSP1-GFP-Str (II.2.2.1) and then 
kept for three days. Total soluble protein (TSP) was extracted from leaves and analysed by 
immunoblot using an anti-GFP antibody or Strep-Tactin (II.2.3.3). Four distinct bands were 
detected with molecular masses of ~120 kDa, ~106 kDa, ~28 kDa, and ~19 kDa using an anti-
GFP antibody, whereas two bands were visualized using Strep-Tactin at ~120 kDa and ~106 kDa 
(Figure III-34B). The highest molecular mass band at ~120 kDa represents the proprotein, while 
~106 kDa band is the NtSP1 fusion protein without propeptide. The ~28 kDa is free GFP and ~19 
kDa represents GFP degradation product. From this experiment it is obvious that Strep II-tag was 
removed via C-terminal processing of fusion protein. This result confirmed expression of the 
NtSP1 fusion protein.  
 
Figure III-34: Immunoblot analysis of the recombinant NtSP1 produced transiently in N. 
benthamiana. N. benthamiana leaves were infiltrated by Agrobacteria carrying pTRAkt-NtSP1-GFP-Str 
in combination with Agrobacteria carrying p19 (II.2.2.1). The infiltrated leaves were kept approximately 
for 72 h in a growth chamber. Total soluble protein (TSP) was extracted using extraction buffer in a ratio 
of 1:2 (II.2.2.5). Around 40 µl of extract containing equal amount of total soluble protein (TSP) was 
separated by 12% (w/v) SDS-PAGE (II.2.3.2), blotted onto nitrocellulose membrane (II.2.3.3), and probed 
either by (A) a primary mouse anti-GFP antibody (0.4 µg/ml) followed by detection with secondary 
antibody goat anti-mouse AP-labeled Fc-specific antibody (0.12 µg/ml) or by (B) Strep-Tactin-AP (0.046 
µg/ml). The membranes were incubated with NBT/BCIP solution to develop color. M: prestained protein 
marker. 
 
III.3.2 Expression and purification of NtSP1-GFP-Str from BY-2 cells 
The wild type BY-2 cells were used to produce the NtSP1-GFP-Str protein. Initially the wild type 
cells were stably transformed with the Agrobacterium (II.2.1.7) harbouring pTRAkt-NtSP1-GFP-
Str (II.2.1.1). After three to four weeks the expression of GFP in transgenic BY-2 calli was 
analysed using Schott cold light source (KL 2500) in combination with filters (blue filter for 
excitation and yellow for emission). Two transgenic BY-2 calli (#16 and #17) which had high 
levels of GFP expression were selected for the establishment of suspension cultures. The 
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Strep‐Tactin
expression of the NtSP1 fusion protein was analysed by immunoblot. To this end, total soluble 
protein (TSP) was extracted (II.2.2.5) from BY-2 cell line number #17 and then visualized by 
immunoblot (II.2.3.3) using an anti-GFP antibody (Figure III-4A) or Strep-Tactin (Figure III-4B), 
respectively. 
 
Four prominent bands were detected with molecular masses of ~120 kDa, ~106 kDa, ~57 kDa 
and ~28 kDa using an anti-GFP antibody (Figure III-35A). The highest molecular mass band at 
~120 kDa is proprotein, while the ~106 kDa band represents NtSP1fusion protein without 
propetide. The middle band at ~57 kDa may be processing intermediate and the lower band with 
molecular mass of ~28 kDa represents free GFP. Immunoblot analysis using Strep-Tactin showed 
the elimination of Strep II-tag when NtSP1-GFP-Str stably produced in tobacco BY-2 cells 
(Figure III-35B). It was therefore supposed that Strep II-tag was removed during C-terminal 
processing either via autocatalytic enzyme activity or other endogenous proteases in BY-2 cells. 
This result confirmed expression of the NtSP1 fusion protein in BY-2 cell line #17. 
(A)                     (B) 
 
 
 
 
 
 
 
 
 
 
 
 
Figure III-35: Immunoblot analysis of the recombinant NtSP1 produced stably in tobacco BY-2 
cells. Tobacco BY-2 cell line #17 producing NtSP1-GFP-Str (II.2.1.1) was harvested five days after 
subculture and then total soluble protein (TSP) was extracted using extraction buffer (II.2.2.5). Around 40 
µl of cell extract was separated by 12% (w/v) SDS-PAGE (II.2.3.2) and visualized either by using a 
primary mouse anti-GFP antibody (0.4 µg/ml) followed by detection with secondary antibody goat anti-
mouse AP-labeled Fc-specific (0.12 µg/ml) or by using Strep-Tactin (0.046 µg/ml). The membranes were 
incubated with NBT/BCIP solution to develop color. M: prestained protein marker. 
 
 
The NtSP1-GFP-Str was purified from transgenic BY-2 cell line #17 using an anti-GFP antibody 
coupled to magnetic beads (II.2.2.4). To study the influence of pH in processing of NtSP1 fusion 
protein, proteins retained by the magnetic field were eluted by shifting the pH to 3.0 or 11.0. The 
eluted proteins were separated on a SDS-PAA gel and analysed by immunoblot using an anti-
GFP antibody (II.2.3.4) (Figure III-36).  
From this study it is obvious that the processing of NtSP1-GFP-Str varies at different pH. When 
the NtSP1fusion protein was eluted by shifting the pH to 3.0, nine bands were detected with 
molecular masses of ~120 kDa, ~57 kDa, ~50 kDa ~28 kDa, ~24 kDa, ~19 kDa, ~17 kDa, ~15 
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kDa and ~13 kDa (Figure III-36, lane 1). In contrast, 10 distinct bands were visualized when 
protein was eluted by shifting the pH to 11 with molecular masses of ~120 kDa, ~106 kDa, ~72 
kDa, ~67 kDa, ~57 kDa, ~50 kDa, ~28 kDa, ~24 kDa, ~19 kDa, ~17 kDa (Figure III-36, lane 2). 
These data suggested that alkaline condition probably caused autocatalytic processing of the 
NtSP1-GFP-Str. This process led to the cleavage of propeptide and formed a faint band at ~106 
kDa. Interestingly, this band was not detected when the NtSP1fusion protein was eluted by 
shifting the pH to 3.0 (Figure III-36, lane 1). From previous studies it is known that the 
propeptide of tomato SlSBT3 is removed auto-catalytically during enzyme processing at alkaline 
condition (Cedzich et al., 2009). As the amino terminal residues of the mature SlSBT3, NtSP1 
fusion protein and other plant subtilases are conserved (Thr-Thr-(Arg/His)-(Ser/Thr), it has been 
suggested that the process of NtSP1 may occur auto-catalytically at alkaline condition.  
 
 
Figure  III-36: Immunoblot analysis of purified NtSP1 fusion protein produced stably in tobacco 
BY-2 cells. The NtSP1-GFP-Str was purified from BY-2 cell line #17 using an anti-GFP antibody coupled 
to magnetic beads (II.2.2.4). For this purpose, total soluble protein (TSP) was extracted from 5-day-old 
BY-2 cell line producing NtSP1-GFP-Str (II.2.2.5). The resulted extraction was directly applied on 
immobilized anti-GFP IgG matrix (II.2.2.4) and then eluted either by (lane 1) acidic or (lane 2) alkaline 
elution buffers (II.2.2.4). To visualize purified NtSP1 fusion protein, around 40 µl of each elution 
fractions was separated by 12% (w/v) SDS-PAGE (II.2.3.2), blotted onto nitrocellulose membrane 
(II.2.3.3), and then probed by a primary antibody mouse anti-GFP (0.4 µg/ml) followed by detection with 
secondary antibody goat anti-mouse AP-labeled Fc-specific antibody (0.12 µg/ml). The membranes were 
incubated with NBT/BCIP solution to develop color. M: prestained protein marker. Arrow indicates 
processing intermediate of NtSP1 fusion protein after cleavage of propeptide. 
 
The activity of the purified NtSP1 fusion protein was assayed using Suc-Ala-Ala-Pro-Phe-pNA 
as a substrate for chymotrypsin (Delmar et al., 1979). In this thesis, the activity of the 
NtSP1fusion protein was not confirmed because the substrate was not specific for the respective 
fusion protein. Recently, Khera showed that purified NtSP1 could degrade 2F5 antibody in vitro 
(Master thesis of Twinkle Khera, Fraunhofer IME, Aachen, Germany). 
III.3.3 Subcellular localization of the NtSP1 fusion protein  
In silico analysis using Plant-mPloc (http://www.csbio.sjtu.edu.cn/bioinf/plant-multi/) it was 
predicated that the NtSP1 fusion protein secretes to apoplast. This prediction is based on the 
sequence similarity search of NtAP1 protein with 978 different plant protein sequences stored in 
Plant-mPloc database. These proteins are distributed among 12 plant subcellular locations. To 
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substantiate this prediction in vivo, tobacco BY-2 cells were stably transformed with the plant 
expression cassette pTRAkt-NtSP1-GFP-Str (II.2.2.2). Transgenic BY-2 cell line #17 was studied 
using laser scanning confocal microscopy (LSCM) at log and stationary phases of growth (Figure 
III-37). Interestingly, GFP signals were detected within the central vacuole of transgenic cell line 
(Figure III-37C-D), but not in wild-type cells (Figure III-37A). Moreover, confocal images 
showed that the NtSP1 fusion protein is located within central vacuole at log (day 3 and 5) and 
stationary (day 7) phase of cells growth (Figure III-37B-C). To check the accumlation of NtSP1 
fusion protein in the medium of BY-2 cell line #17, the supernatant was checked by immublot 
using an anti-GFP antibody. The result showed that the NtSP1 fusion protein was not secreted to 
the medium (data not shown). 
 
Figure III-37: Confocal images of transgenic BY-2 cells producing NtSP1-GFP-Str.  Wild type and 
tobacco BY-2 cell line #17 producing NtSP1-GFP-Str (II.2.2.2) were analyzed using laser scanning 
confocal microscopy (LSCM). A: Wild type tobacco BY-2 cells three days after sub-culturing. B, C, D: 
The transgenic tobacco BY-2 cell line #17 producing NSP1-GFP-Str three, five and seven days after sub-
culturing. White light transmission is shown on the left, green fluorescence in the middle, and the overlaid 
image on the right. Bar 50 µM. 
III.3.4 Vacuolar targeting of the NtSP1 fusion protein  
Vacuolar targeting of NtSP1 was investigated by using vesicular trafficking inhibitors (PLCPs 
inhibitor) and colocalization with the endocytosis tracer FM4-64. 
Chapter III                                                                                                                               Results 
 
-79- 
III.3.4.1 Study of vacuolar targeting of NtSP1 using vesicular trafficking inhibitors  
As described above (III.1.5) the drug brefeldin A (BFA) caused the inhibition of the secretory 
traffic between the endoplasmic reticulum (ER) and the Golgi apparatus in transgenic BY-2 cells 
(Nebenfuhr et al., 1999 and Ritzenthaler et al., 2002). BFA was applied to transgenic BY-2 cells 
producing NtSP1-GFP-Str to inhibit ER to Golgi trafficking. To this end, transgenic BY-2 cell 
line #17 was harvested five days after subculture and treated for 20 h with 35.6 µM BFA 
(II.2.5.2). As shown in Figure III-38B, targeting of NtSP1 fusion protein to the vacuole was 
inhibited by the addition of BFA. It was therefore concluded that NtSP1 is transported through 
the Golgi to reach the vacuole.  
 
Moreover, PLCPs inhibitors E-64 and antipain were used to inhibit vesicular trafficking 
downstream of the Golgi (Yamada et al., 2005). To this end, transgenic BY-2 cell line #17 were 
treated E-64 and antipain for at least 20 h (II.2.5.2) and then analysed by laser scanning confocal 
microscopy (LSCM) (II.2.5.1). Confocal images of treated transgenic BY-2 cell line #17 by 
PLCPs inhibitors (Figure III-38C and D) showed that vesicular trafficking inhibitors caused the 
accumulation of aggregates in transgenic BY-2 cells. Beside this, the intensity of GFP signals in 
the central vacuole of treated transgenic BY-2 cells was reduced (Figure III-38C and D) 
compared to untreated transgenic BY-2 cells (Figure III-38A). These results demonstrated that 
PLCPs inhibitors have led to the interruption of the vacuolar targeting of NtSP1. It was therefore 
deduced that aggregates induced by PLCPs inhibitors E-64 and antipain are probably 
corresponding to TGN/EE or PVC/LE in transgenic BY-2 cells.  
 
Figure III-38: Inhibitor studies of tobacco BY-2 cell line producing NtSP1-GFP-Str. Transgenic 
tobacco BY-2 cell line #17 producing NtSP1-GFP-Str (II.2.2.2) was treated with vesicular trafficking 
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inhibitors  for 20 h (II.2.5.2) and then analyzed by laser scanning confocal microscopy five days after sub-
culturing. A: Untreated transgenic tobacco BY-2 cell line #17. B: Transgenic BY-2 cell line #17 treated by 
BFA (35.6 µM) for 20 h. C: Transgenic BY-2 cell line #17 treated by E-64 (10 µM) for 20 h. D: 
transgenic BY-2 cell line #17 treated by antipain (16.5 µM) for 20 h. White light transmission is shown on 
the left, green fluorescence in the middle, and the overlaid images on the right. Arrows indicate aggregates 
induced by PLCPs inhibitors. Bar 50 µM. 
III.3.4.2 The colocalization study with fluorescent markers for endocytosis   
To elucidate whether aggregates induced by PLCPs inhibitors (E-64 and antipain) are TGN/EE or 
PVC/LE, colocalization studies were performed using the red fluorescent endocytosis tracer 
FM4-64 (Tse et al., 2004). As concluded from previuos results (III.1.5) FM4-64 colocalizes with 
TGN/EE. Accordingly, tobacco BY-2 cell line #17 producing NtSP1-GPF-Str was harvested four 
days after subculture and co-incubated with E-64 (10 µM) and FM4-64 (20 µM) for 20 h 
(II.2.5.2). When transgenic BY-2 cell line #17 was treated with E-64 (10µM), aggregates were 
induced (Figure III-39D) whereas no accumulation of aggregates was seen during treatment with 
FM4-64 (20 µM) (Figure III-39B). To decipher whether FM4-64 colocolizes with E-64 induced 
aggregates, the transgenic BY-2 cell line #17 was co-incubated with FM4-64 and E-64 for 20 h 
and then observed by laser scanning confocal microscopy (LSCM). Confocal images displayed 
that FM4-64 labelled the E-64 induced aggregates (Figure III-39 D and E). This result 
demonstrated that aggregates induced by E-64 correspond to TGN/EE. Therefore, it was 
concluded that vacuolar transport of NtSP1 is mediated by the classical route in BY-2 cells.  
 
Figure III-39: Colocalization study of BY-2 cell line producing NtSP1-GFP-Str. Tobacco BY-2 cell 
line #17 producing NtSP1-GFP-Str was harvested four days after subculture, co-incubated with E-64 (10 
µM) and the fluorescent endocytosis tracer FM4-64 (20 µM) for 20 h (II.2.5.2) and then analysed by 
LSCM (II.5.2.1). A: Transgenic tobacco BY-2 cell line #17 producing NtSP1-GFP-Str. B: Transgenic 
tobacco BY-2 cell line producingNtSP1-GFP-Str by FM4-64 (20 µM). C: Overlaid images of A and B 
using Adobe Photoshop CS5. D: Transgenic tobacco BY-2 cell line producing NtSP1-GFP-Str treated by 
E-64 (10 µM). E: Tobacco BY-2 cell line producing NtSP1-GFP-Str co-incubated with E-64 (10 µM) and 
FM4-64 (20 µM). F: Overlaid images of D and E using Adobe Photoshop CS5. The arrow indicates 
aggregates induced by E-64. 
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III.3.5 Type of vacuolar sorting signal in NtSP1 
To determine the vacuolar sorting signals of NtSP1, N and C-terminal parts of NtSP1 were 
compared with reported vacuolar sorting signals. No specific signal was found in the amino acids 
sequence of NtSP1. Therefore, it was assumed that vacuolar sorting signal of NtSP1 may be 
present in the C-terminal domain. To substantiate this hypothesis, a C-terminal deletion mutant 
was generated by deleting 238 amino acids (NtSP1555) from the C-terminal extension. To 
facilitate the visualization and purification, the cDNA of NSP1555 was fused to the cDNAs of 
GFP and StrepII-tag (S) (Figure III-40).  
 
 
 
Figure III-40: The schematic representation of NtSP1 fusion protein and its C-terminal deletion 
mutant. A: The cDNA sequence of NtSP1 fused to the cDNAs of GFP and Strep II-tag; B: The cDNA 
sequence of C-terminal deletion mutant of the NtSP1 with 238 amino acids deletion (NtSP1555) fused to 
the cDNAs of GFP and Strep II-tag). SP: signal peptide; PP: propeptide; CD: catalytic domain; PA: 
proteases-associated domain; GFP: green fluorescent protein; S: Strep II-tag. 
 
 
To generate the plant expression vector pTRAkt-NtSP1555-GFP-Str (Figure III-40B), the cDNA 
encoding the NtSP1555 was fused to the cDNAs of GFP and the Strep II-tag proteins and then 
cloned into pTRAkt vector (II.1.8). The C-terminal deletion mutant construct (NtSP1555-GFP-Str) 
was stably transformed to tobacco BY-2 cells via Agrobacteria harbouring pTRAkt-NtSP1-GFP-
Str (II.2.2.2). The transgenic BY-2 calli #31 which had high levels of GFP expression were 
selected among eight transgenic calli for the establishment of suspension cultures. To confirm 
accumulation of the NtSP1555 fusion protein, BY-2 cell line #31 was harvested after five days 
subculture and analysed by immunoblot (II.2.3.3) using an anti-GFP antibody. Three prominent 
bands were detected with molecular masses of ~100 kDa, ~50 kDa, and ~28 kDa (Figure III-41). 
In immunoblot under reducing condition (Figure III-41). The upper band at ~100 kDa represents 
proprotein. The middle band at ~50 kDa is likely mature enzyme and the lower band at ~28 kDa 
is free GFP. This result confirmed expression of the NtSP1555 fusion protein in BY-2 cell line 
#31.  
  
(B) 
(A) 
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Figure III-41: Immunoblot analysis of the NtSP1555 fusion protein produced stably in BY-2 cell line 
#31. Tobacco BY-2 cell line #31 producing NtSP1555–GFP-Str was harvested five days after subculture 
and then total soluble protein (TSP) was extracted using extraction buffer (II.2.2.5). Around 40 µl of cell 
extract was separated by 12% (w/v) SDS-PAGE (II.2.3.2) and visualized by immunoblot (II.2.3.2) using a 
primary antibody mouse anti-GFP (0.4 µg/ml) followed by detection with secondary antibody goat anti-
mouse AP-labeled Fc-specific antibody (0.12 µg/ml). The membrane was incubated with NBT/BCIP 
solution to develop color. M: prestained protein marker. 
 
Subsequently, the transgenic BY-2 cell line #31 was analyzed by laser scanning confocal 
microscopy (LSCM). Confocal images showed that vacuolar targeting of the NtSP1555-GFP-Str 
was interrupted and retained in the ER (Figure III-42A), whereas the full-length NtSP1 was 
targeted to the central vacuole (Figure III-42B). This result is in agreement with the hypothesis 
that the vacuolar determinant for NtSP1 resides within the C-terminal domain. Therefore, it was 
concluded that the type of vacuolar sorting signal of NtSP1 is ctVSS. 
 
Figure III-42. Confocal microscopy of BY-2 cells producing NtSP1 fusion construct and its C-
terminal deletion mutant. Tobacco BY-2 cell line #31  producing NtSP1-GFP-Str or tobacco BY-2 cell 
line #31 producing  NtSP1555-GFP-Str were analyzed by LSCM (II.2.5.1) five days after sub-culturing, 
respectively. A: Tobacco BY-2 cell line #31 producing the C-terminal deletion mutant (NtSP1555-GFP-Str) 
(Figure III-40B). B: Tobacco BY-2 cell line #31 producing NtSP1-GFP-Str (Figure III-40A). White light 
transmission is shown on left, green fluorescence in the middle, and the overlaid images on the right. The 
scale bar indicates a distance of 50 µM. 
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IV Discussion 
Microbial (bacteria or yeast) and mammalian cells have been traditionally used as hosts for 
production of therapeutic proteins. Over the last decades, other systems with unique advantages 
have also been explored including transgenic animals, transgenic plants, baculovirus-insect 
cultures, and plant tissue cultures (Boehm, 2007; Streatfield, 2007; Egelkrout et al., 2012). Plant-
based production systems provide some advantages over the other systems, including low-cost 
production, absence of health hazardous components (i.e., endotoxins in bacteria, human/animal 
pathogens in mammalian cell cultures, and highly glycosylated products in yeast), the presence of 
eukaryotic post-translational modifications, the capability for rapid scale-up, and the possibility 
for oral consumption of vaccines with limited downstream processing (Egelkrout et al., 2012; 
Schillberg et al., 2013; Fischer et al., 2013).  
 
A handful of factors should be studied before production of heterologous proteins in plants such 
as (1) the nature of foreign protein and its effect on the host plant, (2) the post-translational 
modification(s) required, (3) a proper host tissue and subcellular location for targeting, and (4) 
the degree of downstream processing required. Accordingly, several options are available for 
protein production, including choice of host plant (dicot, monocot, food, or non-food), type of 
transformation technique (physical: biolistic, electroporation; biological: viral, bacterial), type of 
expression (stable or transient, constitutive or tissue-specific), and choice of subcellular location 
(cytosol, organelle, apoplast) (Egelkrout et al., 2012). Moreover, the pharmaceutical proteins can 
be produced either in whole-plants or plant cell/tissue suspension cultures. The cultured plant 
cell/tissue system is considered as a better production platform in terms of cGMP compliance 
(Hellwig et al., 2004; Schillberg et al., 2013), and it is thus not surprising that two plant-made 
pharmaceuticals which passed regulatory approval are produced in plant cells (ConcertTM in 
tobacco BY-2 cells and ElelysoTM in carrot cells). However, the major challenge to 
commercialize the plant cell bioproduction platform is the low yield (0.01-0.2 g/L) compared to 
the other systems (0.5-5g/L in bacteria, 0.1-2 g/L in yeast, 1-3 g/L in mammalian cells, and 0.1-2 
g/L in insect cells) (Huang and McDonald, 2009). The yield of recombinant proteins in plant 
cell/tissue suspension cultures is amenable to the rates of synthesis and degradation. The 
degradation is mainly dependent on susceptibility of recombinant proteins to decompose, which 
can be significantly influenced by the endogenous plant proteases (Egelkrout et al., 2012). 
 
IV.1 Degradation of recombinant biopharmaceuticals in BY-2 cells 
The majority of biopharmaceuticals produced in plant cell cultures are glycoproteins, which 
travel along the plant secretory pathway and secrete into the culture medium. Downstream 
processing of secreted products is easier and cheaper due to the depletion of the contaminating 
proteins present in the cell (Huang and McDonald, 2009). The plant secretory pathway is 
composed of the different organelles including the endoplasmic reticulum (ER), Golgi apparatus, 
trans-Golgi network (TGN), plasma membrane, and vacuole. The plasma membrane interfaces 
the cellular content with the extracellular milieu (Kim and Brandizzi, 2014). In fact, the plant 
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secretory pathway has two endpoints: (1) the secretion to the extracellular milieu (default 
secretion pathway/bulk flow) or (2) the transport to the vacuole (vacuolar pathway). The 
recombinant biopharmaceuticals are subject to proteolysis by endogenous plant proteases while 
they travel through the secretory pathway, after secretion into the extracellular milieu or when 
mis-sorted to the vacuole (Callis, 1995; Doran, 2006; Sharp and Doran, 2001; Schiermeyer et al., 
2005; Stevens et al., 2000; Yang et al., 2005; Hadlington et al., 2003). The degradation of 
recombinant proteins reduces the final yield and quality of the product. Schiermeyer and his 
colleagues reported that secreted metalloproteases might participate in the degradation of 
DSPAα1 produced in tobacco BY-2 cells (Schiermeyer et al., 2005). Subsequent in vitro analysis 
indicated that the purified tobacco matrix-metalloprotease (NtMMP1) is responsible for DSPAα1 
degradation (Mandal et al., 2010). To increase recombinant glycoprotein production in tobacco 
BY-2 cells, a detailed understanding of the plant proteolytic machinery is necessary. Several 
proteases have been identified in tobacco BY-2 cells. In this chapter, the involvement of three 
endogenous tobacco proteases in the degradation of valuable recombinant proteins is discussed in 
frame of the available literature.  
 
The aim of this thesis was the biochemical characterization and subcellular localization of the 
three proteases previously cloned from tobacco BY-2 cells: cysteine (NtCP1), serine (NtSP1), 
and aspartic (NtAP1) proteases. In vivo confocal microscopy findings and mutational analysis 
revealed that all three proteases accumulate within the central vacuole. The proteolytic activity of 
NtCP1 was confirmed using the artificial substrate for cysteine proteases (cathepsin B, L and 
papain). Beside this, purified NtSP1 could degrade the recombinant human HIV-specific 2F5 
antibody in vitro (Master thesis of Twinkle Khera, Fraunhofer IME, Aachen, Germany). In the 
case of NtAP1, its proteolytic activity was demonstrated on some biopharmaceuticals, e.g. human 
serum albumin (HSA) and the human vitronectin-specific M12 antibody. These data show that 
these vacuolar proteases might be involved in the degradation process of recombinantly produced 
biopharmaceuticals in tobacco BY-2 cells. From recent study it seems that the degradation must 
occur in the first part of the secretory pathway (Hehle et al., 2011). Therefore, a detailed 
elucidation of vacuolar signaling and functional properties of these proteases along the 
biosynthetic (secretory) pathway is desirable. This information is essential to overcome crucial 
problems in degradation of recombinant glycoproteins by the proteolytic machinery of tobacco 
BY-2 cells.  
 
The majority of glycoproteins reach the vacuole through the classical route in tobacco BY-2 cells. 
This route is composed of the endoplasmic reticulum (ER), Golgi apparatus (GA), trans-Golgi 
network (TGN), and pre-vacuolar compartment (PVC). The vacuolar proteins are separated from 
secreted proteins (default secretion pathway) through the identification of vacuolar sorting signals 
(VSS) at GA level. To date, three types of VSSs have been described: (1) the sequence specific 
(ssVSS); (2) the C-terminal sequence (ctVSS); and (3) the physical structure (psVSS) (Nakamura 
and Matsuoka, 1993; Neuhaus and Rogers, 1998; Dombrowski et al., 1993; Jolliffe et al., 2003). 
The ssVSS consists of the conserved motif (NPIXL/NPIR) that resides within the N-terminal 
domain. The ctVSS contains the C-terminal signals with very low sequence specificity (no 
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conserved motif). However, these signals constitute a short string of hydrophobic acid residues. 
The psVSS is related to the protein physical structure. These signals include one or two motifs 
which are exposed to the protein surface. This type of signal has been described for storage 
proteins like e.g. phaseolin. 
IV.2 Characterization of NtCP1 from BY-2 cells 
IV.2.1 Structural properties of recombinantly produced NtCP1 
According to the MEROPS database the NtCP1 belongs to the C1A subfamily/papain family 
(family C1, clan CA). Comparison of the NtCP1 amino acid sequence with other plant C1A 
proteases (refer to appendix VI.3) indicated that they share many distinguishable features as 
follows: (1) their propeptides contain NPIR (contiguous), GxNxFxD (not contiguous), and 
ERFININ (not contiguous) motifs. The NPIR motif is known as sequence-specific vacuolar 
sorting signal (ssVSS), suggesting that NtCP1 is transported to the central vacuole via classical 
route. The GxNxFxD motif seems likely to be essential for correct processing. The ERFININ 
motif is present in cathepsin H- and L-like families (Martinez et al., 2012; Richau et al, 2012) 
and its function is still unclear. (2) Their catalytic domain is composed of a highly conserved 
catalytic triad (C, H, and N) and Q residue that function in activity mechanism. (3) Their amino 
acid sequence has two potential N-glycosylation sites (NCS: 127 and NIT: 256). (4) The putative 
cleavage site of propeptide is between the V142 L143 residues similar to other C1A proteases 
(Figure III-22). Moreover, the tertiary structure of the mature NtCP1 is most likely similar to 
other C1A proteases from plant and animal origin. The polypeptide chain of NtCP1 is folded to 
produce a globular protein with two interfacing domains and one interdomain cleft. Catalytic 
residues are located within this cleft (Figure IV-1) (Kamphuis et al., 1985). 
(A)                                                                                              (B) 
 
 
Figure IV-1: Primary and tertiary structure of mature NtCP1 from tobacco BY-2 cells. A: Stereo 
ribbon representation of the mature NtCP1 was comparatively prepared by the Chimera software 
(http://www.cgl.ucsf.edu/chimera/) based on the tertiary structure of papain from the latex of the papaya 
fruit (PDB code: 9PAP) (Kamphuis et al., 1985). B: Primary structure of mature NtCP1. () indicates the 
putative cleavage site of the propeptide. Catalytic residues are shown by green balls. The α-helix is shown 
in red color, and the β–sheet is shown in purple color. 
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IV.2.2 Functional properties of recombinantly produced NtCP1 
The recombinant NtCP1 was active after purification from transiently transformed N. 
benthamiana leaves. In this thesis, the enzymatic activity of NtCP1 was determined by using 
synthetic substrate (Z-Phe-Arg-AMC) for cathepsin B, L and papain (Tchoupe et al., 1991).  
 
Processing and vacuolar targeting of NtCP1  
The plant C1A proteases are produced as zymogen including the signal peptide, propeptide, 
catalytic domain and C-terminal domain. Upon translocation to the ER, the signal peptide is 
removed by a luminal signal peptidase, folded and glycosylated. The glyco-C1A proteases are 
transported to the central vacuole or are secreted externally (Martinez et al., 2009; Herman and 
Larkins, 1999). The vacuolar C1A proteases harboring an ssVSS (NPIXL/NPIR) are separated 
from secreted proteins (bulk flow pathway) by binding to vacuolar sorting receptors (VSRs). The 
VSR1/BP-80 receptor recognizes the NPIR motif and directs those proteins into clathrin-coated 
vesicles (CCVs). These vesicles deliver their cargo into the prevacuolar compartments (PVCs), 
and then PVCs fuse with the central vacuole. The C1A proteases remain inactive until they reach 
the acidic compartments such as TGN/EE or vacuole for activation. The propeptide covers the 
active site cleft, hampering enzyme activity. To become active, the propeptide is removed by 
limited autocatalytic and/or heterocatalytic processing during the vacuolar transport or inside the 
vacuole (Wiederanders et al., 2003). Overall, the maturation of plant C1A proteases relies on 
optimal pH and other processing proteases. Confocal microscopy findings demonstrated that 
NtCP1 is targeted to the central vacuole (III.2.3). The inhibitor studies using BFA confirmed that 
COPII vesicles mediate NtCP1 transport from the ER to the Golgi (III.2.4). Colocalization 
studies using vacuolar trafficking inhibitors (E-64 and antipain) and endocytic tracer (FM4-64) 
revealed that the trans-Golgi network (TGN) is involved in NtCP1 vacuolar transport (III.2.4). 
Moreover, the NPIR motif is found within the propeptide of NtCP1. These data elucidated that 
NtCP1 is transported to the central vacuole via classical route. Recent in vivo analysis revealed 
that the most acidic compartment within plant cells is the trans-Golgi network (TGN/EE) 
(Martiniere et al., 2013). Therefore, the NtCP1 precursor becomes most likely active inside the 
TGN/EE. The acidic pH of these organelles provides the condition for inter-or-intra-molecular 
proteolysis to remove the inhibitory propeptide. The immunolot analysis of NtCP1 fusion protein 
suggests that the maturation of NtCP1 fusion protein involves two sequential steps (Figure III-
27): (1) the signal peptide is eliminated upon entrance to the lumen of the ER and resulting in the 
formation of the glyco-NtCP1 (~70 kDa); (2) the propeptide is removed inside acidic organelles 
(TGN/EE or lytic vacuole), and produces the mature NtCP1 fusion protein at ~53 kDa. 
Accordingly, the NtCP1 might participate in the degradation of secreted recombinant 
biopharmaceutical at the TGN/EE, where the default secretory stream and vacuolar pathway are 
divergent.  
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IV.3 Characterization of NtSP1 from BY-2 cells 
IV.3.1 Structural properties of recombinantly produced NtSP1 
The tobacco NtSP1 belongs to the subtilase family of serine proteases (family S8, clan SB). This 
family has catalytic residues (D, H, and S) in a specific order same as subtilisins from Bacillus 
species (Dodson and Wlodawer, 1998; Schaller, 2013). Similar to other subtilases from bacterial, 
yeast and mammalian, plant subtilases are synthesized as a zymogen including a signal peptide, a 
propeptide, a catalytic domain, and a C-terminal domain. The catalytic domain of all plant 
subtilases has an additional insertion around 130 amino acids between the His and the Ser 
residues, which is known as protease-associated (PA) domain. The PA domain functions 
probably in ligand-substrate binding and protein-protein interaction (Luo and Hofmann, 2001; 
Lawrence et al., 1999).  
 
Previous studies showed that the C-terminal domain of animal subtilases contains specific signals 
for subcellular sorting (Henrich et al., 2005; Thomas, 2002; De Bie et al., 1996). For example, 
the C-terminal domain of PC7, PC5B, and furin from human contain signals that are responsible 
for recycling from the cell surface to the TGN/EE (Mayer et al., 2008). In plant subtilases, the C-
terminal domain also contains signals for subcellular sorting. The tomato SlSBT3 includes C-
terminal signals for secretion. Mutational analysis showed that the C-terminal truncated versions 
of SlSBT3 lacking five or more amino acids remain intracellulary, and not secreted. The authors 
of this study suggested that the C-terminal SPI motif might be a potential signal peptide for 
SlSBT3 secretion to the medium (Cedzich et al., 2009). This motif is also found in the C-terminal 
domain of NtSP1. However, there is no experimental evidence that it contributes in subcellular 
sorting of NtSP1.  
 
The crystal structure of two plant subtilases has been reported: tomato subtilases 3 or S1SBT 
(Ottmann et al., 2009) and cucumisin from Muskmelon (Murayama et al., 2012). As the NtSP1 
amino acids sequence shows around 50% similarity with cucumisin (Table III-3) it is most likely 
folded into three domains: (1) catalytic domain; (2) protease-associated (PA) domain; and (3) the 
C-terminal fibronectin (Fn III)-like domain. The catalytic domain of NtSP1 might fold like other 
subtilases, including highly conserved twisted β-sheets flanked by α-helices. The PA domain 
presumably contains three α-helices and nine β-strands. The C-terminal fibronectin (Fn III)-like 
domain probably forms an eight-stranded β-sandwich structure (Figure IV-2) (Murayama et al., 
2012). 
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(A)                                                                                           (B) 
 
 
Figure IV-2: Primary and tertiary structure of mature NtSP1 from tobacco BY-2 cells. A: Stereo 
ribbon representation of the mature NtSP1 was prepared by Chimera software 
(http://www.cgl.ucsf.edu/chimera/) based on the tertiary structure of cucumusin from the Cucumis melo 
(PDB code: 3VTA) (Murayama et al., 2012). B: Primary structure of mature NtSP1. Catalytic residues are 
shown by magneta ball. The catalytic domain is shown in blue. The protease-associated (PA) domain is 
shown in orange, and the C-terminal fibronectin (Fn III)-like domain is shown in green. 
 
IV.3.2 Functional properties of recombinantly produced NtSP1 
In this thesis, the NtSP1 fusion protein was purified successfully from transgenic tobacco BY-2 
cells, but no activity was found by using the synthetic substrate Suc-Ala-Ala-Pro-Phe-pNA 
(Delmar et al., 1979). Recent studies showed that 2F5 antibody was degraded by secreted serine 
proteases found in tobacco BY-2 cells culture medium (Master thesis of Twinkle Khera, 
Fraunhofer IME, Aachen, Germany). The proteolytic activity of NtSP1 was determined using the 
synthetic substrate 2-Aminobenzoyl TLFGVPIA-Nitro-Tyr-NH2 at alkaline pH. This substrate 
was produced based on the N-terminal sequence data of cleaved 2F5 antibody by secreted serine 
proteases in BY-2 spent medium. As 2F5 antibody degradation is significantly reduced by adding 
serine protease inhibitors to the spent BY-2 culture medium (e.g. diisopropyl fluorophosphates), 
it is evident that secreted serine proteases participate in the proteolytic degradation process. From 
this in vitro study it is assumed that NtSP1 might degrade pharmaceutical proteins produced in 
BY-2 cells through the secretory pathway in alkaline plant cell compartments like ER.  
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Processing and vacuolar trafficking of NtSP1  
The maturation of plant subtilases includes at least two processing steps: (1) the elimination of 
the signal peptide and (2) the deletion of the propeptide. In animal subtilases, the cleavage of the 
propeptide occurs auto-catalytically in the ER, which is essential for proper folding (Anderson et 
al., 2002; Nour et al., 2003; Steiner, 1998). In plant subtilases, autocatalytic cleavage of the 
propeptide has also been reported (Cedzich et al., 2009; Yamagata et al., 1994) similar to the 
bacterial (Li and Inouye, 1994) and mammalian counterparts (Molloy et al., 1994; Leduc et al., 
1992). Cedzich et al. (2009) reported that the propeptide of tomato SlSBT3 is removed auto-
catalytically in an intramolecular process. Furthermore, mutational analysis revealed that the C-
terminal deletion mutants of SlSBT3 lacking five or more amino acids remain as unprocessed 
form. These data demonstrated that the C-terminal domain of SlSBT3 plays an important role in 
processing and subcellular sorting (Cedzich et al., 2009). In plant subtilases, the cleavage site of 
the propeptide is determined at the N-terminus of T116T117 residues based on the published N-
terminal sequence data of mature cucumisin (Yamagata et al., 1994) and the presence of these 
conserved residues among other plant subtilases from tomato (Meichtry et al., 1999; Tornero et 
al., 1996) and Arabidopsis (Rautengarten et al., 2006).  
 
For maturation, some of the plant subtilases are further processed at the N- and C-terminus. For 
example, cucumisin  from Muskmelon and Arabidopsis SDD1 are additionally processed at the 
C-terminal part to produce truncated versions (Yamagata et al., 1994; Groll et al., 2002). 
Maturation of SlSBT1 involves further deletion of 21 amino acids from the N-terminal part of the 
mature enzyme that occurs auto-catalytically at acidic compartments (Janzik et al., 2000). In the 
case of NtSP1, two conserved residues T116 T117 are present within the amino acid sequence. 
Immunoblot analysis of purified NtSP1 fusion protein showed one distinct band with molecular 
mass of ~106 kDa, when eluted by shifting the pH to 11.0 (Figure III-36). Based on theoretical 
molecular mass of NtSP1-GFP-Str, this band represents processing intermediate without 
propeptide. It is therefore conceivable that propeptide processing occurs auto-catalytically at 
alkaline condition.  
 
In silico analysis predicted that the NtSP1 is secreted to the extracellular matrix. The majority of 
reported plant subtilases are secreted peptidases. However, there are some reports about plant 
subtilases with dual location. Subcellular localization studies of p69 protein demonstrated that it 
accumulates inside the vacuole and intercellular spaces of leaf paranchyma cells of tomato (Vera 
et al., 1989). Confocal microscopy analysis indicated that NtSP1 accumulates predominantly 
inside the central vacuole (III.3.3). Vacuolar trafficking studies using inhibitors (BFA and E-64) 
and endocytic tracer (FM4-64) revealed that vacuolar transport of NtSP1 is mediated via the 
classical route (III.3.4). In addition, mutational analysis showed that C-terminal truncated version 
of NtSP1 lacking 238 residues remain in the ER. From this study is is obvious that vacuolar 
sorting signal resides within the C-terminal part of NtSP1 (ctVSS) (III.3.4). Taken together, the 
NtSP1 may convert to mature form after elimination of the propetide. The propeptide is likely 
cleaved in the ER similar to animal subtilases (Anderson et al., 2002; Nour et al., 2003; Steiner, 
1998). Recent in vivo studies revealed that the ER is alkaline compartment in tobacco cells (pH 
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7.5) (Martiniere et al., 2013). The alkaline condition of the ER might cause the autocatalytic 
cleavage of the propeptide. As the ER is the first organelle within the secretory pathway, the 
NtSP1 might degrade recombinant biopharmaceuticals in this intracellular compartment.  
 
IV.4 Characterization of NtAP1 from BY-2 cells 
IV.4.1 Structural properties of recombinantly produced NtAP1 
The tobacco NtAP1 belongs to the pepsin family of aspartic proteases (A1, pepsin family) 
(Rawling et al., 2012). The full-length NtAP1 protein contains all the specific characteristics 
found in aspartic proteases from microbial and animal cells, including a signal peptide, 
propeptide, catalytic domain, and C-terminal domain. However, the NtAP1 includes some unique 
features, which are not found in other APs. The catalytic sequence motif of the NtAP1 constitutes 
DTG/DSG, whereas microbial and animal APs include a DTG motif at both sides of the active 
site (Kervinen and Wlodawer, 2013). Beside this, the NtAP1 has an additional domain, the so-
called plant-specific insert (PSI), which is highly similar to saposin-like proteins (SAPLIPs) and 
is not present in microbial and animal APs. This internal region is a unique sequence of about 
100 residues found in all plant APs (phytepsins) except phytepsin from the tobacco chloroplast 
nucleoids (Nakano et al., 1997), nucellin from barley ovaries (Chen and Foolad, 1997), and 
phytepsin encoded by the cdr-1 gene from Arabidopsis (Xia et al., 2004). In 1997, the name 
phytepsin was suggested to designate all related plant APs and was accepted by the NC-IUBMB 
(Nomenclature Committee of the International Union of Biochemistry and Molecular Biology) 
(Barrett et al., 1997).  Previous studies suggested that the PSI plays an important role in vacuolar 
targeting of phytepsins (Guruprasad et al., 1994; Kervinen et al., 1999; Pereira et al., 2013). In 
addition, the PSI is probably required for proper folding of the zymogen (White et al., 1999). The 
C-terminal domain of NtAP1 shows similarity with other plant phytepsins and cereal lectins, 
including a short string of hydrophobic acid residues. The Arabidopsis genome encodes 51-69 
phytepsin genes that have been categorized into three subgoups: typical plant APs, nucellin-like 
APs, and atypical plant APs (Faro and Gal, 2005). The NtAP1 is classified into the typical plant 
AP subgroup in which the PSI and the C-terminal HTVFD sequence are present (Simoes and 
Faro, 2004). 
IV.4.2 Functional properties of recombinantly produced NtAP1 
The recombinant NtAP1 was active after affinity purification from transgenic tobacco BY-2 cells 
(III.1.1). In this thesis, the activity of recombinant NtAP1 was studied by using the synthetic 
substrate for cathepsin D/E and the two pharmaceutical proteins human serum albumin (HSA) 
and the human M12 antibody. The cathepsin D/E is an aspartic protease most active at acidic pH. 
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The processing of NtAP1 
Purified recombinant NtAP1 showed activity after elution with acidic buffer (Figure III-6) but not 
active at alkaline condition. Therefore, it is evident that the acidic pH has a profound effect on the 
activation process of NtAP1. Previous studies reported that the proteolytic activity of APs 
remains inactive at neutral pH (Dunn, 1997; Khanand James, 1998; Runeberg-Roos et al., 1994; 
Glathe et al, 1998). The acidic condition of the stomach in human and plant vacuoles results in 
the disruption of salt bridges between the propetide and aspartic catalytic residues, and 
subsequent conformational changes leads to the autocatalytic removal of the propetide. It has 
been described that the precursor of gastric APs converts to the mature form only via an 
autocatalytic process (Kervinen et al., 1999), but phytepsins require additional heterocatalytic 
steps by other processing peptidases. In general, prophytepsin converts to the processed form 
after removal of the propeptide and the PSI domain. Nevertheless, there are some differences in 
terms of the order and mechanism of those deletions. In the case of cardosin A from Cynara 
cardunculus, the PSI is completely removed followed by the removal of the propeptide 
(Ramalho-Santos et al., 1998). In contrast, prophytepsin from barley roots undergoes proteolytic 
processing to remove first the propeptide and then the PSI is deleted partially (Glathe et al., 1998; 
Tormakangas et al., 2001). According to the tertiary structure of two known plant APs 
(prophytepsin from barley and mature cardosin A from cardoon), the inactivation mechanism of 
plant APs has been described (Kervinen et al., 1999; Frazao et al., 1999). Kervinen and his 
colleagues (1999) showed that three parts of the barley prophytepsin efficiently block the active 
site cleft: (1) propeptide; (2) the 11 residues of the N-terminus part of the mature enzyme; and (3) 
the flap which is a β-hairpin protein structure. This blockage is mediated by the interaction 
between conserved residues within the N-terminal part of the mature enzyme (Lys and Tyr) and 
catalytic aspartic residues (Kervinen et al., 1999). These highly conserved residues are present in 
most of the phytepsins except carsodin A, cardosin B and two rice APs. Therefore, it is suggested 
that procardosin do not follow the inactivation mechanism of barley prophytepsin (Simoes and 
Faro, 2004). The NtAP1 amino acids sequence shows around 70% similarity with cardosin A and 
barley phytepsin (Table III-1). Thus, it seems that the NtAP1 tertiary structure might be highly 
similar to cardosin A and barley phytepsin. As the residues K78 and Y80 are found within the 
NtAP1 amino acids sequence, the pro-NtAP1 inactivation mechanism probably follows the 
scheme of prophytepsin from barley and not the one of procardosin.  
 
Based on the tertiary structure of barley prophytepsin, the mechanism of pro-NtAP1 inactivation 
is suggested as follows: the propeptide (aa 25-68), the 11 residues of the N-terminal part of the 
mature enzyme (aa 69-80), and the flap (aa 142-158) cover the active site cleft (Figure IV-3).  
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(A)                                                                                    (B) 
 
 
Figure IV-3: Primary and tertiary structure of pro-NtAP1 from tobacco BY-2 cells. A: Stereo ribbon 
representation of the pro-NtAP1 was prepared by the Chimera software 
(http://www.cgl.ucsf.edu/chimera/) based on the tertiary structure of prophytepsin from barley (PDB code: 
1QDM) (Kervinen et al., 1999). B: Primary structure of NtAP1. The propeptide is highlighted by gold 
color. Catalytic sequence motifs (DTG/DSG) are highlighted in red color, which is located in interdomain 
cleft. Conserved Lys78 and Tyr80 residues within N-terminus part of mature enzyme are marked with an 
asterisk, The flap is highlighted by cyan color, which is β-hairpin protein structure. The PSI domain is 
underlined by pink color, and four potential N-glycosylation sites are marked with green dots. 
 
Mass spectrometry analysis (refer to VI.6) of purified NtAP1fusion protein revealed that the PSI 
domain is not completely cleaved during maturation. From this study it seems that the processing 
of NtAP1 fusion protein might follow the pattern of the barley phytepsin (Glathe et al., 1998): (1) 
the signal peptide is removed after translocation to the ER lumen; (2) at acidic compartments, the 
propeptide and the N-terminus part of the mature enzyme are detached from the active site cleft 
which causes the removal of the propeptide by an autocatalytic process. After that, some parts of 
the PSI are auto-catalytically deleted to render the mature form. As TGN/EE is the most acidic 
compartment in tobacco cells (Martiniere et al., 2013) the recombinant biopharmaceuticals might 
be degraded by the endogenous NtAP1 within this compartment, representing the crossroads of 
secretory and vacuolar biosynthetic pathways.    
 
The vacuolar targeting of NtAP1 
The subcellular localization studies of phytepsins revealed that they accumulate predominantly 
inside the central vacuole (Guruprasad et al., 1994; Paris et al., 1996; Kervinen et al., 1999; 
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Schaaf et al., 2004; Simoes and Faro, 2004). For example, vacuolar targeting of phytepsin has 
been reported in different barley organs, including seeds (Marttila et al., 1995), roots and leaves 
(Runeberg-Roos et al., 1994). Moreover, phytepsins are found in seeds of Arabidopsis (Mutlu et 
al., 1999), buckwheat (Elpidina et al., 1990), castor bean (Hiraiwa et al., 1997), and flowers of C. 
candunculus (Ramalho-Santos et al., 1997). However, some of the phytepsins are targeted to 
other intracellular compartments or secreted to the extracellular matrix. For instance, phytepsin is 
targeted to the photosystem II membranes of spinach plastids (Kuwabara and Suzuki, 1997), to 
the cell wall of maize pollen (Radlowski et al., 1996) or secretion to the extracellular matrix of 
tobacco leaves (Rodrigo et al., 1991), tomato leaves (Rodrigo et al., 1989) and floral transmitting 
tissue of C. candunculus (Schaller and Ryan, 1996).  
 
Confocal microscopy analysis showed that NtAP1 is targeted to the vacuole of BY-2 cells. 
Previous studies demonstrated that the PSI contains signals for vacuolar targeting of phytepsins. 
Mutational analysis of barley phytepsin indicated that the deletion of the PSI leads to secretion of 
the mutant protease while the intact phytepsin still targets to the vacuole (Tormakangas et al., 
2001). Moreover, it was reported that either the PSI or the C-terminal peptide 
(VGFAEAA/FAEA) acts independently as a vacuolar signal in cardosin A. A previous study 
showed that these signals direct proteins to the vacuole via two distinct routes: (1) the classical 
route which is mediated by the C-terminal peptide and (2) the Golgi-independent route which is 
mediated by the PSI (Pereira et al., 2013). It was also shown that the C-terminal signal is 
dominant over the PSI signal. This dominancy might explain why the intact cardosin A is 
transported to the vacuole via the classical route and not via the Golgi independent pathway. 
Contrary to cardosin A, the PSI directs barley phytepsin (Tormakangas et al., 2001) and cardosin 
B (da Costa et al., 2010) to the vacuole via the classical route. The authors of this study assumed 
that this transport disparity might be due to the differences in the PSI composition. The barley 
phytepsin and the cardosin B contain a conserved N-glycosylation site, which is not present in 
cardosin A (Pereira et al., 2013). Multiple sequence alignments of NtAP1 with other plant APs 
(refer to VI.2) indicated that both the PSI and the C-terminal peptide (VGFAEAA/FAEA) are 
found within proenzyme. In addition, the NtAP1 PSI contains one conserved potential N-
glycosylation site. Mutational analysis of the NtAP1 demonstrated that the C-terminal deletion 
mutant (NtAP1474-GFP) remains in the ER. Therefore, it is obvious that the vacuolar sorting 
signal resides within the C-terminal part of NtAP1 (ctVSS) but not in the PSI. Crystal structure 
analysis of barley phytepsin showed that the PSI forms an external loop on the surface of the 
protein (Figure IV-3), which might have a putative binding region (Kervinen et al., 1999). 
Moreover, other studies showed that the PSI interfaces with membrane lipids (Bryksa et al., 
2013; Munoz et al., 2011). These finding suggested that the PSI is probably involved in vacuolar 
targeting indirectly via membrane associated receptors or it interacts directly with certain lipids in 
the membrane. This domain might direct the zymogen to specific intracellular compartments or 
brings it in the vicinity of a vacuolar membrane receptor. Propably the ER retention of NtAP1474-
GFP contributes to the PSI membrane association, which it is expected to cause ER translocation 
rather than secretion. Co-localization analysis using cysteine protease inhibitors (E64 and 
antipain) and endocytosis tracer (FM4-64) indicated that TGN/EE contribute in vacuolar 
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trafficking of NtAP1 (III.1.5). In summary, these data suggest that the vacuolar transport of 
NtAP1 is mediated by the classical route using a C-terminal sorting signal and the short string 
hydrophobic amino acids residue (VGFAEAA/FAEA) might act as ctVSS.  
 
In this PhD thesis, granulin-containing PLCPs (RD19C and RD21B) were identified as endosome 
localized papains (ENPs) (III.1.6). From previous studies it is known that the PLCP RD21 
accumulates inside the vacuole of senescing Arabidopsis leaves (Yamada et al., 2001). The 
processing of RD21 occurs auto-catalytically from intermediate stage (iRD21) to mature form 
without granulin domain (mRD21). Since the maturation of RD21 is an autocatalytic process (Gu 
et al., 2012) the inhibition of vacuolar trafficking with cysteine protease inhibitors suggests that 
the alteration of iRD21 to mRD21 is essential for transport of vacuolar proteins from the TGN to 
the vacuole. 
 
IV.5 Conclusions and future prospects 
In this thesis, characterization and subcellular localization studies of three endogenous tobacco 
proteases were performed (NtCP1, NSP1, and NAP1). The proteolytic activity of these enzymes 
was analyzed by artificial substrates. It was shown that the activity of these endogenous proteases 
is mainly dependent on prevailing pH. Accordingly, the NtAP1 and NtCP1 are categorized as 
acidic proteases, and NtSP1 is grouped into alkaline proteases. In vivo confocal microscopy 
findings revealed that all three proteases are targeted to the central vacuole. Vacuolar trafficking 
and colocalization studies demonstrated that transport to the vacuole occurs via the classical 
route. In addition, mutational analysis showed that the NtAP1 and the NtSP1 has C-terminal 
vacuolar sorting signal (ctVSS), while the NtCP1 contains sequence specific vacuolar sorting 
signal (ssVSS). As the pH of organelles is different in BY-2 cells, the endomembrane proteases 
can be activated within the secretory pathway and may cause the degradation of recombinantly 
produced biopharmaceuticals.  
 
Albeit there are so many data available regarding vacuolar trafficking of proteins in plants, some 
questions still remain. Our knowledge about the function of plant proteases in vacuolar 
trafficking of proteins is limited. It has been described that application of cysteine protease 
inhibitors such as E-64 and antipain abolish vacuolar trafficking of proteins in Nicotiana tabacum 
cv. BY-2 cells. When we overexpressed our target vacuolar proteases in BY-2 cells, the vacuolar 
targeting of these proteases were inhibited by the application of cysteine protease inhibitors. 
Hence, it is obvious that plant cysteine proteases play an important role in transport of vacuolar 
proteins through plant endomembrane system as a signal transduction. Nevertheless, this 
mechanism is still obscure. Unraveling the mechanism of proteases trafficking route in plants will 
aid to elucidate proteolytic degradation process of recombinantly produced proteins. This 
information can be helpful to improve the plant-based biopharmaceuticals production system. In 
this thesis, we already have isolated RD19 and RD21-like cysteine proteases (papain-like) from 
tobacco BY-2 cells using an ABPP probe symplostatin (targets cysteine proteases). To find out 
the role of plant proteases on the vacuolar trafficking of proteins in plant cells, it is necessary to 
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recognize which and whether they are acting alone or in combination with other proteases. The 
recognition of proteases in different growth stages will be conceivable by using a robust 
technique known as activity-based protein profiling (ABPP). To gain a comprehensive image 
concerning intracellular proteolysis during a typical plant cell cycle, it is possible to employ a 
panel of ABPP probes that target different classes of proteases. After that, mass spectrometry can 
be exploited to identify labeled proteases allowing the cloning of the corresponding cDNA 
sequences. The sequence information can be used to produce the recombinant proteins in order to 
identify the corresponding substrates of the cysteine proteases in vivo by using different 
approaches such as yeast-two-hybrid split-ubiquitin (Thamin et al., 2004), 2-dimensional 
difference in-gel electrophoresis (DIGE) (Unlu et al., 1997), and diagonal gel electrophoresis 
(Samelson, 2001).   
 
On the other hand, to reduce degradation of recombinantly produced pharmaceutical proteins in 
BY-2 cells, different techniques can be used as follows. (1) Knock out proteases by using gene 
editing approaches such as Zinc Finger Nucleases (ZFNs), Transcription Activator-Like Effector 
(TALENs), the CRISPR/Cas system, and engineered meganuclease re-engineered homing 
endonucleases (Esvelt and Wang, 2013). (2) Knock down of proteases by using gene-silencing 
techniques, including antisense, microRNA, and siRNA. (3) Reduction of proteases activity by 
means of proteases inhibitors. 
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V Summary  
 
Tobacco BY-2 suspension cells are used as a platform for production of valuable recombinant 
glycoproteins. The main drawback of plant cell cultures is the low expression level of 
biopharmaceuticals due to the presence of proteases. The recombinant biopharmaceuticals are 
subject to proteolysis by endogenous plant proteases while they travel through the secretory 
pathway, after secretion into the extracellular milieu or when mis-sorted to the vacuole. The 
degradation of recombinant proteins reduces the final yield and quality of the product. To 
increase recombinant glycoprotein production in tobacco BY-2 cells, a detailed understanding of 
the plant proteolytic machinery is necessary. The aim of this thesis was the biochemical 
characterization and subcellular localization of the three proteases previously cloned from 
tobacco BY-2 cells: cysteine (NtCP1), serine (NtSP1), and aspartic (NtAP1) proteases. 
 
To facilitate the detection and purification of aforementioned proteases, the C-termini have been 
fused to GFP (green fluorescent protein) and Strep II-tag. In vivo confocal microscopy findings 
revealed that theses proteases are targeted to the central vacuole. Recombinant proteases were 
purified from transgenic BY-2 cells via a anti-GFP antibodies coupled to magnetic beads or from 
transiently transformed N. benthamiana leaves via immobilized Strep-Tactin. In addition, 
proteolytic activity of these proteases was confirmed in vitro using artificial substrates. The 
maturation of NtAP1 was studied by mass spectrometry. From this study it was obvious that the 
NtAP1-GFP-Str converts to a mature form after deletion of propetide, part of PSI, and GFP. 
Beside this, in vitro analysis showed the purified NtAP1-GFP-Str can degrade pharmaceutical 
proteins used as model including M12 antibody and human serum albumin (HSA). Inhibitors and 
colocalization studies using endocytosis tracer FM4-64 revealed that these proteases deliver to 
the central vacuole via the classical route, which is composed of endoplasmic reticulum (ER), 
Golgi, trans-Golgi network/early endosome (TGN/EE) and pre-vacuolar compartment/late 
endosome (PVC/LE). Mutational analysis indicated the type of vacuolar sorting signal (VSS) 
within aforementioned proteases. The NtCP1 contains sequence specific vacuolar sorting signal 
(ssVSS), while the NtSP1 or NAP1 comprises C-terminal vacuolar sorting signal (ctVSS). 
 
These data showed that these vacuolar proteases may be involved in the degradation process of 
recombinantly produced biopharmaceuticals in tobacco BY-2 cells. From this study it seems that 
the degradation may occur in the first part of the secretory pathway. 
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VII Appendices 
VII.1 Abbreviations 
 
2,4-D 2,4-Dichlorophenoxyacetic acid 
Amp Ampicillin 
AP Alkaline phosphatase 
BCIP 5-bromo-4-chloro-3-indolyl phosphate 
bp Base pair 
BSA Bovine serum albumin 
CaCl2 Calcium chloride 
CaMV Cauliflower mosaic virus 
CAPS N-cyclohexyl-3-aminopropanesulfonic acid 
Carb Carbenicillin 
cDNA Complementary DNA 
COPI Coat protein I 
COPII Coat protein II 
Cfu Colony-forming units 
CTAB Cetyltrimethylammonium bromide 
Cys Cysteine 
cv. Cultivar 
DEPC Diethylpyrocarbonate 
DMSO Dimethyl sulfoxide 
DNA Deoxyribonucleic acid 
dNTP Deoxyribonucleoside triphosphate 
DSPA-α1 Desmodus rotundus salivary plasminogen activator alpha 1 
DTT 1,4-dithiothreitol 
E. coli Escherichia coli 
EDTA Ethylenediamine tetraacetic acid 
ELISA Enzyme-linked immunosorbent assay 
ER Endoplasmatic reticulum 
ERGIC ER-Golgi intermediate compartment 
EE Early endosome 
EtOH Ethanol 
Fab Fragment antigen binding 
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Fc Fragment crystalline 
G Relative centrifugal force (RCF) 
Ga Golgi apparatus 
H Hour(s) 
HCl Hydrochloride 
His Histidine 
IE Intermediate endosome 
Kbp Kilobase pair 
kDa Kilodalton 
KV KDEL vesicles 
KH2PO4 Potassium dihydrogen phosphate 
Km Kanamycin 
LE Late endosome 
LV Lytic vacuole 
M Molarity 
MES 2-(N-morpholino)-ethanesulphonic acid 
Min Minute(s) 
MgSO4 Magnesium sulfate 
MnCl2 Manganese(II) chloride 
MOPS 3-(morpholino) propanesulfonic acid) 
mRNA Messenger RNA 
NaAc Sodium acetate 
NaCl Sodium chloride 
NaH2PO4 Sodium dihydrogen phosphate 
Na2HPO4 Disodium monohydrogen phosphate 
OD Optical density 
o/n Overnight 
ORF Open reading frame 
Ori Origin of replication 
PBS Phosphate buffered saline 
PBST 0.1%  (v/v) Tween-20 in PBS 
PCR Polymerase chain reaction 
PDP Plant-derived pharmaceutical proteins 
pH A negative logarithmic measure of hydrogen ion concentration 
PSI Plant-specific insert 
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pNPP p-nitrophenyl phosphate 
PVDF Polyvinylidene fluoride  
PVPP Polyvinyl polypyrrolidone 
PSV Protein-storage vacuole 
PVC Prevacuolar compartment 
RbCl Rubidium chloride 
RE Recycling endosome 
Rif Rifampicin 
RNA Ribonucleic acid 
RNase Ribonuclease 
rpm Revolutions per minute 
RT Room temperature 
scFv Single-chain variable fragment 
SDS-PAGE Sodium dodecyl sulphate-polyacrylamide gel electrophoresis 
TBE Tris- buffered saline electrophoresis buffer 
TGN Trans-Golgi network 
TEMED N,N,N, N-tetramethylene-ethylenediamine 
UTR untranslated region 
V Volt 
v/v Volume per volume 
w/v Weight per volume 
w/w Weight per weight 
YNB Yeast nitrogen base 
ZnCl2 Zinc chloride 
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VII.2 Multiple sequence alignment of NtAP1 with plant APs 
 
Preprocirsin      MGTSIKASLLALFLLFLLSPTAISVSNDGLIRVGLKKRKVDQINQLSGHGASMEGKARKD 60 
Cyprosin          MGTAIKASVLALFLFFLLSPTAFSVSNGGLLRVGLKKRKVDQINQLSGHGVSMEAKARKD 60 
Cenprosin         MGTAIKASLLALFLFVLLSPTAFSASNGGLLRVGLKKRKVDQINQLRNHGASMEGKARKD 60 
Ha-AspP           MSTTIKTSLLALFLLFILSPTAFSSTKGGLLRVGLKKRKTNQFNRVSEHGLSMEGTDRRN 60 
Nt-AP1             ----------------------------------------QAFGGIDSNGAN----SART 16 
At-AspP           --------------------GRFAERNDGTFRVGLKKLKLDSKNRLAARVESKQEKPLRA 40 
Phytepsin         ------------------------------VRIALKKRPIDR-NSRVATGLSGGEEQPLL 29 
                                                          :  .       .         
 
Preprocirsin      FGFGGTLRDSDSDIIALKNYMDAQYYGEIGIGAPPQKFTVIFDTGSSNLWVPSAKCYFSV 120 
Cyprosin          FGFGGALRDSGSDIIALKNYMDAQYYGEIGIGSPPQKFTVIFDTGSSNLWVPSAKCYFSV 120 
Cenprosin         FGFGGSLRDSDSDIIELKNYMDAQYYGEIGIGSPAQKFTVIFDTGSSNLWVPSAKCYFSV 120 
Ha-AspP           FGFYDTLRNSEGDVIVLKNYMDAQYFGEIGIGTPPQKFTVVFDTGSANLWVPSSKCFLSV 120 
Nt-AP1             YHLGGNIGDSDTDIIALKNYLDAQYFGEICIGSPPQKFTVIFDTGSSNLWVPSARCYFSL 76 
At-AspP           YRLGD---SGDADVVVLKNYLDAQYYGEIAIGTPPQKFTVVFDTGSSNLWVPSSKCYFSL 97 
Phytepsin         SGANPLRSEEEGDIVALKNYMNAQYFGEIGVGTPPQKFTVIFDTGSSNLWVPSAKCYFSI 89 
                          .   *:: ****::***:*** :*:*.*****:*****:******::*::*: 
 
Preprocirsin      ACLFHSKYKSSHSSTYKKNGTSAAIQYGTGSISGFVSQDSVKLGDLVVKEQDFIEATKEP 180 
Cyprosin          ACLFHSKYKSSHSSTYKKNGTSAAIQYGTGSISGFVSQDSVKLGDLVVKEQDFIEATKEP 180 
Cenprosin         ACLFHSKYKSSHSSTYKKNGTSAAIQYGTGSISGFVSQDSVKLGDLVVKEQDFIEATKEP 180 
Ha-AspP           ACLFHQKYKASRSSTYKKNGTAAAIQYGTGAISGVFSRDSVKLGDLVVKEQDFIEATREP 180 
Nt-AP1             ACYLHPKYKSSHSSTYKKNGTSAAIRYGTGSISGYFSNDNVKVGDLIVKDQDFIEATREP 136 
At-AspP           ACLLHPKYKSSRSSTYEKNGKAAAIHYGTGAIAGFFSNDAVTVGDLVVKDQEFIEATKEP 157 
Phytepsin         ACYLHSRYKAGASSTYKKNGKPAAIQYGTGSIAGYFSEDSVTVGDLVVKDQEFIEATKEP 149 
                  ** :* :**:. ****:***..***:****:*:* .*.* *.:***:**:*:*****:** 
 
Preprocirsin      GITFLAAKFDGILGLGFQEISVGKSVPVWYNMVNQGLVQEPVFSFWFNRNANEEEGGELV 240 
Cyprosin          GITFLAAKFDGILGLGFQEISVGKSVPLWYNMVNQGLVQEPVFSFWFNRNADEEEGGELV 240 
Cenprosin         GVTFLAAKFDGILGLGFQEISVGKSVPVWYNMVNQGLVQEPVFSFWFNRNADEEEGGELV 240 
Ha-AspP           GITFLAAKFDGILGLGYQDISVGKAVPVWYNMVNQGLVQEPVFSFWFNRHTGEEEGGELV 240 
NtAP1             GITFLAAKFDGILGLGFQEISVGKSVPVWYNMVNQGLVKKPVFSFWFNRNAQEEEGGELV 196 
At-AspP           GITFVVAKFDGILGLGFQEISVGKAAPVWYNMLKQGLIKEPVFSFWLNRNADEEEGGELV 217 
Phytepsin         GITFLVAKFDGILGLGFKEISVGKAVPVWYKMIEQGLVSDPVFSFWLNRHVDEGEGGEII 209 
                  *:**:.**********:::*****:.*:**:*::***:..******:**:. * ****:: 
 
Preprocirsin      FGGVDPNHFKGKHTYVPVTEKGYWQFNMGDVLIEDKTTGFCSDGCAAIADSGTSLLAGPT 300 
Cyprosin          FGGVDPNHFKGKHTYVPVTEKGYWQFDMGDVLIEDKTTGFCSDGCAAIADSGTSLLAGPT 300 
Cenprosin         FGGVDPNHFKGKHTYVPVTQKGYWQFNMGDVLIEDKTTGFCADGCAAIADSGTSLLAGPT 300 
Ha-AspP           FGGVDPNHFKGKHTYVPVTQKGYWQFDMGDVLIGDKTTGFCSGGCAAIADSGTSLLAGPT 300 
NtAP1             FGGVDPNHFKGKHTYVPVTHKGYWQFDMGDVLVGGETTGFCSGGCSAIADSGTSLLAGPT 256 
At-AspP           FGGVDPNHFKGKHTYVPVTQKGYWQFDMGDVLIGGAPTGFCESGCSAIADSGTSLLAGPT 277 
Phytepsin         FGGMDPKHYVGEHTYVPVTQKGYWQFDMGDVLVGGKSTGFCAGGCAAIADSGTSLLAGPT 269 
                  ***:**:*: *:*******.******:*****: . .**** .**:************** 
 
Preprocirsin      AIITEINHASGAKGVMSQQCKTLVSQYGKSIIEMLLSEAQPDKICSQMKLCTFDGARDVS 360 
Cyprosin          AIITEINHAIGAKGVMSQQCKTLVSQYGKTMIEMLLSEAQPDKICSQMKLCTFDGARDAS 360 
Cenprosin         AIITQINHAIGAKGVMSQQCKTLVDQYGKTIIEMLLSEAQPDKICSQMKLCTFDGARDVS 360 
Ha-AspP           TIITQINHAIGAAGVMSQQCKTLVDQYGKTIIEMLLSEAQPDKICSRMNLCTFDGSRDVS 360 
Nt-AP1             TIITQINHVIGASGVVSQECKSLVTEYGKTILDLLESKAAPQKICSQIGLCSSDGSRDVS 316 
At-AspP           TIITMINHAIGAAGVVSQQCKTVVDQYGQTILDLLLSETQPKKICSQIGLCTFDGTRGVS 337 
Phytepsin         AIITEINEKIGAAGVVSQECKTIVSQYGQQILDLLLAETQPKKICSQVGLCTFDGTRGVS 329 
                  :*** **.  ** **:**:**::* :**: ::::* ::: *.****:: **: **:*..* 
 
Preprocirsin      SIIESVVDKNNGKSSGGANDEMCTFCEMAVVWMQNQIKRNETEDNIINYVNELCDRLPSP 420 
Cyprosin          SIIESVVDENNGKSSSGVHDEMCTFCEMAVVWMQNQIKRNETEDNIINYVNELCDRLPSP 420 
Cenprosin         SIIESVVDKNNGKSSGGVHDEMCTFCEMAVVWMQNQIKRNQTEDNIINYVNELCDRLPSP 420 
Ha-AspP           SIIESVVDKNNGKSSAGLNDGICAFCEMAVVWMQSQLKRNQTEDSIINYVNELCDRIPSP 420 
Nt-AP1             MIIESVVDKHNG-ASNGLGDEMCRVCEMAVIWMQNQMRRNETADSIYDYVNQLCDRLPSP 375 
At-AspP           MGIESVVDKENAKLSNGVGDAACSACEMAVVWIQSQLRQNMTQERILNYVNELCERLPSP 397 
Phytepsin         AGIRSVVDDEPVKSNGLRADPMCSACEMAVVWMQNQLAQNKTQDLILDYVNQLCNRLPSP 389 
                    *.****..    .    *  *  *****:*:*.*: :* * : * :***:**:*:*** 
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Preprocirsin      MGESAVDCNSLSSMPNIAFTIGGKVFELCPEQYILKIGEGEAAQCISGFTAMDVAPPRGP 480 
Cyprosin          MGESAVDCNSLSSMPNIAFTIGGKVFELCPEQYILKIGEGEAAQCISGFTAMDVAPPRGP 480 
Cenprosin         MGESAVDCNDLSSMPNIAFTIGGKVFELCPEQYILKIGEGEAAQCISGFTAMDVAPPRGP 480 
Ha-AspP           MGESAVDCQTLSNMPNIAFTIGGKTFDLTPEQYILKVGEGEVAQCISGFTALDVAPPHGP 480 
NtAP1             MGESAVDCSSLASMPNVSFTVGNQTFGLTPQQYVLQVGEGPVAQCISGFTALDVPPPRGP 435 
At-AspP           MGESAVDCAQLSTMPTVSLTIGGKVFDLAPEEYVLKVGEGPVAQCISGFIALDVAPPRGP 457 
Phytepsin         MGESAVDCGSLGSMPDIEFTIGGKKFALKPEEYILKVGEGAAAQCISGFTAMDIPPPRGP 449 
                  ********  *..** : :*:*.: * * *::*:*::*** .******* *:*:.**:** 
 
Preprocirsin      LWILGDVFMGRYHTVFDYGKSRVGFAEAA 509 
Cyprosin          LWILGDVFMGRYHTVFDYGKLRVGFAEAA 509 
Cenprosin         LWILGDVFMGQYHTVFDYGKLRVGFAEAA 509 
Ha-AspP           LWIHGDVFMGQYHTVFDFGKSRVGFAEAA 509 
NtAP1             LWILGDVFMGRYHTVFDYGNSRVGFAEAA 464 
At-AspP           LWILGDVFMGKYHTVFDFGNEQVGFAEAA 486 
Phytepsin         LWILGDVFMGPYHTVFDYGKLRIGFAKAA 478 
                  *** ****** ******:*: ::***:** 
 
Figure  VII-1: Multiple sequence alignment of NtAP1 with other published plant APs.  
The alignment was performed using ClustalW2 algorithm. “*” = the residues in that column are identical 
in all sequences in the alignment. “:” = conserved substitutions. “.” = semi-conserved substitutions. “-” = 
no match. Preprocirsin: Cirsium vulgare; Cyprosin: Cynara cardunculus; Cenprosin: Centaurea 
calcitrapa; Ha-AspP: Helianthus annuus; Nt-AP1: Nicotiana tabacum; At-AspP: Arabidopsis thaliana; 
Phytepsin: Hordeum vulgare. 
 
VII.3 Multiple sequence alignment of NtCP1 with plant CPs 
 
Aleurain        MAHAR-VLLLALAVLA-TAAVAVASSSSFADSNPIRPVTDRAASTLESAVLGALGRTRHA 58 
Oryzain         MAHRRIILLLAVAAVA-ATSAVAAASSGFDDSNPIRSVTDHAASALESTVIAALGRTRGA 59 
NtCP23          MSR--FSLLLALVVAGGLFASALAGPATFADENPIRQVVSDGLHELENAILQVVGKTRHA 58 
NbCP1           MSR--FSLLLALVVAGGLFAAALAGPATFADENPIRQIVSDGLHELENGILQVVGKTRHA 58 
NtCP1           MSR--FTLLLALVVAGGLFAAALAGPATFAVENPIRQVVSDGLHELENGILQVVGQSRHA 58 
SEUU3           MSR--LSLVLILVAG--LFATALAGPATFADKNPIRQVVFP--DELENGILQVVGQTRSA 54 
Actindin        MARTSFSLLIILIAC----VAGASSASTFDDENPIRTVVSDALREFETSILSVLGDSRHA 56 
Cathepsin       --------------------AEIKHKYLWSE----------------------------- 11 
                                            :                                
Aleurain        LRFARFAVRYGKSYESAAEVRRRFRIFSESLEEVRSTNRKGLPYRLGINRFSDMSWEEFQ 118 
Oryzain         LRFARFAVRHGKRYGDAAEVQRRFRIFSESLELVRSTNRRGLPYRLGINRFADMSWEEFQ 119 
NtCP23          LSSARFAHRYGKRYESVEEIKQRFEVFLDNLKMIRSHNKKGLSYKLGVNEFTDLTWDEFR 118 
NbCP1           LLFARFAHRYGKRYETVEEIKQRFEVFLDNLKMIRSHNKKGLSYKLGVNEFTDITWDEFR 118 
NtCP1           LSFVRFAHRYGKRYESVEEIKQRFEVFLDNLKMIRSHNKKGLSYKLGVNEFTDLTWDEFR 118 
SEUU3           LSFARFAIRHRKRYDSVEEIKQRFEIFLDNLKMIRSHNRKGLSYKLGINEFTDLTWDEFR 114 
Actindin        LSFARFAHRYGKRYETAEETKLRFAIFSENLKLIRSHNKKGLSYTLGVNHFADWTWEEFR 116 
Cathepsin       ------------------------------------------------------------ 
                                                                             
Aleurain        ATRLGAAQTCSATLAGNHLMRDAAALPETKDWREDG-IVSPVKNQAHCGSCWTFSTTGAL 177 
Oryzain         ASRLGAAQNCSATLAGNHRMRDAPALPETKDWREDG-IVSPVKDQGHCGSCWPFSTTGSL 178 
NtCP23          RDRLGAAQNCSATTKGNLKVTN-VVLPETKGWREAG-IVSPVKNQGKCGSCWTFSTTGAL 176 
NbCP1           RDRLGAAQNCSATTKGNLKLTN-VVLPETKDWREAG-IVSPVKNQGKCGSCWTFSTTGAL 176 
NtCP1           RDRLGAAQNCSATTKGNVKLTN-AVLPETKDWREDG-IVSPVKNQGKCGSCWTFSTTGAL 176 
SEUU3           KHKLGASQNCSATTKGNLKLTN-VVLPETKDWRKDG-IVSPVKAQGKCGSCWTFSTTGAL 172 
Actindin        RHRLGAAQNCSATTKGNHKLTE-EALPEMKDWRVSG-IVSPVKDQGHCGSCWTFSTTGAL 174 
Cathepsin       ------PQNCSATKSNYLRGTG--PYPPSVDWRKKGNFVSPVKNQGACGSCWTFSTTGAL 63 
                      .*.****  .          *   .**  * :***** *. *****.*****:* 
 
Aleurain        EAAYTQATGKNISLSEQQLVDCAGGFNNFGCNGGLPSQAFEYIKYNGGIDTEESYPYKGV 237 
Oryzain         EARYTQATGPPVSLSEQQLADCATRYNNFGCSGGLPSQAFEYIKYNGGLDTEEAYPYTGV 238 
NtCP23          EAAYSQAFGKGISLSEQQLVDCAGAFNNFGCNGGLPSQAFEYIKSNGGLDTEEAYPYTGK 236 
NbCP1           EAAYGQAFGKGISLSEQQLVDCAGAFNNFGCNGGLPSQAFEYIKSNGGLDTEEAYPYTGK 236 
NtCP1           EAAYSQAFGKGISLSEQQLVDCAGAFNNFGCNGGLPSQAFEYIKSNGGLDTEEAYPYTGK 236 
SEUU3           EAAYAQAFGKGISLSEQQLVDCAGAFNNFGCNGGLPSQAFEYIKFNGGLDTEEAYPYTGK 232 
Actindin        EAAYKQAFGKGISLSEQQLVDCAGAFNNFGCSGGLPSQAFEYVKYNGGLDTEEAYPYTGK 234 
Cathepsin       ESAIAIATGKMLSLAEQQLVDCAQDFNNYGCQGGLPSQAFEYILYNKGIMGEDTYPYQGK 123 
                *:    * *  :**:****.***  :**:**.**********:  * *:  *::*** *  
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Aleurain        NGVCHYKAENAAVQVLDSVNITLNAEDELKNAVGLVRPVSVAFQVIDGFRQYKSGVYTSD 297 
Oryzain         NGICHYKPENAGVKVLDSVNITLVAEDELKNAVGLVRPVSVAFQVINGFRMYKSGVYTSD 298 
NtCP23          NGLCKFSSENVGVKVIDSVNITLGAEDELKYAVALVRPVSIAFEVIKGFKQYKSGVYTST 296 
NbCP1           NGLCKFSSENVGVKVIDSVNITLGAEDELKYAVALVRPVSIAFEVIKGFKQYKSGVYTST 296 
NtCP1           NGLCKFSSENVGVKVIDSVNITLGAEDELKYAVALVRPVSIAFEVIKGFKQYKSGVYSST 296 
SEUU3           NGICKFSQANIGVKVISSVNITLGAEYELKYAVALVRPVSVAFEVVKGFKQYKSGVYAST 292 
Actindin        NGECKFSSENVGVQVLDSVNITLGAEDELKHAVAFVRPVSVAFQVVNGFRLYKEGVYTSD 294 
Cathepsin       DGYCKFQPGKAIGFVKDVANITIYDEEAMVEAVALYNPVSFAFEVTQDFMMYRTGIYSST 183 
                :* *::.  :    * . .***:  *  :  **.: .***.**:* ..*  *: *:*:*  
 
Aleurain        HCGTTPDDVNHAVLAVGYGVENGVPYWLIKNSWGADWGDNGYFKMEMGKNMCAIATCASY 357 
Oryzain         HCGTSPMDVNHAVLAVGYGVENGVPYWLIKNSWGADWGDNGYFTMEMGKNMCGIATCASY 358 
NtCP23          ECGNTPMDVNHAVLAVGYGVENGVPYWLIKNSWGADWGDNGYFKMEMGKNMCGIATCASY 356 
NbCP1           ECGNTPMDVNHAVLAVGYGVENGVPYWLIKNSWGADWGDNGYFKMEMGKNMCGIATCASY 356 
NtCP1           ECGNTPMDVNHAVLAVGYGVENGVPYWLIKNSWGADWGDDGYFKMEMGKNMCGIATCASY 356 
SEUU3           ECGDTPMDVNHAVLAVGYGVENGTPYWLIKNSWGADWGEDGYFKMEMGKNMCGVATCASY 352 
Actindin        TCGRTPMDVNHAVLAVGYGVENGVPYWLIKNSWGADWGDSGYFKMEMGKNMCGVATCASY 354 
Cathepsin       SCHKTPDKVNHAVLAVGYGEKNGIPYWIVKNSWGPQWGMNGYFLIERGKNMCGLAACASY 243 
                 *  :* .*********** :** ***::*****.:** .*** :* *****.:*:**** 
 
Aleurain        PVVA- 361 
Oryzain         PIVA- 362 
NtCP23          PVVA- 360 
NbCP1           PVVA- 360 
NtCP1           PVVA- 360 
SEUU3           PIVA- 356 
Actindin        PVIA- 358 
Cathepsin       PIPLV 248 
                *:    
 
Figure  VII-1: Multiple sequence alignment of NtCP1 with other published plant CPs.  
The alignment was performed using ClustalW2 algorithm. “*” = the residues in that column are identical 
in all sequences in the alignment. “:” = conserved substitutions. “.” = semi-conserved substitutions. “-” = 
no match. NtCP-23: Nicotiana tabacum; NbCP1: Nicotiana benthamiana; SENU3: Solanum lycopersicum 
Actindin: Actinidia deliciosa; Aleurain: Hordeum vulgare; Oryzain γ: Oryza sativa; Cathepsin H: Homo 
sapiens. NtCP1: Nicotiana tabacum. 
 
VII.4 Multiple sequence alignment of NtSP1 with plant SPs 
 
P69A            MGFLKILLVF-IFCSFPWPTIQSNLETYLVHVESPESLISTQSSLT-DLDSYYLSFLPKT 58 
P69D            MGFLKILLVF-IFGSFPWPTIQSNLETYLVHVESPESLISTQSSLT-DLDSYYLSFLPKT 58 
P69C            MGFFKILFVF-IFCSFPWPTIQSDLETYIVHVESPESLITTQSSLT-DLDSYYLSFLPKT 58 
P69B            MGLLKILLVF-IFCSFQWPTIQSNLETYIVHVESPESLVTTQSLLT-DLGSYYLSFLPKT 58 
NtSP1           MKILKIFLVFSILGCLSWPSIQSDLTTYIVQVESPESRISTQSLSDQDLESWYRSFLPNT 60 
                * ::**::** *: .: **:***:* **:*:****** ::***    ** *:* ****:* 
 
P69A            TTAISSSGNEEAATMIYSYHNVMTGFAARLTAEQVKEMEKIHGFVSAQKQRTLSLDTTHT 118 
P69D            TTAISSSGNEEAATMIYSYHNVMTGFAARLTAEQVKEMEKIHGFVSAQKQRTLSLDTTHT 118 
P69C            TTTISSSGNEEAATMIYSYHNVMTGFAARLTAEQVKEMEKKHGFVSAQKQRILSLHTTHT 118 
P69B            ATTISSSGNEEAATMIYSYHNVMTGFAARLTAEQVKEMEKKHGFVSAQKQRILSLHTTHT 118 
NtSP1           IASTRSN-DEEEPRLVYSYRNVMKGFAARLSAEQVKEMEKKEGFISAWPERILSLHTTHT 119 
                 ::  *. :** . ::***:***.******:********* .**:**  :* ***.**** 
 
P69A            SSFLGLQQNMGVWKDSNYGKGVIIGVIDTGILPDHPSFSDVGMPPPPAKWKGVCESNFTN 178 
P69D            SSFLGLQQNMGVWKDSNYGKGVIIGVIDTGILPDHPSFSDVGMPPPPAKWKGVCESNFTN 178 
P69C            PSFLGLQQNMGLWKDSNYGKGVIIGVIDTGIVPDHPSLSDVGMPSPPAKWKGVCESNFTN 178 
P69B            PSFLGLQQNMGVWKDSNYGKGVIIGVIDTGIIPDHPSFSDVGMPPPPAKWKGVCESNFTN 178 
NtSP1           PSFLGLQQNEGVWRHSNYGKGVIIGVLDTGISPDHPSFSDEGMPPPPAKWKGKCELNFTT 179 
                .******** *:*:.***********:**** *****:** ***.******* ** ***. 
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P69A            KCNNKLIGARSYQLGHGSPIDDDGHGTHTASTAAGAFVNGANVFGNANGTAAGVAPFAHI 238 
P69D            KCNNKLIGARSYQLGHGSPIDDDGHGTHTASTAAGAFVNGANVFGNANGTAAGVAPFAHI 238 
P69C            KCNNKLIGARSYQLANGSPIDDDGHGTHTASTAAGAFVNGANVFGNANGTAVGVAPLAHI 238 
P69B            KCNNKLIGARSYQLGNGSPIDSIGHGTHTASTAAGAFVKGANVYGNADGTAVGVAPLAHI 238 
NtSP1           KCNNKLIGARTFPQANGSPIDDNGHGTHTAGTAAGGFVKGANVFGNANGTAVGIAPLAHL 239 
                **********::  .:*****. *******.****.**:****:***:***.*:**:**: 
 
P69A            AVYKVCNSDGCADTDVLAAMDAAIDDGVDILSISLGGGGSSDFYSNPIALGAYSATERGI 298 
P69D            AVYKVCNSDGCADTDVLAAMDAAIDDGVDILSISLGGGGSSDFYSNPIALGAYSATERGI 298 
P69C            AIYKVCSSDGCSDSDILAAMDAAIDDGVDILSISLGGS-PIPLYEDSIAMGAYSATERGI 297 
P69B            AIYKVCNSVGCSESDVLAAMDSAIDDGVDILSMSLSGG-PIPFHRDNIAIGAYSATERGI 297 
NtSP1           AIYKVCDSFGCSDSGILSAMDAAIDDGVDILSLSLGGS-TNPFHSDPIALGAYSATQRGI 298 
                *:****.* **:::.:*:***:**********:**.*. .  :: : **:******:*** 
                        
P69A            LVSCSAGNNGPSTGSVGNEAPWILTVGASTQDRKLKATVKLGNREEFEGESAYRPKISNS 358 
P69D            LVSCSAGNNGPSTGSVGNEAPWILTVGASTQDRKLKATVKLGNGEEFEGESAYRPKISNS 358 
P69C            LVSCSAGNDGHSMGSVDNSAPWILTVGASTLDRKIKATVKLGNREEFQGESAYRPQISNS 357 
P69B            LVSCSAGNSGPSFITAVNTAPWILTVGASTLDRKIKATVKLGNGEEFEGESAYRPKISNA 357 
NtSP1           LVSCSAGNTGPFEGAVVNEAPWILTVGASTLDRKIKATVRLGNKEEFEGESAFHPKVSKT 358 
                ******** *    :. * *********** ***:****:*** ***:****::*::*:: 
 
P69A            TFFALFDAGKNASDEFETPYCRSGSLTDP--VIRGKIVICLAGGGVPRVDKGQAVKDAGG 416 
P69D            TFFALFDAGKNASDEFETPYCRSGSLTDP--VIRGKIVICLAGGGVPRVDKGQAVKDAGG 416 
P69C            TFFTLFDAAKNASDEFKTPYCRPGSLTDP--AIRGKIVLCLAFGGVTIVDKGQAVKDAGG 415 
P69B            TFFTLFDAAKNAKDPSETPYCRRGSLTDP--AIRGKIVLCSALGHVANVDKGQAVKDAGG 415 
NtSP1           KFFPLFNPGENLTDDSDNSFCGPG-LTDLSRAIKGKIVLCVAGGGFNSIEKGQAVKNAGG 417 
                .**.**:..:* .*  ...:*  * ***   .*:****:* * * .  ::******:*** 
 
P69A            VGMIIINQQRSGVTKSADAHVIPALDISDADGTKILAYMNSTSNPVATITFQGTIIGDKN 476 
P69D            VGMIIINQQRSGVTKSADAHVLPALDISDADGTKILAYMNSTSNPVATITFQGTIIGDKN 476 
P69C            VGMIIINSPDDGVTKSADAHVLPALDVSDADGTKILAYMNSTSNPVATIAFQGTIIGDKN 475 
P69B            VGMIIINPSQYGVTKSADAHVLPALVVSAADGTKILAYMNSTSSPVATIAFQGTIIGDKN 475 
NtSP1           VGMILINRPQDGLTKSADAHVLPALDVASFDGNNIIDYMKSTKKPVARITFQGTIIGDKN 477 
                ****:**    *:********:*** ::  **.:*: **:**..*** *:********** 
 
P69A            APIVAAFSSRGPSGASIGILKPDIIGPGVNILAAWPTSVDDNKNTKSTFNIISGTSMSCP 536 
P69D            APIVAAFSSRGPSGASIGILKPDIIGPGVNILAAWPTSVDDNKNTKSTFNIISGTSMSCP 536 
P69C            APMVAAFSSRGPSRASPGILKPDIIGPGVNILAAWPTSVDDNKDTKSTFNIISGTSMSCP 535 
P69B            APMVAAFSSRGPSRASPGILKPDIIGPGANILAAWPTSVDDNKNTKSTFNIISGTSMSCP 535 
NtSP1           APVLAGFSSRGPSTASPGILKPDIIGPGVNVLAAWPTPVENKTNTKSTFNIISGTSMSCP 537 
                **::*.******* ** ***********.*:******.*:::.:**************** 
 
P69A            HLSGVRALLKSTHPDWSPAAIKSAMMTTADTLNLANSPILDERLLPADIYAIGAGHVNPS 596 
P69D            HLSGVAALLKSTHPDWSPAAIKSAMMTTADTLNLANSPILDERLLPADIYAIGAGHVNPS 596 
P69C            HLSGVAALLKSTHPDWSPAAIKSAIMTTADTLNLANSPILDERLLPADIFATGAGHVNPS 595 
P69B            HLSGVAALLKCTHPDWSPAVIKSAMMTTADTLNLANSPILDERLLPADIYAIGAGHVNPS 595 
NtSP1           HLSGIAALLKSAHPTWSPAAIKSAIMTTADIVNLGNESLLDEMLAPAKIFAYGSGHVNPS 597 
                ****: ****.:** ****.****:***** :**.*..:*** * **.*:* *:****** 
 
Figure  VII-2: Multiple sequence alignment of NtSP1 with other published plant SPs.  
The alignment was performed using ClustalW2 algorithm. “*” = the residues in that column are identical 
in all sequences in the alignment. “:” = conserved substitutions. “.” = semi-conserved substitutions. “-” = 
no match. P69A, B, C, D, and E: Solanum lycopersicum. NtSP1: Nicotiana tabacum. 
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VII.5 Mass spectrometric analysis results 
 
(A) 
 
 
 
 
(B) 
1. Precursor form of NtAP1-GFP-Str without SP (~100 kDa) 
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2. Processing intermediate of NtAP1-GFP-Str without SP and PP (~76 kDa) 
 
 
 
 
3. Mature form of NtAP1 without SP, PP, GFP and part of the PSI (~55 kDa) 
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4. Further processed form of GFP (~19 kDa)  
 
 
 
Figure  VII-4: Mass spectrometry analysis results. A: The different domains of NtAP1-GFP-Str are 
shown in a schematic illustration. SP: signal peptide; PP: propeptide; CD: catalytic domain; PSI: plant-
specific insert; C-T: c-terminal domain; EmGFP: emereled green flourscence protein; Str: Strep II-tag; B: 
Mass spectrometric results. Protein database searching using search engines like Mascot found matching 
proteins to the identified peptides after chromatographic separation. Numbers indicate excised bands 
which analyzed by mass spectrometry. The identified amino acids are highlighted in red colour. 
 
VII.6 Schematic presentation of plant expression vectors 
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Figure  VII-3: Schematic presentation of the plant expression vectors used in this thesis. 
LB and RB are left and right border of the T-DNA; Pnos and pAnos: promoter and terminator of the 
nopaline synthase gene, respectively; nptII: coding sequence of the neomycin phosphotransferase gene; 
hygR: coding sequence of the hygromycin resistance gene; bla: coding sequence of the beta-lactamase 
gene SAR: scaffold attachment region; P35S and pA35S: 35S promoter with doubled enhancer and 
terminator of the Cauliflower mosaic virus (CaMV) 35S gene, respectively; RK2 ori and ColE1 ori: 
plasmid origin of replication; AP1: full-length of aspartic proteases; AP1474: C-terminal deletion mutants 
lacking 34 aa; AP1417 : C-terminal deletion mutant without 91 aa; AP1355: C-terminal deletion lacking 155 
aa; AP1299 : C-terminal deletion mutant without 209 aa. SP1753: full-length of serine protease; SP1555: C-
terminal deletion mutant without 198 aa; CP1360: full-length of cysteine protease; SP: cDNA of signal 
peptide; TP: cDNA of transit peptide. GFP: cDNA of green fluorescence protein; Str: cDNA of Strep II-
tag. 
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proteolysis in plant molecular farming: tobacco BY‐2 cells as a case study, Berlin‐Dahlem, Germany; 
17‐19 June, 2014.  
Languages 
 Languages: Pesian: mother‐tongue; English: fluent; Grerman: intermediate 
Laboratory Skills 
 DNA and RNA isolation 
 DNA digestion and ligation 
 PCR, SOE PCR, cloning and standard recombinant DNA techniques 
 Bacterial, mammalian and plant transformation 
 Recombinant protein purification  
 Immunostaining, Western blotting, and Northern blotting 
 Laser scanning confocal microscopy (LSCM) 
 Mass spectrometry analysis 
 Activity assay in vitro 
 Activity based protein profiling approach (ABPP) 
Computer skills 
 Microsoft office, Adobe Photoshop CS5, Adobe Flash, Adobe Dreamweaver, primary knowledge  in 
bioinformatics tools including Chimera, PyMol, Clone Manager 9, and Vector NTI. 
Hobbys 
 Playing Basketball and Soccer; Playing Guitar and Piano, Reading 
10‐12 Jun, 2006 
13 ‐17 Nov, 2005 
12/2013‐01/2014 
